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ABSTRACT  
To elucidate the molecular mechanisms involved in persistency/latency of the 
H. pylori infection or in its progression towards serious diseases, it is 
necessary to analyse the host pathogen interaction in vivo. The circulating 
antibody repertoire represents an important source of diagnostic information, 
serving as biomarker to provide a “disease signature”.  
The aim of this work is the identification of H. pylori epitopes responsible for 
host immuno-response modulation through: a discovery-driven approach that 
couples “phage display” and deep sequencing (interactome-sequencing) and 
the development of a specific webtool for interactome-sequencing data 
analysis. 
We used this approach to identify novel antigens by screening gDNA libraries 
created from the pathogen’s genome, directly with sera from infected patients. 
Two genomic phage display libraries from 26695 and B128 H. pylori strains 
have been constructed by using ß-lactamase ORF selection vector. Genomic 
DNA was sonicated, fragments cloned into the filtering vector, after 
transformation libraries of 1x106 clones were obtained and sequenced by 
Illumina technology. More than 93% of Hp CDSs were represented in the 
phage genomic libraries therefore being representative of the whole H. pylori 
antigenic ORFeome. 
A webtool for interactome-sequencing data analysis was developed and used 
to identify the H. pylori antigens/epitopes which could be considered specific 
for infection progression towards three different pathological outcomes. 
Putative antigens were selected from libraries using sera from patients affected 
by: i) gastric adenocarcinoma; ii) autoimmune gastritis; iii) MALT lymphoma. 
The results, obtained thanks to the new interactome sequencing pipeline 
developed, show that the diversity of the libraries after selection is significantly 
reduced. Furthermore, individual ranks, for each infection condition, have been 
compared highlighting the pattern of putative antigens, shared by all the 
conditions, and some that can distinguish the different stages of infection. 
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One of this new antigens, that seems to be specific for infection progression 
towards more serious diseases, has been successfully validated through 
ELISA assay on a wide number of sera from patients. Other more specific 
antigens identified by our approach and by the application of the new data 
analysis pipeline here described are in validation. 
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SOMMARIO 
Per comprendere al meglio i meccanismi molecolari coinvolti nella 
persistenza/latenza dell'infezione da H. pylori o nella sua progressione verso 
patologie più gravi, è necessario analizzare l'interazione ospite patogeno in 
vivo. Il repertorio di anticorpi circolanti rappresenta un importante risorsa di 
informazioni diagnostiche, utili per la definizione di una "disease signature".   
Lo scopo di questo lavoro è l'identificazione degli epitopi di H. pylori 
responsabili per la modulazione della risposta immunitare attraverso un 
approccio guidato che accoppia la tecnologia del “phage display” e del 
sequenziamento ultra-massivo (interactome-sequencing) e lo svilippo di una 
specifica applicazione Web per l'analisi di questa tipologie di dati.  
Questo approccio è stato applicato per identificare nuovi antigeni attravero lo 
screening di librerie fagiche costruite a partire dal  DNA genomico di H. pylori 
direttamente con i sieri di pazienti affetti e con diversi outcome patologici. Sono 
state costruite due librerie fagiche genomiche dai ceppi H. pylori 26695 e B128 
utilizzando un vettore di selezione delle ORF che sfrutta come folding reporter 
la ß-lattamasi. Il DNA genomico è stato sonicato e i frammenti sono stati 
clonati nel un vettore di filtraggio utilizzato poi per la trasformazione di E. coli; 
sono state così ottenute librerie di 1x106 cloni e sequenziate con la tecnologia 
Illumina. Più del 93% delle sequenze codificanti (CDS)  di H. pylori sono 
rappresentate nelle librerie genomiche che posso quindi essere considerate 
rappresentative dell'intero ORFe-oma/Domain-oma antigenico del patogeno.  
Successivamente ho sviluppato un webtool per l'analisi dei dati provenienti da 
esperiemnti di interctome-sequencing e lo strumento di analisis sviluppato in 
questo lavoro di tesi è stato utilizzato nell'identificazione di antigeni di H. pylori 
specifici per le tre patologie prese in considerazione: i) adenocarcinoma 
gastrico ii) gastrite autoimmune iii)  linfoma MALT. . I risultati prodotti grazie al 
nuovo strumento di analisis sviluppato, dimostrano che la diversità delle 
librerie dopo la selezione è significativamente ridotta. Inoltre le liste ottenute 
per ognuna delle tre patologie sono state confrontate evidenziando un 
 V 
pannello di antigeni comuni e di antigeni specifici per i diversi outcome 
patologici. 
Uno degli antigeni identificati, che sembra essere specifico per la progressione 
dell’infezione verso patologie più gravi, è stato già validato con successo 
tramite saggi ELISA su un numero ampio di sieri di pazienti. Altri antigeni 
identificati con questo approccio e grazie alla nuova strategia di analisi da me 
sviluppata e qui descritta sono attualmente in fase di validazione. 
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1. INTRODUCTION 
 
1.1. Helicobacter pylori 
The pathogen, Helicobacter pylori is a gram-negative, neutralophilic organism, 
that colonizes half of the world’s human population. H. pylori was discovered in 
1984 by Barry Marshall and Robin Warren and for demonstrating its role in 
inducing gastritis, peptide ulcer formation and gastric cancer [1], they were 
awarded the Nobel Prize for medicine in 2005. This finding broke the dogma of 
the stomach as a sterile organ. In 1994 the International Agency for Research 
on Cancer classified H. pylori as a class I carcinogen [2]. H. pylori has evolved 
specific mechanisms to colonize and persist within the stomach in spite of the 
harsh acidic conditions encountered in this environment. Different genomic 
analysis has revealed symbiotic relationship between human host and H. 
pylori. Perturbation of this relationship leads to the dysregulation of this host-
pathogen interaction, resulting in the development of severe gastroduodenal 
disease, including adenocarcinoma, autoimmune gastritis and gastric MALT 
lymphoma [3]. H. pylori is an epsilonproteobacterium and a member of the 
Helicobacteraceae family [4]. Helicobacters are classified into two types 
according to their customary niche: gastric and enteric. The Helicobacter 
species adapted to humans is H. pylori and is a gastric Helicobacter.  
 
1.2. Epidemiology 
The World Health Organization (WHO) has estimated that close to half of the 
world’s population is positively infected with H. pylori. As human populations 
transmigrated across the world their endemic H. pylori strains diverged aboard  
them leading to phylogeographic differentiation of this infective agent that can 
be grouped into Amerindian, European,Asian and Africans subgroups. In 
various nonindustrial states, more than 81% of the population is positive 
affected by H. pylori, and infection occurs even among young people [5]. The 
H. pylori prevalence in developed countries is under 41% and is substantially 
higher in adults or in elderly individuals than young people [6]. In certain 
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geographical areas, the proportion of individuals affected bt H. pylori infection 
is reciprocally correlates with social and economic status, in particular there is 
a specific correlation to life conditions during prepuberty [7]. Meanwhile the 
prevalence of H. pylori infection in underdeveloped countries is relatively 
constant, in the industrialized countries is rapidly declining [8]. The causes of 
this decrease is due to the improvement of hygiene and sanitation via 
antimicrobial treatment [9]. 
 
1.3. Transmission  
The mechanisms of transmission whereby H. pylori is acquired are not well 
known. H. pylori infection is believed to occur as a effect of direct person-to-
person transmission, via either an oral-oral or fecal-oral route or both. H. pylori 
has been found in different biological specimens like saliva, feces, vomitus and 
also in gastric refluxate, but there is no clear evidence for prevalent 
transmission through any of these specimens [10,11]. Various reports have 
shown the contamination of H. pylori DNA in environmental water sources, but 
this is due to the contamination with dead H. pylori organisms [12]. An 
increased risk of infection was observed among hospitalized adolescent 
people during outbreaks of gastroenteritis [13]. Conjugated with the extreme 
sensitivity of the organism to atmospheric oxygen pressure, lack of nutrients, 
and temperatures outside the range of 34°C-40°C, direct human-to-human 
transmission is the most probable transmission route [14]. 
 
1.4. Genomic diversity and flexibility  
The H. pylori genome consists of 1.65 million bp and codes for about 1,500 
proteins and it has an average GC content of 38.9% [12]. H. pylori expresses 
an uncommon genetic variability that could potentially account for the 
bacterium’s ability to adapt within the host gastric stomach [13]. These 
adaptations comprehend both temporary and permanent changes to the 
genomic conformation such as regulatory mechanisms that modulate gene 
expression [14]. Analyses of numerous whole genome sequences indicate that 
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H. pylori has evolved clusters of genes within genomic islands that create 
distinct areas of variability, called “plasticity zones”. These plasticity zones are 
are prevalent and widely distributed among almost all H. pylori strains and are 
also implicated in lateral gene transfer, they allow fitness advantages to the 
organism by promoting genetic recombination events, which are involved in  
immune evasion and host colonization mechanisms [15]. Research recent  
published supports this hypothesis and indicates that genetic modifications 
occur ten times faster during host infection, when H. pylori is initially 
encountering the host’s immune response. A study published by Linz B. et al 
have shown that H. pylori mutation rates of genes encoding for outer 
membrane proteins (OMPs) are higher than any other bacteria tested [16]. 
Brodsky IE et al. have shown that OMPs are involeved in host-pathogen 
interaction and are targets for the adaptive immune response [17]. H. pylori 
mutating these exposed antigens promotes the chronicization of infection and 
the genes encoding OMPs under high selective pressure [18].                                                                                                                                                                                                                                                                                                                                                    
 
2. HELICOBACTER PYLORI ASSOCIATED DISEASES 
H. pylori typically is localized in the mucus away from the epithelial surface and 
does not directly adhere with gastric epithelial cells. Interaction of H. pylori with 
host cells activates many signaling pathways, the release of toxins or other 
signaling molecules [19]. In all subjects persistently colonized by H. pylori 
occurs a humoural immune response together with tissue infiltration by 
mononuclear and polymorphonuclear leukocytes [20]. The host inflammatory 
response is comparatively weak when compared with the response that occurs 
against others transient bacterial pathogens. As mentioned above, H. pylori 
persistently colonizes the human stomach for many years, causing alterations 
in the gastric niche and induces the host immune response, but its own 
peculiarity is to be a symbiotic organism usually and in many cases does not 
cause adverse effects [21]. What factors contribute to the stability of the H. 
pylori-host equilibrium? One important element is the presence of the 
bacterium within the gastric mucus layer, without any substantial adhesion of 
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host tissue. Another important element is the synthesis of H. pylori factors that 
are highly adapted to decrease the intensity of the host defense system [22].  
H. pylori lipopolysaccharide (LPS) is distinguished by modifications of the lipid 
A component that make it less proinflammatory than lipoglycans found in the 
outer membrane of other Gram-negative bacteria [23]. Although H. pylori 
typically colonizes the stomach for many years without specific symptoms, its 
presence is correlated with an increased risk of several pathological outcomes 
[24]. The risk of these outcomes is related to different factors like host genetic 
and environmental factors host responses and interactions between host and 
microbe. The progression steps from normal stomach to inflammation and 
precancerous conditions were described by Correa in 1992 [25]. In Correa's 
cascade, host responses and interactions between host and microbe modulate 
the transition from one step to next. The main gastric pathological outcomes 
related to H. pylori infection are (Figure 2):  
• Gastric adenocarcinoma (GA), which develops in gastric cancer 
in 1-3% of infected individuals; 
• Autoimmune gastritis (AIG), developed by the great majority of 
patients but that mostly remains asymptomatic; 
• Gastric mucosa-associated lymphoid tissue lymphoma (MALT 
lymphoma), which develops in 0.1% of infected subjects; 
 
2.1. Gastric adenocarcinoma 
Gastric adenocarcinoma (GA) is the second principal cause of cancer-related 
death worldwide and between the common cancer is the fourth, every year  
causes about 700,000 deaths. The incidence rates of GA is not uniform and 
varies depending on the country, with the highest rates found in Asia (mainly in 
the east), Central America, some regions of South America, and Eastern 
Europe [26] (Figure 1). 
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Figure 1 - Map  of  global  distribution  of  Incidence  from  gastric  cancer. Image reprinted by 
[26].  
 
As shown in Figure 2 GA is initiated by the transition from normal mucosa to 
chronic superficial gastritis; this is followed by the development of atrophic 
gastritis and metaplasia, finally leading to dysplasia and adenocarcinoma [27].  
GA affects male twice as frequently as female; it is thought that estrogen may 
confer some protection in women. Over the past century, the incidence rate of 
GA in developed countries is remarkably decreased [2]. This decline can 
primarily be attributed to a decline in intestinal-type adenocarcinomas in the 
distal stomach [26]. Currently, in the USA, distal GA is diagnosed most 
commonly in elderly people and occurs more often in African-Americans, 
Hispanic-Americans, and Native Americans than among other ethnicities. 
While the incidence of GA of the distal stomach has been declining, the 
incidence rates of proximal GA as well as those originating in the 
gastroesophageal junction have been increasing in both the United States and 
Europe [28]. 
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Figure 2 - Correa’s cascade proposed in 1992. Image reprinted from [25]  
 
2.1.1. Signs and symptoms 
It is usually difficult to diagnose GA at an early onset stage of because it often 
does not cause particular symptoms. When symptoms do occur, they may be 
not specific and these symptoms can also be caused by many other illnesses, 
such as a stomach virus or an ulcer. The signs and symptoms associated with 
GA are similar to other gastric disease and they include indigestion, discomfort 
in the abdomen, nausea and vomiting, diarrhea or constipation, loss of 
appetite, sensation of food getting stuck in the throat while eating, unexplained 
weight loss [29]. 
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2.1.2. Cause 
Besides H. pylori, the pathogenesis of GA is correlated with diet and cigarette 
smoking. High dietary salt intake was found to be associated with an increased 
risk of GA [30]. Two studies, from South Korea and Japan stated that H. pylori-
infected subjects taking high-salt diet had a greater risk of GA than subject 
who underwent a low-salt diet [31], even if the mechanisms that link a high-salt 
diet with the increase of GA development remains unclear. The risk of 
developing GA in H. pylori infected subjects is also associated with cigarette 
smoking. By several studies, it emerges that exists a relationship between H. 
pylori infection and sigarette smoking with enhanced risk of developing GA 
[32,33]. 
 
2.1.3. Pathophysiology 
The pathogenesis of H. pylori associated to GA is a multi-factorial and multi-
step process, and as mentioned in the previous chapter its development 
depends on a combination of host, bacterial and environmental factor as 
shown in Figure 3. Many studies focused on the effects of H. pylori infection on 
the host epithelium. The gastric epithelium has the function to protect the 
underlying tissue and has also the responsibility for digestive processes. H. 
pylori has developed sophisticated mechanisms to avoid host defence and to 
adapt to the immune system response in order to colonize the gastric niche, 
such, for example, disruption of epithelial junctions, stimulation of cytokine 
production, overproliferation, DNA damage, apoptosis and DNA transformation 
[34,35]. H. pylori disrupts intercellular apical junctions, these are critical in 
keeping the integrity of mucus layer, furthermore these intercellular junctions 
are indispensable for cellular functions because through the binding to specific 
cellular receptors they stimulate the signaling pathways [36]. The H. pylori 
virulence factor CagA is translocated into epithelial cells through the Type IV 
secretion system (T4SS) and interacts with membrane proteins like E-cadherin 
and ZO-1 and disrupts the tight of adherence junctions. It has been confirmed 
that E-cadherin interacts with β-catenin, a component of a cell adhesion 
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complex [37]. The complex E-cadherin/β-catenin play pivotal role in 
maintaining epithelial integrity and in the stabilization of cellular architecture 
[34,38]. During H. pylori infection, the structure of this complex is destabilized 
by the virulence factor CagA in a phosphorylation independent manner [39]. 
The evidences support that also the virulence factor VacA interacts with 
epithelial cells inducing autophagy [40]. Other studies demonstrated that to 
facilitate the intracellular survival and for promoting the carcinogenesis H. 
pylori suppress autophagy [41]. Saberi S. et al have shown that the fast 
turnover of epithelial cells is an important element to protect the gastric 
epithelium from infection, but  H. pylori blocks this turnover inducing apoptosis 
in order to favour its survival [37]. A deleterious consequence of apoptosis 
iduction is an imbalance in normal gastric mucosal homeostasis leading to 
dysregulated tissue growth [42].  The mechanism behind this process is not 
clear, enzymes such as urease and virulence factors such as VacA lead to 
cellular apoptosis by damaging the gastric epithelium and activating the 
immune response [43]. The high level of free radicals generated by neutrophils 
and cytokines like IFN-γ in inflammatory response can damage DNA and 
stimulate apoptosis of gastric epithelial cells. Proinflammatory cytokines 
including IL-8, IL-6, MCP-1, TNF-α, MIF, IL-1α, TGF-β and IL-1β are secreted 
by epithelial cells and these play a fundamental role in pathogenesis of GA 
[44]. Another important aspect involved in pathogenesis of GA is the 
polymorphisms of cytokine genes. As reported by Amieva et al. the risk of GA 
in many populations was affected by the polymorphism of the genes encoding 
IL-1β, TNFα, IL-8, IL-17 and IL-10 [45]. These polymorphisms are important in 
gastric carcinogenesis because they affect the oxidative stress process and 
DNA mutagenesis, this phenomenon could also explain the occurrence of GA 
only in a small proportion of H. pylori-infected individuals [46].   
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Figure 3 - Role of H. pylori in the gastric carcinogenesis. Host genetics, environmental factors, 
and bacterial strain differences in virulence properties contribute to disease progression and 
increased risk of negative outcomes. Image reprinted from [36] 
 
2.1.4. Diagnosis  
The diagnosis of GA is based on endoscopy and biopsy. Endoscopic 
ultrasonography and computed tomography (CT) of the chest and abdomen 
are currently the primary means of staging for the diagnostic of gastric cancer. 
Endoscopic ultrasonography and computed tomography are uncomfortable, 
painful and expensive, emphasizing the need for rapid and non-invasive tests 
for screening and monitoring the patients with dyspeptic symptoms. Recently 
has been developed a panel which combines a serum pepsinogen-I (PGI) and 
-II (PGII), gastrin-17 (G-17) and HP IgG antibodies (IgG-HP) [47,48]. These 
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biomarkers were tested in a cohort of 91 patients revealing a low sensitivity 
and specificity, for these reasons gastroscopic exams and CT remain the most 
commonly prescribed diagnostic test. 
 
2.2. Autoimmune Gastritis 
Autoimmune gastritis (AIG) is a chronic inflammation of the stomach caused by 
an indirect action of the H. pylori on the immune system. The term AIG 
includes a variety of definitions such as atrophic body gastritis and pernicious 
anemia [49].  
 
2.2.1. Signs and symptoms 
Patients with AIG are asymptomatic for many years, until parietal cell mass 
reduced capacity to secrete HCL acid causing hypochlorhydria or achlorhydria. 
Abnormal gastrin production (hypergastrinemia) occurs in achlorhydric 
patients, the clinical features of AIG are largely due to the pernicious anemia, 
weight loss occurs in about 50% of patients and AIG are occasionally 
associated also with sore tongue and neurological problems including 
numbness, weakness, and ataxia. Patients with AIG may have other 
autoimmune diseases such as Graves’ disease, a condition in which the 
thyroid gland produces excessive hormones and idiopathic adrenocortical 
insufficiency [49]. 
 
2.2.2. Cause 
H. pylori is the main aetiologic factor for AIG, the degree of mucosal 
inflammation results from the interplay of H. pylori virulence factor, genetic host 
susceptibility and environmental factors. AIG associated with H. pylori infection 
is limited to the antrum of the stomach (Type B gastritis). Other causes are the 
excessive and long term assumption of Nonsteroidal anti-inflammatory drug 
(NSAID); less common causes include alcohol, cocaine and Crohn disease 
[50]. 
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2.2.3. Pathophysiology 
AIG is an immune-based, non-infectious inflammation of the stomach, as a 
result of molecular mimicry between H. pylori antigens and H+/K+-ATPase. 
The hypothesis is based on the observation that H. pylori-infected patients with 
AIG harbour gastric CD4+ T-cells that recognize cross-reactive epitopes in 
common between gastric H+/K+-ATPase and H. pylori proteins. Cross-reaction 
antigens shared by H. pylori induce T-cell proliferation, production of Th1 
cytokine and H+/K+-ATPase antibodies were identified in about 22-30% of H. 
pylori infected patients [51]. The clones deriving from T-cell proliferation 
reacted to epitopes different to the proton pump alone. Consequently, this 
autoimmune response induces the destruction of parietal cells and dysfunction 
of the oxyntic gastric mucosa  [50]. 
 
2.2.4. Diagnosis 
Despite the significant progress in the understanding of pathogenesis of 
chronic inflammation in AIG, diagnosis is based on histology and detection of 
the presence of Parietal Cell Antibody (PCA). Literature data on association of 
AIG with PCA is weak; in a clinical study of 2012 on a cohort of 108 patients 
with AIG 82% were positive for PCA while in a similara study a cohort of 140 
patients with AIG 75% had PCA, which correlated positively with the grade of 
atrophy [50]. Histology coupled with endoscopy can provide a unequivocal 
diagnosis of AIG. Through endoscopy multiple gastric biopsy sampling is 
performed, diagnosis of AIG requires a minimum of 4 biopsies from antrum 
and corpus of stomach [48]. 
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2.3. Gastric mucosa-associated lymphoid tissue lymphoma (MALT 
lymphoma) 
Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid 
tissue (MALT lymphoma) is the third most common subtype of non-Hodgkin's 
lymphoma [52]. The microbial pathogens that underlie such chronic 
inflammatory diseases, also play a pivotal role in both malignant transformation 
and successive clonal expansion of the transformed clone. This is well 
exemplified by the causative role of H. pylori infection in the development of 
gastric MALT lymphoma, the definition of this causative relationship led to 
successful innovative treatment of lymphoma with antibiotics [53].     
 
2.3.1. Signs and symptoms 
Gastric MALT lymphoma is an indolent disease and the clinical presentation is 
poorly specific. Symptoms ranging from fatigue, low-grade fever and nausea to 
alarm symptoms such as gastrointestinal bleeding or persistent vomiting [54]. 
Others symptoms like weight loss or night sweats are extremely rare in 
stomach MALT lymphoma. A systematic review published in 2010 including 
data of 2000 patients found that gastric MALT lymphoma occurs in a wide age 
range of patients and sex ratio incidence is essentially equal, and only in 42% 
of patients alarm symptoms were present [55].       
 
2.3.2. Cause  
Different infections have been involved in the progression of gastric MALT 
lymphoma. There is a clear correspondence between gastric H. pylori infection 
and MALT lymphoma diagnosed in the stomach (90% of cases) [56]. In fact, 
eradication of H. pylori leads to the disappearance of intratumoral H. pylori 
specific T-cells and thus to the removal of the growth support of neoplastic B-
cells inducing the regression of lymphoma [57]. More or less, 5-10% of gastric 
MALT lymphomas are negative for H. pylori and can be associated to 
H.heilmannii infection [58].   
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2.3.3. Pathophysiology 
The importance of H. pylori in the pathogenesis of gastric MALT lymphoma are 
confirmed by direct evidence obtained from in vitro studies. These studies 
show that lymphoma growth is stimulated in culture when exposed to the 
bacterium, through tumour-infiltrating lymphocytes (TILs) involving two 
costimulatory molecules: CD40 and CD40L. The infiltrated B cells are activated 
by T-cells specifically recognising H. pylori and undergo towards malignant 
transformation due to the acquisition of genetic abnormalities [59]. Epithelial 
cells are activated by chronic infectious stimuli, expressing on their surface 
high levels of HLA-DR (Human Leukocyte Antigen - antigen D Related) and 
costimulatory molecules, including CD80. Epithelial cells present antigens 
along with HLA molecules to T cells,  CD40 ligand molecules expressed on the 
activated T cells can react with the CD40 molecule on B cells, consequently 
the expression of B cell CD80 is upregulated. CD80 is a protein found on 
activated B cells that provides a costimulatory signal necessary for T cell 
activation by binding CD28 [60]. Activated CD4 T-cells together with the action 
of various cytokines and chemokines can stimulate B-cells through CD40L-
CD40 interaction. Activated epithelial cells, T cells and B cells allow to survive 
cooperatively in lymphoepithelial lesions (LELs), that are thought to be at the 
origin of lymphomas [61]. 
 
2.3.4. Diagnosis 
Gastric MALT lymphoma associated with H. pylori infection presenting 
nonspecific symptoms, for this reason diagnosis is based on invasive approach 
and requires endoscopic biopsy [62]. Recent advancement in endoscopic 
techniques allow an accurate diagnosis in 91% of case [63]. Endoscopic 
biopsy appearances of MALT lymphoma are an atypical lymphoid infiltrate, 
lymphoepithelial lesions and moderate cytological atypia of lymphoid cells. 
Many biopsy specimens lack some of these characteristics [64]. In 1993, Dr 
A.C Wotherspoon proposed a useful scoring system, shown in the Table 1, 
currently in use, to better defining and differentiating the gastric lymphoid 
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infiltrates [65]. The diagnosis should also consider H. pylori infection, for this 
reason final diagnosis should include histology, rapid urease testing, urea 
breath testing, stool antigen testing, or serologic studies [66]. 
 
 
Score Diagnosis Histological features 
0 Normal Scattered plasma cells in lamina propria. No lymphoid follicles 
1 Chronic active gastritis 
Small clusters lymphocites in lamina propria. No lymphoid follicles. No 
lymphoepithelial lesions. 
2 
Chronic active gastritis with florid 
lymphoid follicle formation 
Prominent lymphoid follicles with a surrounding manntle zone and plasma cells. 
No lymphoepithelial lesions. 
3 
Suspicious lymphoid  infiltrate, 
probably reactive 
Lymphoid follicles surrounded by small lymphocytes that infiltrate diffusely in 
lamina propria and occasionally into the epithelium 
4 
Suspicious lymphoid  infiltrate, 
probably lymphoma 
Lymphoid follicles surrounded by marginal-zone cells that infiltrate diffusely in 
lamina propria and into the epithelium in small groups 
5 MALT lymphoma 
Presence of dense diffuse infiltrate of marginal-zone cells in lamina propria with 
prominent lymphoepithelial lesions. 
 
Table 1 - Histological criteria established by Wotherspoon. Table reprinted by [65].  
 
3. MOLECULAR MECHANISM OF H. PYLORI INFECTION AND 
PATHOGENESIS  
To promote chronic infection H. pylori has evolved a variety of mechanisms to 
survive in the acidic environment of gastric mucosa.  To neutralize the hostile 
acid condition at beginning of infection H. pylori has developed an “acid 
acclimation mechanism” that promotes adjustment of periplasmic pH in the 
stomach by regulating activity of urease and carbonic anhydrase [67]. Once 
the bacterium has created a favourable environment in term of pH, the next 
step is the mobility through the protective layer of gastric mucus in the host 
stomach. Motility of H. pylori depends on the presence of up to 6 functional 
unipolar flagella [68]. H. pylori regulates cell motility by responding chemotactic 
cues: it has been demonstrated that the operon Tlp A B C D, and in particular 
TlpD is necessary for bacterial persistence in the murine stomach and growing 
in the infected and inflamed antrum [69]. Flagella-mediated motility is followed 
by specific interactions between bacterial adhesins with host cell receptors, 
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which thus leads to successful colonization and persistent infection [70]. 
Finally, H. pylori releases several effector proteins/toxins causing host tissue 
damage.   
The molecular mechanism by which H. pylori causes disease in humans can 
be described as a multi-step process. In summary, four steps are critical for H. 
pylori colonization and pathogenesis (Figure 4):  
• Survival under acid stomach conditions; 
• Movement toward epithelium cells through flagella-mediated motility; 
• Attaching to host receptors by adhesins; 
• Causing tissue damage by toxin release; 
 
 
Figure 4 - Schematic representation of H. pylori infection and pathogenesis mechanism. Image 
reprinted from [71].   
 
3.1. Urease and survival under acidic stomach conditions  
H. pylori has adapted an original mechanisms to colonize and persist within the 
gastric environment, for acid resistance the organism uses urea to produce 
ammonia through the metalloenzyme urease, that catalyzes the conversion of 
urea into ammonia and CO2 .The NH3 produced by this reaction increases the 
local pH surrounding the bacterium thus allowing its survival in the hazardous 
acidic environment of the human stomach [72] 
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The constitutive production of the urease accounts up to 10% of the proteins 
synthesized by the organism at pH 7.0. In several bacterial species ureases 
are entirely cytoplasmic, instead H. pylori urease is found both inside the 
cytoplasmic and outside adhering to the surface of the organism. For many 
years it has been believed that external urease provides the acid resistance of 
H. pylori but there is no evidence supporting this hypothesis, furthermore the 
extreme acidity encountered in the stomach irreversibly inactivates this 
enzyme [22]. 
Instead urease localized in cytoplasmic protects the organism by producing 
uncharged ammonia inside this compartment, after synthesis ammonia is 
carried out to periplasmic space where it can bind protons raising the 
periplasmic pH and preventing a high concentration of protons from migrating 
into the cytoplasm and at the same time avoiding the pH decreasing to toxic 
levels [66]. The massive ammonia synthesis by urease activity constitutes the 
principal protection against proton overload, acid acclimation depends both on 
urea degradation and ammonia synthesis but also on urea uptake across the 
bacterial inner membrane [73]. Urea is transported from the periplasmic space 
into the cytoplasm where it is hydrolysed by urease for the production of 
ammonia through the channel transporter UreI [74]. The control of the 
periplasmic pH on acid exposure is unique to H. pylori, and make H. pylori 
colonization durable and persistent [75]. 
 
3.2 Bacterial motility toward epithelium cells 
Flagella-mediated motility is essential for the H. pylori colonization of gastric 
mucosa, flagella can be considered as an early stage colonization/virulence 
factor [70]. H. pylori flagellum is mainly composed of the basal body hook and 
flagellar filament, that consists of two flagellins (FlaA and FlaB) [76]. The hook 
is composed of FlgE, and it links the basal body and flagellar filament. The 
basal body is composed of several structures, and it plays a role in providing 
the energy source for motility [77]. Several study have indicated flaA and flaB 
as necessary genes for the complete motility of H. pylori [76]. Recently, the 
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role of flagellins in bacterial adherence to mammalian hosts has been 
demonstrated by constructing flagellins (flaA and flaB) and flagellar regulator 
(fibA) mutants and it was shown that all mutants are still able to adher to 
gastric cells, supporting the hypothesis that flagella do not play a direct role in 
adhesion of H. pylori. Although a lower adhesion rate in a flbA mutant 
suggested that in addition to regulating flagella, FlaA may regulate some H. 
pylori adhesins [76] (Figure 5). 
 
 
Figure 5- Schematic model of the flagellar transcriptional regulatory cascade for H. pylori 
flagellar biosynthesis. Image reprinted by [71].  
 
3.3. Adhesins  
Adhesins are a large group of bacterial cell-surface proteins that enable a 
strong interaction with epithelial cells. The adherence of pathogens to mucosal 
epithelial cells is considered to be the first important step in pathogenesis 
onset in the stomach. Bacterial adherence to the gastric mucosa is crucially 
important for protection from acidic pH, mucus, and exfoliation [78].  
H. pylori adhesins are involved in numerous processes during early and 
chronic phases of infection. They also contribute to the differential outcome in 
infected patients by triggering disease development [79]. H. pylori adhesive 
factors belong to the largest outer membrane protein (OMP) family of the 
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bacterium, namely, the Hop family [80]. The Hop family contains the most well-
known adhesins of H. pylori like BabA, BabB, SabA. Additionally, there are 
other proteins, such as NAP and Hsp, which have been implicated in cell 
adhesion and mediate the tropism of H. pylori to the gastric tissue [81].  
 
3.3.1. Blood group binding adhesin (BabA and BabB) 
Three H. pylori bab allelic types have been identified, including babA1, babA2 
and babB. The molecular mass of the BabA protein is nearly 78 kDa, encoded 
by babA2. The babA1 and babA2 coding sequences are highly similar, but the 
translational starting codon is lacking in babA1 [71]. H. pylori employees BabA 
to bind to fucosylated Lewis B blood-group antigen (Leb) expressed on host 
gastric epithelium cells, when H. pylori initially infects the human stomach [82]. 
BabA and BabB are nearly identical in their 5′ and 3′ regions, with most of their 
sequence divergence being in their mid-regions. Importantly, the middle region 
of the BabA sequence determines the adhesion ability of BabA. The function of 
BabB is still unclear, but the expression of BabB was associated with 
increased gastric histologic lesions in patients [72]. To study the dynamics of 
Leb adherence during infection paired H. pylori isolates obtained sequentially 
from chronically infected patients were analysed [73]. The results showed that 
a complete loss or significant reduction of Leb binding was observed in strains 
from 5 out of 23 individuals, indicating that the BabA-Leb binding phenotype is 
quite stable during chronic human infection. Sequence comparisons revealed 
that most amino acid changes were found in the putative N-terminal 
extracellular adhesion domain [73]. This recombination mediates dynamic 
changes in adherence properties, which suggests that it contributes to the 
persistence and adaption of H. pylori in ever-changing gastric environments. 
 
3.3.2. Sialic acid-binding adhesin (SabA) 
SabA binds to sialylated structures such as the sialyl-Lewis X/A (sLex/a) 
antigens also found on mucins and epithelial cells [74]. This suggests that 
SabA adhesin plays a critical role to assist H. pylori to adhere to and colonize 
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the gastric epithelium cells of  patients with gastritis [75]. Especially when 
lacking gastric Leb expression, Lex and Lea were closely related to H. pylori 
colonization. The sabB gene is homologous to sabA, but appears not to be 
involved in sLex binding. Therefore, the function of sabB in bacterial adhesion 
and pathogenesis is worth investigating. SabA is transcriptionally repressed by 
the acid sensitive ArsRS regulonand is therefore down regulated during acidic 
conditions [76]. In addition to this direct regulation by transcription factors, 
expression of the sabA gene is regulated through slipped strand mispairing 
through length variation in the poly(T) repeat tract that lies upstream of the 
promoter element of sabA (Berg et al., 2014). Additionally, the gene contains 
cysteine-thymidine (CT) repeats in the 5’ part of the coding sequence, causing 
on/off phase variation. These dynamic adaptations may allow H. pylori to 
specialise for individual host variation in mucosal glycoprotein sialylation during 
persistent infection. Recently, the crystal structure of the extracellular parts of 
the SabA protein was resolved. The structure is dominated by alpha helices 
and resembles a club with a handle and a head. The head part contains the 
ligand-binding cavity, which is constrained by two highly conserved disulphide 
bridges. One of these pairs of conserved cysteines is also present in BabA, but 
the major part of the ligand-binding region is not homologous between the two 
proteins [78]. 
 
3.3.3. Neutrophil activating protein (NAP)  
Neutrophil activating protein (NAP or HP-NAP) was first identified to stimulate 
high production of oxygen radicals from neutrophils, leading to damage of local 
tissues, and promote neutrophil adhesion to endothelial cells during H. pylori 
infection [83]. NAP upregulates the expression of β2 integrins in neutrophils 
and monocytes [80],  and also is highly associated with the hallmark of chronic 
gastritis, and infiltration of neutrophils and mononuclear cells into the gastric 
mucosal barrier, caused by H. pylori infection. The glycosphingolipids 
expressed on the neutrophil surface serve as a major receptor to interact with 
the NAP expressed on bacterial surface [81]. Moreover, NAP is supposed to 
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facilitate SabA-mediated binding of sialyl-Lewis antigens on the membrane of 
the host cell [82]. To study H. pylori colonization in vivo Wang et al. [83] 
infected mice with both H. pylori napA mutant strain and wild-type strain, 
compare to the mice infected with wild-type strain the degree of survival was 
lower than the mice infected with napA mutant. However, for pathological 
outcomes related to H. pylori infection only one report showed that in sera from 
patients with GA the level of NAP-specific Ab was remarkably higher than that 
from infected patients with AIG [84]. No other studies have shown the direct 
involvement of NAP with gastric inflammation among patients H. pylori 
positive. 
 
3.3.4. Heat shock protein 60 (Hsp) 
Heat shock proteins (Hsp) are a highly conserved protein family found in 
prokaryotes and  eukaryotes. Hsp are induced by several factors like a variety 
temperature, pH change, ischemia, and microbial infection [84]. H. pylori 
produces mainly two heat shock proteins, GroES-like HspA (Hsp10), and 
GroEL-like HspB (Hsp60). The high expression of Hsp60 at low pH, which 
interacts with the receptor-like sulfatide (sulfoglycolipid), indicates that the acid 
stress may change the specificity of H. pylori to receptors [85]. Hsp60 induces 
activation of NF-κB via TLR2 and the mitogen-activated protein kinase 
pathway, and thereby induces human monocytes to secrete IL-8 [86]. 
Moreover, anti-Hsp60 antibodies are consistently detected in H. pylori-infected 
patients, and these antibodies are associated with the progression of gastritis 
or gastric cancer [85]. 
 
3.3.5. Other adhesins 
There are several others know adhesins used by H. pylori to adapt to different 
hosts/tissues, including AlpA, AlpB, HopZ, OipA and HopQ, all of them belong 
to the major Hop family of OMPs. The adherence-associated lipoproteins AlpA 
(HopC) and AlpB (HopB) are highly related and can be found in basically all H. 
pylori isolates. They are transcribed from the same operon, and their loss 
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impairs bacterial binding to the apical side of human gastric tissue sections, 
and in animal models. Unlike other OMPs, they are not subjected to phase 
variation but are expressed in virtually all clinical isolates [87]. The ligand of 
AlpA and AlpB has not yet been determined, although extracellular matrix 
laminins have been proposed as possible candidates, and the understanding 
of their role in human infection is still incomplete. The outer inflammatory 
protein A OipA (HopH) has been proposed to amplify IL-8 secretion and 
activate β-catenin, in parallel to cagPAI. OipA is phase-variable and can be 
switched “on” and “off” by slipped strand mispairing during chromosomal 
replication [88]. OipA expression status is associated with the presence of 
cagPAI and VacA s1m1 alleles in western isolates, and it has therefore been 
difficult to assess the separate influence of OipA on clinical manifestations [19]. 
Like AlpA/AlpB, the host surface receptor/interaction partner of OipA has not 
yet been identified. Other Hop proteins that have been implicated in adhesion 
are HopZ and HopQ. HopZ has been shown to be involved in the early phase 
of colonisation and is regulated by phase variation of CT repeats in the region 
encoding for the signal sequence. HopQ has also been implicated in binding to 
epithelial cells, but the binding partner has not yet been identified [89]. 
 
3.4. Virulence factors 
Several Helicobacter pylori genes have been shown to modulate virulence of 
bacterial isolates. H. pylori yields various virulence factors that may 
dysregulate host intracellular signaling pathways and decrease the threshold 
for neoplastic transformation. Among all the virulence factors, cagA (cytotoxin-
associated gene A) and its pathogenicity island (cag PAI) vacA (vacuolating 
cytotoxin A) are the most relevant. 
 
3.4.1.  cag Pathogenicity Island (CagPAI) and CagA 
Cag pathogenicity island (cagPAI) is a genetic element of exogenous origin 
that has been inserted by horizontal transfer into the glutamate racemase gene 
and is made up of 27-31 genes, with a total size of approximately 37 kb [90]
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These genes encode structural components of a type four secretion system 
(T4SS) and an effector protein, the cytotoxicity associated virulence factor 
CagA. The T4SS pilus is used to inject CagA into the host cells, where it 
interferes with a series of host proteins and signalling pathways. The presence 
of this pathogenicity island highly varies between different strains: almost all 
East Asian isolates but only approximately 60-70% of Western isolates are 
cagPAI positive [91]. The actions of CagA can be divided into phosphorylation 
dependent inside the host cell, and phosphorylation-independent. The crucial 
region for CagA phosphorylation is represented by EPIYA (glutamic acid-
proline-isoleucine-tyrosine-alanine) motifs in the C-terminal region. The 
tyrosines of these motifs can be phosphorylated by host Src-family kinases, 
and show a variability that has been linked to strain virulence and geographical 
origin [90]. On the basis of sequences flanking the EPIYA motifs, 4 different 
segments, termed EPIYA-A, -B, -C and -D, have been described (Figure 6).  
 
 
 
Figure 6 - Schematic Representation of the Western type CagA and the East Asian type CagA. 
Image reprinted by [92].  
 
Most CagA positive strains have the A and B segments, while EPIYA-C is 
characteristic only of European strains and it is thus termed Western CagA. 
EPIYA-D is specific of East Asian strains CagA and consequently it is known 
as East Asian CagA. The East Asian CagA has been shown to have more 
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oncogenic potential than Western CagA, but Western CagA can also vary in 
the number of C regions, where more repeats are correlated to greater 
oncogenic potential. The effects of CagA on host cells include dysregulation of 
cell-cell adhesion and loss of polarisation in the epithelial cell, cellular 
elongation that resembles epithelial to mesenchymal transition (EMT), and the 
activation of the Ras-Erk cascade. The latter increases interleukin 8 (IL-8) 
release and the activation of NFκB, which leads to an increase in tumour 
necrosis factor alpha (TNF-α) and cyclooxygenase 2 (COX-2) pathway, among 
other effects [27]. Within the cell, phosphorylated CagA activates the SHP-2 
phosphatase and the MAPK-ERK signalling cascade, causing effects 
resembling those induced by growth factor signalling. Reported 
phosphorylation-independent effects include the interaction with E-cadherin, 
the c-met receptor, and phospholipase C, which disrupts cell-cell junctions and 
induces loss of cell polarity, and pro-inflammatory and mitogenic effects [19].  
 
3.4.2. The vacuolating cytotoxin A (VacA) 
Along with CagA, the vacuolating cytotoxin (VacA) is the best-studied virulence 
factor. VacA is a toxin that forms hexameric, anion-selective pores through 
lipid bilayers such as the cytoplasmic and organelle membranes and, as the 
name implies, induces vacuolisation in the host epithelial cells [92]. There is 
significant variation among strains in their capacity to induce cell vacuolization 
[93]. This variation is attributed to the genetic structural diversity of the vacA 
gene that can assume different polymorphic rearrangements (Figure 7) [94].  
 
Figure 7 - Schematic representation of H. pylori vacA gene showing the s-, i-, d- and m-
polymorphic regions. Image reprinted from [92].  
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The initial studies on vacA detected two main polymorphic regions, the signal 
(s)- and the middle (m)- regions. The s-region encodes a different signal 
peptide and assumes two forms, s1 or s2, s1 form is active while s2 form 
encodes a different signal peptide cleavage site which results in a short N-
terminal part that display attenuated vacuolating activity. The m-region 
encodes the VacA binding site to host cells, and like s-region it can have two 
isoforms: the m1 and the m2 forms; m1 is the more effective of the two [92]. 
More recently, new regions of variations were found in vacA, the intermediate 
(i)- and deletion (d)-regions [92]. Like signal (s)- and middle (m)- regions they 
have two main polymorphic forms (i1,i2 and d1,d2) [92]. the mosaic 
combination of these forms discriminate among H.pylori strains vacuolating 
and strains non-vacuolating,  for example the s2 type of VacA has been shown 
to be virtually nontoxic [95], while strains with the s1/m1/i1 genotype have 
been shown to be associated with a higher risk of advanced disease and are 
found in patients with higher gastric cancer risk. However, this genotype 
commonly coincides with cagA positivity, making the distinct contribution of the 
two virulence factors in these strains hard to be evaluated [92]. VacA can be 
transferred to host epithelial cells either by secretion or by contact-dependent 
transfer and is cleaved during its transport through the bacterial outer 
membrane [92]. The precise mechanism of VacA secretion and entry to the 
host cell is still controversial but both epithelial derived growth factor receptor 
(EGFR), the receptor tyrosine phosphatase alpha and beta (RPTPa/RPTBb), 
and sphingomyelin in lipid rafts have been shown to act as interaction partners 
[87]. Apart from its capacity to induce vacuolisation by forming pores in 
endosomes, VacA can also induce apoptosis in epithelial cells and 
lymphocytes by interfering with membrane trafficking, leading to loss of 
mitochondrial membrane potential, mitochondrial instability and the 
subsequent release of cytochrome C [96]. VacA interacts with epithelial cells 
as well as with immune cells, including B- cells, T-cells and phagocytes. In 
phagocytes, VacA can inhibit processing and presentation of antigen peptides 
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to T-cells; however, VacA can also interfere with T-cell function directly by 
blocking antigen-dependent proliferation or by inhibiting the activation of 
nuclear factor of activated T-cells (NFAT) [69]. 
 
3.4.3. Other virulence factors 
Aside from VacA and the Cag pathogenicity island, several other factors have 
been proven to play a role in the virulence and severity of H. pylori infection. 
High temperature requirement A (HtrA) is a serine protease that is well 
conserved in gram-negative bacteria and has been described to increase the 
viability of the organism under stressful conditions. H. pylori HtrA is secreted 
into the extracellular space in its active form where it can cleave E-cadherin, a 
tumour suppressor commonly lost in several cancer settings, that is involved in 
cell-cell adhesion [94]. The extent to which the cleavage of E- cadherin affects 
E-cadherin signalling and function is not yet known, but this cleavage has also 
been shown to allow for bacterial entry into the intercellular space by disrupting 
the adherence junctions [72]. Gamma-glutamyl transpeptidase (GGT) is a 
virulence factor that has gained increased attention in recent years. GGT is an 
enzyme that converts glutamine into glutamate and ammonia, and glutathione 
into glutamate and cysteinylglycine. This has been shown to lead to glutamine 
and glutathione consumption in the host cells, which interferes with the 
oxidative capacity of the cell, resulting in the production of ammonia and ROS. 
These products affect many central cell functions, inducing cell-cycle arrest, 
apoptosis, and necrosis in gastric epithelial cells. GGT can also induce 
immune tolerance by influencing dendritic cell differentiation and inhibition of T 
cell-mediated immunity, affecting the efficiency of the immune response 
towards H. pylori [97]. Duodenal ulcer promoting gene A (DupA) is another 
virulence factor that was identified based on its positive relationship to 
duodenal ulcer and inverse relationship to gastric cancer [98]. DupA has been 
suggested to form a Type IV secretion systems (T4SS) with vir genes that 
make up the dupA gene cluster. The presence of a complete dupA cluster was 
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found to significantly increase the risk of duodenal ulcer compared to H. pylori 
infection with an incomplete dupA cluster or without the dupA gene [99].  
 
3.6. Diagnosis of H. pylori infection 
A number of tests with varying accuracy and sensitivity have been developed 
to diagnose H.pylori infection. These tests could be separated into invasive 
and non-invasive approaches depending on whether an endoscopy is needed. 
The choice of the test depends on factors such as age, clinical situations, 
availability, cost and prevalence of infection in the population. The numerous 
tests used to diagnose H. pylori infection in adults may also be used in children 
but some non-invasive tests like urea breath test (UBT) and serology have 
limitations because at age below 6 years, the UBT can lead to nonspecific 
results, and serology may not be enough sensitive [100]. Non-invasive tests 
can identify H. pylori in a sample, but do not reveal the amount of tissue 
damage, on the contrary invasive approaches not only diagnoses the amount 
of damage in the stomach but also allows the clinician to directly sample the 
tissue to test it for the presence of  H. pylori infection [101].  
 
3.6.1. Invasive tests  
Invasive procedures available for detection of H. pylori are endoscopy, 
histology, culture, rapid urease test (RUT) and polymerase chain reaction 
(PCR) [102]. The procedures are rather expensive and laborious and scarcely  
applicable to wide samplesets. Histopathology staining remains one of the best 
methods for detecting H. pylori infection and together with endoscopy, it 
provides important information on the pathological condition of the stomach. 
Endoscopy is expensive, unpleasant for the patients and requires highly 
specialized operator to be used as a routine diagnostic test. Bacterial culture is 
the gold standard for diagnosis of H. pylori infection, because at the same time 
it is possible to test the antibiotic susceptibility [101]. The clinical application of 
bacterial culture is limited because H. pylori is difficult to cultivate on culture 
media, costly, and compared to other methods time consuming, for this reason 
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the use of this procedure is limited to research and epidemiologic purpose 
[103]. Measuring urease production from biopsy specimen can be 
accomplished by rapid urease test (RUT). A small biopsy sample is placed in a 
vial containing the urease test solution and incubated overnight, the sample is 
observed for a change in a color, pink indicates positive result. This test has 
the advantages of being more rapid than histology or culture, and has a high 
sensitivity, but false negative urease tests may occur if patient has taken 
antibiotics or compounds containing bismuth [102]. Molecular methods like 
PCR have been used successfully to detect H. pylori DNA in gastric tissues by 
amplifying genes such us urease gene, adhesion genes and 16S rRNA gene. 
The 16S rRNA is one of the specific targets for PCR diagnosis of H. pylori 
infection [104]. Urease is another specific gene for detecting H. pylori infection 
and positive amplification can be considered as a direct evidence of the 
presence of the pathogen [105]. The disadvantages of PCR as a routine test 
are that it is a technically demanding and expensive test compared to culture 
and the rapid urease tests, and it requires special laboratory conditions. The 
technique is highly sensitive, but it is subject to false-positive results due to 
possible environmental contamination. A positive result obtained by PCR does 
not indicate active infection but could also detect the presence of DNA of dead 
bacteria. 
 
3.6.2. Non-invasive tests  
Non-invasive procedures available for detection of H. pylori are urea breath 
test, fecal antigen test and serological tests. The first two are considered active 
tests because can detect the presence of H. pylori and provide an evidence of 
an active infection, while serological tests are considered passive tests 
because provide the evidence of exposure to H. pylori and are usually not 
indicated in cases of eradication [106]. These tests are based on the detection 
of antibodies to H. pylori. The urea breath test is the preferred non invasive 
choice for H. pylori diagnosis before and after treatment. This test exploits the 
fact that H. pylori metabolizes urease (see above), so for this test patients 
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ingest a small amount of urea that is radioactively labeled (13C), bacterial 
urease split off radio-labeled carbon dioxide, which is detect in the breath. In 
patients not infected by H. pylori radio-labeled carbon dioxide will not be 
detected in their breath and the urea ingested will be completely eliminated 
within urine. This test is considered the "gold standard" for in vivo detection of 
H. pylori infection and is also a good measure for the follow-up of the 
eradication therapy [107]. The disadvantage of this technique is that the 
detection of 13C requires a mass spectrometer, which may not be easily 
available in clinics. Fecal antigen test is a relatively new diagnostic procedure 
that uses an enzyme linked immunosorbent assay to detect the presence of  
H. pylori stool antigen (HpSA) in the stool with the use of polyclonal anti-H. 
pylori antibody. This test has a high sensitivity and specificity but its 
disadvantage is the increasing of false-negative results for the stool antigen 
test during proton pump inhibitor (PPI) treatment [108]. Serological tests 
measure circulating IgG, IgM and IgA antibodies in a patient's serum and have 
sensitivity and specificity of 94% and compared to invasive techniques are 
extremely cheap. The heterogeneity of H. pylori strains has been well 
documented and is characterized by a considerable variation in the prevalence 
of specific strains, especially from different geographical areas [109], thus the 
success of a serology test depends on the use of antigens that are present in 
H. pylori strains from a given population. Serological tests have several 
advantages, namely they are non-invasive and they do not produce false 
negative results in patients receiving treatment (proton pump inhibitors and 
antibiotics) or presenting acute bleeding [110], for this reason several H. pylori 
immunogenic proteins have been presented as candidates to detect infection, 
such as the FlidD protein, multiple recombinant (CagA, VacA, GroEL, gGT, 
HcpC and UreA) proteins, CagA or Omp18 [111]. All current diagnostic 
procedures have its own advantages, disadvantages and limitations, between 
non-invasive methods and especially between serology tests there's the need 
to improve the diagnostic yield of H. pylori infection detection in specific clinical 
conditions [100]. At the same time, for wider applications, it would be 
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fundamental to identify novel biomarkers that could allow the diagnosis and/or 
prognosis of the progression of infection towards specific different pathological 
outcomes such ad Gastric Cancer, Autoimmune Gastritis and MALT lymphoma 
[19]. 
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4. PHAGE-DISPLAY TECHNOLOGY 
Biomarkers are indispensable tools for diagnostics and play roles in molecular 
medicine in the identification, prevention, and diagnosis being also very 
important for practical clinical disease management. Nowdays there is an 
increasing awareness of the need for new biomarkers that could contribute to 
diagnosis and prognosis, various protein detection techniques have been 
applied in biomarker discovery. SDS-PAGE and Western blotting are the most 
basic and traditional techniques, these techniques have been combined with 
high-throughput techniques, indeed different experimental methods, such as 
two-dimensional electrophoresis (2-DE), protein or peptide microarray, high-
performance liquid chromatography (HPLC) and mass spectrometry (MS) have 
been employed for the discovery of immunogenic proteins [112]. However, the 
identification of the antigens that trigger specific systemic antibody responses 
is still difficult and limits the applications of these technologies. To serve this 
purpose phage display technology was proposed in 1985 by George P. Smith 
to identify polypeptides with specific binding activity and subsequently evolved 
with many versatile applications [113]. The phage-display technology was 
recently used to identify novel potential biomarkers from phage genomic 
libraries produced from different Mycoplasma species [114], Salmonella 
Typhimurium [115] and Neisseria gonorrhoeae [116]. However, the ability of 
phage display libraries to be enriched for epitopes of monoclonal antibodies 
has long been demonstrated [117]. Phages contain the genetic information of 
the proteins displayed on their capsids, thus genotype and phenotype are 
linked together, in this way this technology allows the direct determination of 
the genetic information (ORF/ORF fragment) from which the protein/antigen 
derives [118]. 
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4.1 ORF PHAGE-DISPLAY  
A link between the genotype and phenotype of the phage is provided by 
inserting DNA inside of the phage that encode for peptides which are 
displayed on the phage surface [105]. Each phage expresses on his capsid a 
unique peptide but the whole library includes a large number of different 
displayed peptides that afterwards will be used by affinity selection in order to 
identify specific ligands for different target [106]. The affinity selection 
technique, called biopanning, is the procedure of selecting specific binding 
partners from phage display libraries [107]. One interesting advantage of ORF 
Phage-Display is that this technique does not need prior knowledge of the 
identity and attributes of the target, furthermore once generated, libraries can 
reuse for an unlimited number of screenings [108]. This technology has 
applications in drug discovery [109],  antibody engineering and epitope 
mapping [110], gene/drug delivery [111], enzyme technology, organ targeting 
[112], bioimaging and biosensing [113], study of interactions protein–DNA and 
protein–protein [114], antiviral research [115].   
 
4.1.1 Phage display and ORF selection 
Phage display technology application was expanded to include the display of 
antibodies and many other proteins [116]. As mentioned in the previous 
paragraph cDNA phage display has been successfully and widely applied both 
to identify antibody epitopes or binding partners [108,117] but the large 
number of non-functional clones present made the cDNA libraries inefficient 
and difficult to use. Although this high rate of non-functional clones may be 
tolerable when starting to work with DNA from a single gene or even a small 
genome but become unfunctional if employing more complex DNA sources.  
To solve this problem the first strategy applied was to use λ-based vectors for 
cDNA display, despite this vector C-terminal intracellular vectors increase the 
likelihood that ORFs will be displayed, they do not provide any selective 
pressure for ORFs suggesting then the need for a further selective step to filter 
DNA fragments encoding ORFs [118].  Different attempts have been made to 
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filter DNA fragments, the first strategy was proposed in the 1992 by Seehaus 
[119], the selection was made with an antibiotic resistant gene to remove 
deletion mutants from antibody library with a plasmid in which antibody library 
was cloned upstream of a β–lactamase gene, thus only those antibody genes 
in frame were capable to allow ampicillin resistance by the creation of an 
antibody–lactamase fusion protein, whereas those that contained deletions or 
frameshifts were not conferring ampicillin resistance. Zacchi et al in 2003 [120] 
applied a similar strategy with a phagemid, they inserted the cDNA fragment 
followed by the gene of β–lactamase delimited by two homologous lox sites. 
To obtain efficient display of foreign polypeptides at N-terminus, the selection 
step with ampicillin , β–lactamase selection was removed by Cre recombinase-
mediated recombination [120]. Faix et al [104] further improved this approach, 
they first selected fragments with a β–lactamase gene in a plasmid, after this  
fragments were extracted from ampicillin-resistant plasmids and re-cloned into 
a phagemid and afterwards rescued by hyperphage system. D’Angelo e al. 
[121] in order to demonstrate the feasibility of filtering method with antibiotic 
resistant gene have applied β–lactamase filtering vector at whole genome level 
in Clostridium thermocellum for domain-based functional annotation purposes. 
They demonstrated that domainome libraries are easy to generated by 
applying β–lactamase filtering vector to randomly fragmented bacterial gDNA 
libraries and that once a library is generated, it can be used for an unlimited 
number of screenings.   
 
4.1.2 Comparison of Phage display with other techniques for interactome 
analysis 
To elucidate protein physical association and elucidate protein functions 
different technologies have been widely used such as protein affinity 
purification coupled with 1D or 2D gel electrophoresis and mass spectrometry 
(AP-MS) or yeast two-hybrid (Y2H  to identify protein-protein interactions [119]. 
Both AP-MS and Y2H have been applied for the recognition of binding 
peptides for specific protein bait as well as for domain-scale interactome 
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mapping. AP-MS has been well demonstrated for efficient mapping of 
interactome for yeast, E.coli  [120] and human [121] .  
AP-MS technology is more flexible than Y2H but has several limitations, it has 
a low sensitivity, consequently, less abundant proteins my not be detected 
(Table 2). Although Y2H and AP-MS have been widely used to identify protein-
protein interactions, they are limited to high cost, technical complexity, 
instruments requirements, Li and Caberoy. [122] estimated the error rate that 
is more or less 50% for AP-MS (15% with tandem affinity purification), more or 
less 48% for Y2H while for ORF phage display is 29% (Table 2). One of the 
advantages of ORF phage display is that can significantly reduce the time 
required to identify a peptide with binding characteristics. Phage has a robust 
growth rate and another advantage is the versatility, Y2H is applicable only to 
protein-protein interactions studies. Several studies have shown that phage 
display is applicable to proteins, antibodies, peptides, multi-molecular 
complexes and affinity selection may be performed in vivo and in vitro [123]. 
One disadvantage of bacterium-based ORF phage display is that proteins 
displayed on phage surface lack appropriate post-translational modifications  
but this approach facilitates the identification of binding compounds with high 
affinity in a large scale with an efficiency and sensitivity comparable to Y2H 
and AP-MS [119]. Other limiting factors for these experiments are the 
availability of expression constructs, data analysis and the downstream 
validations.    
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ORF Phage 
Display Y2H 
MS-based 
approach 
Capacity of the technologies  
   Protein-protein interaction Yes Yes  Yes 
Protein-polysaccharide 
interaction Yes No Yes 
Protein-lipid interaction Yes No Yes 
Protein-antibody interaction Yes No Yes 
Protein-DNA interaction Yes Yes  Yes 
Protein-RNA interaction Yes Yes  Yes 
Protein-virus interaction Yes No No 
Protein-cell interaction Yes No No 
Protein-tissue interaction Yes No No 
In vivo selection  Yes No No 
 
Table 2 - Comparison of different technologies for functional proteomics. Table reprinted [124] 
with modifications. 
 
4.2 Phage Display evolution: INTERACTOME-SEQUENCING 
Nowadays the advent of high-throughput sequencing (HTS) techniques is 
transforming multiple research fields as well as the analysis of the intrinsic 
heterogeneity of phage libraries [125]. The complex high throughput data 
provided by deep sequencing enables the analysis of highly complex samples 
such as phage display libraries and holds the potential to circumvent the 
traditional laborious picking and testing of individual phage rescued clones 
[126]. In the recent times there have been significant attempts in coupling HTS  
with phage display, in 2009 Dias-Neto et al. [127] proposed the use of NGS 
coupled with RT-PCR to improve phage analysis of the library inserts encoding 
phage-displayed variants.  
Pyrosequencing was employed for deep-sequencing amplicons obtained from 
phage ssDNA libraries, recovered directly from four human tissue biopsies, 
using primers flanking the library gragment within the fusion by Di Niro et al 
(2010) [129]. Thus combining phage display and NGS they increased of two 
orders the number of affinity-selected clones. Authors screened an ORF-
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filtered cDNA phage library, obtained from several human cell lines mRNA , to 
identify proteins in contact with tissue transglutaminase 2 (tTG2), an enzyme 
involved in different clinical outcomes. This approach has driven the 
characterization of a “landscape” of binding variants from the phage display 
library. Another relevant application of NGS coupled with phage display was 
shown by Gourlay et al. [128] , these authors generated a ORF-filtering library 
using the Burkholderia pseudomallei genome in order to develop a high-
throughput tool to identify soluble protein domains from the entire protein 
repertoire of the bacterium. With this approach they demonstrated that the 
extension of the filtering power of β–lactamase based filtering selection 
strategy to identify outer membrane protein domains is very useful in the 
context of host-pathogen interaction studies. Between the 1279 ORFs 
represented in the library the focus fell on a potential antigen, BPSL2063, 
which was recognized by positive antibodies from patients that tested positive 
for B. pseudomallei. To identify the domains of this antigen a second single-
gene domain filtering library was constructed and after a specific bioinformatic 
analysis two domains were revealed at N- and C- termini, respectively; 
afterwards they were produced in soluble form and successfully crystallized.  
In conclusion the ORF-filtering library approach allows the characterization of 
the whole ORF-eome and Domain-ome of any intronless genome, favoring the 
selection of ORFs encoding for proteins that are potentially exposed on the cell 
surface or involved in transport mechanisms. It allows the identification of outer 
membrane localized protein domains supporting the identification of antigens.  
The Domain-filtering library approach applied to single gene/proteins (very long 
more than 1000 aa and transmembrane) allows the selection of protein domain 
boundaries, and can accelerate and improve the steps leading to soluble 
protein production for crystallogenesis.  
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4.3 ORF-filtering library analysis 
The output generated by ORF-filtering libraries sequencing can't be analyzed 
with the existing bioinformatics resources, as a matter of facts the kind of data 
do not resemble other sequencing data like ChIP-seq or RNA-Seq for which 
there are many free tools and softwares that are constantly released or 
updated. Phage display technology coupled to sequencing was introduced 
only in 2010 by Di Niro et al [129] and from a bioinformatic point of view the 
analysis of this kind of data was always performed by adapting tools designed 
for other purposes. In two recent works from D’Angelo et al. [130] and Gourlay 
and et al. [128] the analysis for the identification of specific domains/antigens 
was performed through NGS-TreX developed by Boria et al. [131]. NGS-TreX 
is a free available web-tool designed for the analysis of RNA-Seq data and it is 
not specific for the analysis of Interactome-Seq data. In literature, up to date, 
there aren’t dedicated pipelines able to reveal enriched domains from dataset 
generated by Interactome-Seq technology. Therefore, at the beginning of my 
thesis work, there was the urgent need to develop a robust workflow that 
should be able to manage Interactome-Seq data, both with fixed or user-
defined parameters, and to perform specific testing for the identification of 
enriched domains/antigens. At the same time the visualization and the sharing 
of the features identified was not possible so I decided not only to develop a 
new pipeline of analysis but to implement it into a web-tool easy to use, user 
friendly and available to the whole scientific community interested in analysing 
and consulting Interactome-Seq data. 
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5. AIMS OF THESIS  
 
The aim of this thesis was the identification of H. pylori epitopes responsible for 
host immuno-response modulation through: a discovery-driven approach that 
couples “phage display” and deep sequencing (interactome-sequencing) and 
the development of a specific webtool for interactome-sequencing data 
analysis. 
 
To this purpose my thesis work was focused on the:  
 
• Identification of novel biomarkers to provide a “disease signature” by 
screening genomic DNA libraries, created from H. pylori genome, 
directly with sera from infected patients with different pathological 
outcome. 
 
• Development of a new pipeline for interactome-sequencing data 
analysis.  
 
• Implementation of a Webtool for functional analysis and visualization of 
interactome-sequencing data.  
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6. MATERIALS AND METHODS 
 
6.1. Bacterial strains  
Bacterial strains HP-26695 and HP-B128 used in this study were isolated at 
the Carregi Hospital and gently provided by Dott. Mario Milco D'Elios.  
 
6.2. H. pylori genomic ORF-filtering library construction and 
sequencing 
To identify all the potential soluble domains on a genomic scale we applied our 
strategy, based on the construction of an ORFeome library from two H. pylori 
genomes. The procedure initially involves the fragmentation of a whole 
genome into DNA fragments of 200-800 bp (D'Angelo et al., 2011, Heger & 
Holm, 2003) with the purpose to create a library of fragments coding for 
potential domains (or parts of). DNA fragments encoding well-folded protein 
domains, fused upstream of ß-lactamase, allow the reporter enzyme to fold 
correctly and allow bacteria to survive the selective pressure posed by the 
antibiotic. Genomic DNA from H. Pylori strains HP-26695 and HP-B128 was 
fragmented by ultra-sonication (Covaris) (Duty Cycle 10%; Intensity 5.0; 
Cycles per burst 200; Duration 2X60 seconds, total 120 seconds; Mode 
frequency sweeping; temperature 6°C ) to obtain  fragments in a length range 
between 200 and 800 bp (about 65–250 aa). Fragments were collected, blunt-
ended using the Quick Blunting Kit (New England Biosciences) and cloned into 
the pFilter vector using EcoRV cloning site between a pelB leader sequence 
and the mature β-lactamase gene [132]. After ligation the H. pylori genomic 
DNA library was electroporated into DH5a F’ cells and plated on 
chloramphenicol plates (34 mg/ml), supplemented with ampicillin (25 μg/mL). A 
small dilution of the library was also plated and grown in parallel on both 
chloramphenicol and chloramphenicol plus ampicillin resistance in order to 
calculate the size of the library and the efficiency of the filtering.   
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107 bacterial cells were plated and after overnight growth approximately 1% 
cells survived at the highest ampicillin concentration, yielding one library with 
an estimated size of 1x106 clones. 
Bacteria were harvested, mixed, resuspended in 20% sterile glycerol and 
stored in small aliquots at –80°C. One aliquot was used to extract plasmid 
DNA used for the preparation of the phage-library and for sequencing analysis 
of the inserts. To this aim the HP genomic DNA inserts were recovered from 
the pFILTER vector, by amplification with specific primers. The primers used to 
rescue the inserts were linked at their 5’ end to Illumina adaptors sequences, 
thus allowing the direct sequencing of the HP genomic DNA inserts by using 
the MiSeq Illumina sequencer (Figure 8). The libraries were indexed, pooled 
together and sequenced on a MiSeq Illumina sequencer;  250nt paired end 
reads were generated  
Forward primer: 
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGCAGCAAGCGGCGCG
CATGCC;  
Reverse-primer: 
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGGATTGGTTTGCC
GCTAGC;  
In bold are indicated the Illumina adaptors,in italic are indicated the specific 
primers.  
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Figure 8- Schematic Overview of the main steps for the construction of the H.pylori genomic 
ORF-filtering library: 1) Random fragmentation of genomic DNA 2) gDNA fragment cloning into 
the pFILTER vector and filtering using β-lactamase as a folding reporter 3) Collection of all 
colonies and DNA extraction 4) gDNA fragment recovery by amplification using specific primers 
linked to adaptors for sequencing 5) deep sequencing 6 ) data analysis. 
 
6.3. H. pylori Phage-library construction  
In order to create a phage-display library, filtered DNA fragments were collect 
and cloned inside phagemid vector.  Phagemid enables the expression of the 
foreign DNA, purposely introduced in the vector in such a way that it is 
expressed in conjunction with a phage protein, as a fusion protein, for display 
on the phage surface. This instrument is necessary to perform the selections 
with sera, it allows to couple genotype and phenotype in the same phage 
(Figure 9). For the H. pylori phage-library preparation the filtered HP ORF were 
recovered from the pFILTER3 vector and cloned in the pDAN5 [133] upstream 
to the cDNA codifying for the g3p protein. After ligation the library was 
electroporated in DH5aF’ competent bacterial cells and grown for 18h at 37°C 
on 2XTY-Agar plates supplemented with 100 µg/ml of Ampicillin. Bacteria were 
harvested, mixed, resuspended in 20% sterile glycerol and stored in small 
aliquots at -80°C. One aliquot was used to extract plasmid DNA and subjected 
to sequencing analysis of the inserts, performed as described above.  
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Figure 9 - Schematic Overview of the main steps for the construction of the phage library. 
 
 
6.4. Sera selection 
Once recloned into a phage display context, we directly used the ORF-filtering 
libraries to selected putative antigens by capturing the antibodies present in 
the sera from patients affected by H. pylori and presenting increasing degrees 
of infection: A) gastric adenocarcinoma (pool of 2 sera); B) autoimmune 
gastritis and pernicious anemia (pool of 3 sera); C) MALT lymphoma (pool of 2 
sera); at the same time control sera from healthy patients both affected or not 
by H. pylori (D) were used to get a background control for successive 
normalization of the signals. The sera were grouped into different pool and 
each pool was independently used for three consecutive rounds of selection, in 
order to enrich the library for immunoreactive clones, with increasing washing 
and binding stringency Two cycles of selection and amplification were 
performed, and mini-libraries of selected phages were collected after each 
cycle (Table3). Test set antibodies were incubated with library phages, 
immune-complexes were recovered by protein A coated magnetics-beads and 
bound phages were eluted by standards procedures. Selected phages were 
used to infect E. coli and to produce mini-libraries from each cycle of selection. 
DNA inserts were recovered from each individual selected library, purified and 
sequenced by using the Illumina MiSeq sequencer (Figure 10) 
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Table 3 - Library description and library name assigned.   
 
  
Figure 10 - Schematic overview of sera selection. Phage library were used for selection on 
patient serum antibodies immobilized on magnetic beads, three cycles of washes were followed 
by phage amplification on bacteria. E.coli cells plates supplemented with Amplicillin were deep-
sequenced allowing the identification of enriched gene sequences. After data analysis, a list of 
putative antigens were produced and validated with an independent set of sera and assassed 
for their specificity.   
 
  
Library description Library name  
H. pylori ORF-filtering library  Genomic 
Healthy patients both affected or not by H. pylori Control 
Patients affected by gastric adenocarcinoma SelectionA 
Patients affected by autoimmune gastritis  SelectionB 
Patients affected by MALT lymphoma SelectionC 
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6.6. Bioinformatics analysis and web-tools design  
 
6.6.1. De-Novo Assembly of B128 strain 
The assembly tool used in this study was Velvet 1.2.10 [134]. Large contigs 
(length >500nt) obtained were ordered and orientated with CONTIGuator 
version 2.7.4 [135]. Scaffolds were annotated with RAST [136].  
 
6.6.2. Genomic comparison with other H. pylori strains 
For comparative analysis, complete genome sequences of H.pylori were 
downloaded from NCBI database and compared using Gegenees tool (see 
Appendix 10.10) [137]. The tool utilizes a fragmented alignment algorithm to 
calculate average similarity among the compared genomes using BLASTn. 
The fragment size can be optimized according to the user. The tool was run 
with the fragment size set to 200 and a step size of 100 using BLASTn. The 
average similarity was calculated with a BLAST score threshold of 40% 
generating a heat plot matrix that was further used to deduce phylogenetic 
relationships exported in the form of a .nexus file. This nexus tree file was 
supplied as an input to SplitsTree [138] program for building an un-rooted 
phylogenetic tree employing Neighbor-Joining algorithm. 
 
6.6.3. Implementation of Interactome-Seq pipeline and web-tool.  
I developed a data analysis workflow called Interactome-Seq that is a 
combination of custom shell, AWK and python scripts. As part of the analysis 
several tools have been included in the pipeline, namely 1) FastQC (v. 0.11.4) 
for quality check and processing of fastq sequences, 2) Cutadapt (v. 1.10) 
[139] for trimming primers and discarding reads with low Phred quality score, 
3) Bowtie2 (v. 2.2.9)[140] for alignment step, 4) Samtools (v. 0.1.19-44428cd) 
[141] for converting alignment in different formats, 5) Bedtools (v. v2.24.0) 
[142] for working with genomic intervals, 6) EdgeR (v. 3.14.0) [143] for 
differential signal analysis. The Interactome-Seq pipeline can be accessed 
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through an interactive web-based graphical user interface 
(http://cerbero.ba.itb.cnr.it/cricket/ITBHelicobacter). 
Analysis steps are implemented and distributed inside server environment 
through a dispatching application and the whole execution can be launched 
and monitored using a common up-to-date web browser. Interactome-Seq is 
powered on a Ubuntu 14.04LTS Linux operating system. The Web Framework 
application used for development was Google AngularJS, combined with 
HTML5 and CSS3 standards, to enable a better user interaction The server 
was an Intel® Xeon® Processor, 64 GB of RAM, 9 TB (SATA) of hard disk.  
 
6.7. ELISA validation  
Helicobacter pylori ORFs obtained from the second round of selection, and 
resulting specific for progression towards pathological outcomes, were excised 
from the phagemid vector and cloned into a compatible pGEX-FLAG (D’angelo 
et al Clin Immunol, 2013) vector, creating for each output of selection a library 
for the expression of the selected ORFs as GST-fusion products. Plasmid DNA 
was isolated from an aliquot of these libraries and used as a template for an 
inverse PCR-based cloning strategy performed with two back-to-back outward 
specific primers designed centered on the epitope region identified by the 
overlapping reads. Colonies grown on Ampicillin plates were sequenced. 
Positive colonies were grown at 37°C until OD600nm=0,5 and induced by 
IPTG with a final concentration of 0,2mM for 16h at 28°C. Recombinant protein 
was purified with GST affinity resin (Sigma Aldrich) using standard procedures. 
An in-house ELISA assay was used to validate the antigenicity of the selected 
ORF. Briefly recombinant GST-protein was diluted in PBS to 2μg/ml and 100μl 
were coated in ELISA wells (Greiner), overnight at 4°C. Wells were washed 
with PBS and blocked with 200μl of blocking solution (PBS- 0.05% Tween20-
2% milk) for 1h at 37°C. Wells were again washed for three times with PBS-
0,05% Tween20 and incubated with sera samples diluted 1:500 in blocking 
solution, for 2h at 37°C. Extensive washes were performed with PBS-0,05% 
Tween20 and PBS. Secondary antibody was a goat anti-human-IgG HRP 
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conjugated (Sigma Aldrich) diluted 1:5000 in blocking solution, for 1h at 37°C. 
After extensive washing, immune-complexes were revealed with TMB and the 
plate read at 450nm. Samples with absorbance ≥ of the mean OD450 value 
obtained with control sera plus 2 standard deviations (SD) were considered 
positive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 46 
7. RESULTS AND DISCUSSION 
 
My thesis work is divided in four main parts: 
1) construction and comparative analysis of two H. pylori genome ORF-filtering 
libraries; 2) bioinformatics analysis of sequencing data: development of a new 
data analysis pipeline and implementation of a web-tool, 3) phage-library 
production and analysis of the enriched domains after sera selection; 4) 
validation of the results.   
I participated to all the parts of the work, but my personal involvement was 
mainly focused in the bioinformatics analysis of the sequencing data 
generated, on the pipeline development and on the  web-tool implementation. 
 
7.1 HP-26695 and HP-B128 ORF-filtering libraries comparison  
H. pylori is known for its remarkably high level of genetic diversity creating a 
dynamic pool of genetic variants, this pool of genetic variants delivers a 
sufficient genetic diversity to allow H. pylori to occupy all the potential niches in 
the stomach (for example, antrum and corpus mucosa) [144]. 
Since one of the aims of my thesis work was to: identify novel biomarkers, to 
provide a “disease signature”, by screening genomic DNA libraries created 
from H. pylori genome, directly with sera from infected patients with different 
pathological outcomes, first of all I wanted to be sure that the strategy here 
adopted and the instrument here proposed (i.e phage-library coupled with 
interactome-sequencing) could be considered universally valuable. 
For this reason two ORF-filtering libraries were produced: one from the 
genome of the HP-26695 strain and another from the genome of the HP-B128 
strain. Strain HP-26695 originates from patients suffering from a chronic 
gastritis and is considered the reference HP strain, having a complete and very 
well annotated genome sequence, strain HP-B128 originates from patients 
with gastric ulcer, its genome sequence is not complete but consists of 73 
supercontigs. The strain HP-B128 is one of the strain most frequently found in 
infected patients and it is linked to infection progression towards gastric ulcer 
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and/or more serious pathologies such as gastric cancer, autoimmune gastritis 
and MALT lymphoma. 
A comparative analysis of the genomic sequences of these two strains, and of 
the ORF portions that we found represented in their ORF filtering libraries, 
herein produced, was performed in order to understand if the H. pylori genetic 
diversity between these two strains could in some way introduce a bias into 
their ORF filtering libraries content and prevent their use as universal 
instrument for new specific diagnostic and prognostic markers discovery. 
 
7.2. Assembly and phylogenetic analysis of HP-B128  
Since the genome sequence of HP-B128 strain was not complete [145], before 
starting with the production of its ORF-filtering library, HP-B128 genome was  
re-sequenced in our laboratories. The reads obtained were then assembled 
and a comparative sequence analysis between HP-B128 strain new genome 
sequence and all the complete genome sequences of H. pylori strains 
available in public databases was performed.  
In this way we estimated the level of genetic diversity that separates the HP-
B128 strain from the HP-26695 reference strain to understand if the genome 
annotation of the reference strain could be used for the successive steps of 
functional analysis of the two ORF filtering libraries generated, and extended 
to the functional definition of the domains/antigens found enriched after sera 
selection. 
 
7.2.1. HP-B128 genome assembly  
The whole genome sequencing of HP-B128 isolate revealed that the 
chromosome size is around 1.66 Mb similar to others H. pylori strains. The 
genome also revealed a low G+C content of 38.76% which is another 
important characteristic of H. pylori. Detailed assembly metrics of the genome 
sequencing are reported in Table 4: we obtained a total of 61 contigs (>500nt) 
by assembling 180.967 reads produced with 454 GS-FLX+ platform (Roche). 
Afterwards 44 contigs were merged in a single FASTA file by the scaffolding 
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procedure, taking the HP-26695 genome as template, and a single scaffold of  
1.664.509 bp length was obtained (see Appendix 10.1).  The remaining 17 
contigs were duplicates of parts of the 44 contigs assembled into the big 
scaffold, only repeated genomic regions were excluded from this scaffolding 
step. Thus we strongly improved the genome sequence of the HP-B128 strain 
previously available,  that was composed of 73 contigs, and obtained a draft 
genome of this strain.  
 
Sequencing Assembly of HP-B128 
Raw reads  180.967 SE 
Total contigs 61 
# contigs (>= 1000 bp)       34 
# contigs (>= 5000 bp)           23 
# contigs (>= 10000 bp)          21 
# contigs (>= 25000 bp)            17 
# contigs (>= 50000 bp)             9 
Total contigs assembled                  44 
Largest contig               376433 
Total length                 1664509 
GC (%)                          38.76      
N50                         128427 
 
Table 4 - Assembly metrics of HP-B8 strain. In this table are reported the number of raw reads ( 
Raw reads ), number of total contig (Total contigs), number of contig bigger that 
1000,5000,10000,25000,50000 nt, total number of contigs assembled(Total contigs assembled), 
the most large contig assembled(Largest contig), total genome assembled (Total length), 
median of contig lengths (N50).   
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7.2.2. Analysis of HP-B128 genome sequence similarity  
The HP-B128 draft genome obtained was automatically annotated by using  
RAST, 1711 CDSs were annotated, but their functional annotation was quite 
poor, about 25% of the CDSs were described as “hypothetical protein”. Thus to 
improve HP-B128 annotation I decided to compare its draft genome sequence 
to the genomic sequences of 52 strains available in the NCBI database.  A 
similarity phylogenetic tree was constructed using Gegenees and Splitree 
software.  The results of this phylogenetic comparison are shown in Figure 11 
and the formation of distinct cluster (Green square), based on sequence 
similarity, between HP-B128 and HP-B8 strain can be clearly appreciated. HP-
B128 draft genome showed a level of similarity of 96% with HP-B8 
(NC_014256.1). The strain HP-B8 evolved from the human strain HP-B128 
and was adapted to infecting gerbils, used as animal models for HP infection 
and gastric cancer development. This close phylogenetic association among 
HP-B128 and HP-B8 strain is in accordance with the comparative genome 
analysis of Farnbacher et al [145], in this work the authors  found that about 
98% of the whole genome sequence of strain B8, that they obtained, was 
covered by B128-supercontigs with a percentage of sequence similarity 
greater than 90%.  They also performed a comparative analysis between the 
two strains revealing that more than 86% HP-26695 CDSs completely matched  
with the HP-B8 CDSs. At the same time it is possible to observe, from the 
phylogenetic tree, that even between the genome sequence of the strain HP-
26695 and of the HP-B8 and HP-B128 respectively there is a very high level of 
similarity (80%).So after having verified the high level of similarity between our 
draft genome sequence of strain HP-B128 and the already published complete 
genome sequence of strain HP-B8 we associated the well curated genome 
annotation of this second strain to our draft genome. In this way we greatly 
improved HP-B128 CDSs functional annotation and made it comparable with 
the annotation of the whole HP-26695 CDSs set. 
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Figure 11- Gegenees heat-plot over a set of all complete H. pylori genomes. A fragmented 
alignment in BLASTn mode was performed with settings 200/200. The cutoff threshold for non-
conserved material was 20%. A dendrogram was produced in SplitsTree 4 (using neighbor 
joining method) made from a distance matrix Nexus file exported from Gegenees. 
 
7.2.3. Crossmapping comparison of HP-26695 and HP-B128 ORF-filtering 
libraries  
As one of the main advantages of producing ORF-filtering libraries from  intron-
less genomes (i.e bacterial genomes) is the possibility to characterize their 
whole ORF-eome and/or Domain-ome, it is important first to evaluate if the 
ORFs/Domains filtered out by this technique can show relevant differences 
when ORF-filtering libraries are produced from genomes of different strains 
having high level of similarity, such in the case of HP-B128 and HP-26695 
strains. This verification step is fundamental when the genomic ORF-filtering 
library, produced starting from the bacterial genome, should be used to 
perform selections/enrichments with sera from patients. Indeed in this case it is 
important to obtain a genomic ORF-filtering library that could be considered a 
universal instrument able to work equally with different sera regardless of the 
HP strain infecting patients. 
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To this purpose I performed a crossmapping comparison by aligning the reads 
obtained from the sequencing of both the genomic ORF-filtering libraries of 
HP-26695 and of HP-B128 against their respective genomic sequences of HP-
29965 (NC_000915) and HP-B8 (NC_014256) and viceversa.  Table 5 reports 
the metrics of all these crossmapping steps, both raw reads datasets were first 
trimmed then mapped with Bowtie2. In panel A, the 91,61% of the trimmed 
reads of HP-26695 ORF-filtering library aligned  with its own reference genome 
while the 85,75% aligned to HP-B128 (HP-B8) sequence. In panel B the 84,7 
%.of trimmed reads of HP-B128 ORF-filtering library aligned with the HP-B8 
genome while again the  85,75% align with the HP-26695 genome. 
Considering that the  cross-mapping metrics observed in particular for the HP-
B128 ORF filtering library do not differ much when the reads are aligned 
against the HP-B8 and the HP-26695 genome sequences respectively, we can 
conclude that the genetic diversity that separates these two strains does not 
significantly affect the nature of ORFs/Domains sequences filtered out. So in 
the light of these results we  decided to use as reference the HP-26695 
genome and to use its CDSs annotation to functionally read out the results 
obtained after selection with sera from patients.    
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A)  Reads mapping vs HP-26695 genome sequence  
sequencing metrics HP-26695 reads HP-B128 reads 
Raw Reads 1.425.554 1.425.554 
Reads after trimming 1.216.124 1.216.124 
Mapping Reads 1.114.184 1.042.943 
% of Mapping reads 91,61% 85,75% 
Unmapping Reads 11.158 108.581 
Multiple mapping reads  90.782 64.600 
B)  Reads mapping vs HP-B128(B8) genome sequence  
sequencing metrics HP-26695 reads HP-B128 reads 
Raw Reads 1.031.956 1.031.956 
Reads after trimming 954.895 954.895 
Mapping Reads 746.325 802.021 
% of Mapping reads 78,10% 84,70% 
Unmapping Reads 158.301 92.896 
Multiple mapping reads  50.269 59.978 
 
Table 5 - Geonomic ORF filtering library crossmapping results for HP-26695 and HP-B128 
strains. In the panel A are reported the mapping metrics of HP-26695 ORF-filtering library vs 
HP-26695 and HP-B8 strains. In panel B are reported the mapping metrics of HP-B128 ORF-
filtering library vs HP-26695 and HP-B8 strains. Metrics are composed be number of Raw Reads 
(Raw Reads), number of Reads after trimming (Reads after trimming), number of Mapping reads 
(Mapping reads) and percentage (% Mapping reads ), number of unmapped reads (Unmapping 
Reads) and number of reads that map in more than one point of genome (Multiple mapping 
reads). 
 
7.3. Development of a New Bioinformatic Data Analysis Pipeline 
 
7.3.1 The Idea behind 
As previously explained in the paragraph 4.3, the output generated by ORF-
filtering libraries sequencing can't be analysed with the existing bioinformatics 
resources, indeed this kind of data do not completely resemble other 
sequencing data like ChIP-Seq or RNA-Seq. Up to date, there aren’t dedicated 
pipelines able to reveal enriched domains from dataset generated by 
Interactome-Seq technology. So, in order to fill this gap and to correctly 
analyze the Interactome sequencing data herein produced, I designed a new 
dedicated data analysis pipeline.  
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Even if Interactome-seq data stand apart from ChIP-seq and RNA-seq data, 
they have some common features, with these two kind of data, that should be 
taken in consideration. 
1.    One feature in common with ChIPseq analysis is essentially the 
step of detection/calling of enriched domains. For ChIP-Seq 
experiments the input DNA is mandatory to model the background 
noise of the experiment before the Peaks Finding step, even in 
Interactome-Seq experiments, background is necessary both for 
Genomic ORF-eome definition and for building the statistical model 
required to identify the enriched putative domains.  
2.    The features in common with RNAseq are two. The first one is the 
necessity of normalizing data between samples. The normalization can 
be done with an approach similar to that used for RNA-Seq 
experiments, indeed my pipeline counts the reads per kilobase per 
million mapped (RPKM), this normalization step, usually adopted to 
normalize RNA-Seq data, consists of multiplying the raw counts for 
each gene in each sample by a factor incorporating both sequencing 
depth and putative domains lenght and facilitates a trasparent 
comparison for putative domains within and between the selections. 
The second feature in common with RNA-Seq experiments is the 
statistical model used to identify the enriched/differential domains. Like 
in RNA-Seq the data count is fitted as a binomial negative (NB) 
distribution and the false discovery rate (FDR) of p-values obtained are 
controlled with the Benjamini-Hochberg procedure [147].   
The pipeline is divided into 4 main steps of analysis (Figure 12): in the first 
step, all alignment files are scanned for the detection of putative domains 
(Figure 12 Step 1).  Starting from the genome origin of replication (OriC base 
N.1) the coverage depth for each genome position is calculated, then start and 
end coordinates of each domains are defined. The starting coordinate of a 
putative domain is fixed on the first genome position having a coverage depth 
equal or greater than 1, while the ending coordinate of the same putative 
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domain is the next postion having a coverage depth equal to 0. The second 
step of the analysis is: the annotation inside CDSs of the putative domains 
previously determined (more than one domain can be associated to one CDS) 
and the determination of domains enrichment in the selections respect to their 
representation in the genomic phage library, which is used as 
reference/background for the step of “differential analysis” (Figure 12 Step 2). 
In the third and fourth steps of the analysis the lists of domains, significantly 
differentially enriched in the selections respect to the reference genomic phage 
library, are compared, and a subtractive step allows the identification of those 
domains/antigens specific of selections with the sera of sick patients (Figure 12 
Step 3). Thus, all the antigens equally recognized by antibodies of healthy 
patients and of patients affected by Gastric Cancer, Autoimmune gastritis, and 
MALT lymphoma are removed, and lists of antigens specific infection 
progression are obtained (Figure 12 Step 4). These lists of specific antigens 
are given in output as ranking lists associated with statistical values (FDR) thus 
allowing a guided selection of the best targets for validation (i.e. top lists 
antigens).  
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Figure 12 - Workflow of Interactome-Sequencing analysis. Analysis workflow is composed by 
four steps, Step 1 and 2 allow the detection of putative domains and the identification of  only 
those that are enriched compared to the Genomic Phage library used as background. Steps 3 
and 4 allow the identification of the enriched putative domains specific for each Selection group 
by   consecutive subtraction  of all the domains common to the Group D selection (healty 
patients) and intersection of the specific  antigens lists obtai
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7.4. Overview of Interactome-Seq webtool 
 
7.4.1 Input description  
Concerning input data type, Interactome-Seq pipeline can handle Roche-454 
reads in FASTA format, Illumina Fastq or alignment files (BAM), single end and 
paired-end reads are supported. The pipeline is flexible, more than one 
selection can be analysed, but Genomic dataset input is mandatory, and it can 
be also analysed alone, if the focus of research is the identification of all 
potential soluble domains on a genomic scale (Figure 13).  
 
 
Figure 13 - Schematic steps of Interactome-Sequencing pipeline. 
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7.4.2. Pre-processing step  
As shown in Figure 13 during the pre-processing step raw reads are analysed 
and quality checked using FastQC and Cutadapt tools. Reads with no 
identifiable adapters are discarded. During the pre-processing the dataset 
undergoes also quality trimming, a sliding window trimming is performed, this 
means that when the average quality within the window falls below a 
predetermined threshold (Q<30), the remaining part of the read is discarded.  
 
7.4.3. Read alignment step  
After the trimming reads are aligned with Bowtie2 to the genome sequence. 
I used this mapping tool because it is optimized for working with the read 
length and error modes yielded by recent sequencers (Illumina, Roche 454, 
and Ion Torrent platforms). Users can decide the maximum number of 
mismatches allowed; the default mismatch option is set at 2% of reads length, 
only uniquely mapping reads are used for downstream analysis. A SAM file is 
generated and only reads with quality score greater than 30 (Q>30) are 
processed using SAMtools, and converted into a BAM file.  
 
7.4.4. Putative domains Detection  
The Interactome-Seq pipeline after the alignment step invokes bedtools to filter 
reads that overlap at least 80% inside CDSs, for each portion of CDSs covered 
by mapping reads, the coverage is  calculated, and also max depth and focus 
values are calculated in according with NGS-Trex tool definition [131].  
The coverage is the total number of sequences assigned to a gene; the depth 
is the maximum number of reads covering a specific genic position; the focus 
is an index obtained from the ratio between max depth and coverage, and its 
range is between 0 and 1. 
Then, if the focus is higher than 0.8 and the coverage is higher than the 
average coverage observed for all mapping regions in the BAM file, the CDS 
portion is considered a putative domain/epitope.  
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When selections against sera or other interactors are available, domains lists 
are then statistically tested one at a time against the genomic phage library 
alignment file. Differential enrichment is calculated by using the R-package 
edgeR, in order to detect only domains that are enriched after the selections. 
The differential analysis is always performed testing the BAM files of the 
selections phage libraries against the BAM file of the genomic phage library 
that can be considered as the analysis background. .  
 
7.4.5. Output parsing   
The last step of the Interactome-Seq pipeline is the output parsing: the list of 
putative domains, resulted enriched in selection phage libraries respect to the 
genomic one, are annotated and a simple tabular file (.tab; .csv; .xls) 
containing the following fields is generated: Chromosome, Domain Start, 
Domain End, Gene Name, Focus and Annotation.   
 
7.5. Overview of Interactome-Seq webtool 
I decided to included Interactome-Seq pipeline in a web-tool to enable users 
without any bioinformatics or programming skills to perform Interactome-Seq 
analysis directly loading their reads through the graphical interface and to 
obtain their results in an easy and user friendly format. 
 
7.5.2. Webtool design  
Interactome-Seq webtool is available online at       
http://cerbero.ba.itb.cnr.it/cricket/ITBHelicobacter.  
 
This webtool requires the following inputs: 
1. Genome sequence: The Bowtie2 index of the genome of interest 
can be selected from a database of pre-loaded genomes. The 
default genome is set to Hp-26695 for the example.		
2. Raw reads file(s): Users can choose to upload raw reads  
formatted files in two different ways: (i) a single file in ‘.fastq’ 
 59 
(Illumina platform) or ‘.fasta’ (Roche 454 platform) format, (ii) 
alignment files (‘.bam’ or ‘.sam’). Alternatively, the user can also 
select an example file to run the analysis. 
3. Annotation. User can upload custom annotation or use standard 
annotation by interrogating the internal database. 
4. Setting Parameters. Number of Mismatches and sequences of 
Trimming adaptors should be set before launching the analysis.  
 
There are two main components of the web-tool: the first one is the execution 
of Genomic analysis and the second is the performance of Case Sample Files. 
Genomic analysis is mandatory, a user can decide to perform only this step of 
the analysis if his/her objective is the definition of the ORF-eome of a intron-
less genome. The analysis on Case Sample files can be performed only if 
Genomic analysis has been executed, and users can include one or more 
Case Samples in the analysis. The web-tool provides a progress bar that is 
located at the bottom of the web page and shows the processing step of a job 
in real time (Figure 14). 
 
 
Figure 14 - Screenshot of Interactome-Sequencing webtool input. Input files allowed are FastQ 
single or paired end, Fasta or alignment file in format BAM. Others input files mandatory for the 
execution are the genome sequence and annotation file.   
 
 
 60 
7.5.3. Output visualization and description 
As shown in Figure 15 the output result of an analysis, performed with the 
Interactome-Seq web-tool, is a tabular file in which all the putative domains 
detected and/or found statistically enriched, respect to the Genomic Sample, 
are reported. The output file is organized in eight columns containing the 
following information and values (Figure 15):  
• Chromosome 
• Start of putative domain 
• End of putative domain 
• Strand  
• Gene (ID or name of the gene associated with domain)  
• Description (Gene Annotation) 
• Q-Value  
• Fold Change 
These two last values can be used to order domains and/or filter out only 
statistically significantly enriched domains (for example: Q-Value<0.05 and 
Fold Change>2 or <0.5) The web-tool allows to sort lists for each of the fields 
previously described and to download files in tab separated format.  
 
The Interactome-Seq web-tool that I implemented will be useful for scientists 
without any programming skills, and will provide a fast method to quickly 
analyse Interactome-seq datasets. 
Previously, as I mentioned in the Introduction part of this Thesis, the tool used 
up to date, for interactome sequencing data analysis, was NGS-Trex [131], but 
this web-tool was originally created for analysing RNAseq data thus resulting 
quite inconsistent for the analysis of phage libraries sequencing data, being 
also no longer suitable to work with Illumina reads.. 
Recently a paper, in which an approach similar to our Interactome sequencing 
analysis was applied, has been published [145]. In this paper phage diplay 
was coupled with NGS and data analysis was performed. A statistical 
approach, similar to the one that we here describe, based on a two sided 
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parametric t-test, was applied. Sequencing data deriving from an experiment in 
which  a phage library that displays random 7-mer peptides was challenged 
against suspensions of M. tuberculosis, were analysed to identify peptides that 
bind mycobacteria.  
I used the statistical approach described in this recent paper as a scaffold to 
implement my pipeline and to integrate all the consecutive data analysis steps 
previously described. 
The result is a new pipeline statistically consistent and highly flexible that, 
thanks to its integration into the web-tool will be available to a wide plethora of 
users.   
  
 
Figure 15 - Screenshot of Interactome-Sequencing webtool output. The figure shows an 
example of output generated, for each putative domains the information reported is 
Chromosome, that is the name of chromosome used for alignment of the 
reads,Start,End,Strand,Gene Name that are fields with information about coordinates of putative 
domains and CDS associated, Q-Value and Fold Change are fields derived from statistical 
testing. Output can be downloaded or sorted using the arrows near the colums name.  
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7.6. Novel biomarker identification 
The web-tool previously described was used to analyse data deriving both 
from genomic phage libraries and from selections phage libraries sequencing. 
 
7.6.1. Analysis of the two genomic phage libraries 
The two genomic phage libraries constructed, starting from the two strains HP-
26695 and HP-B128, were analysed with my new Interactome–seq pipeline in 
order to define the Domains filtered out by our filtering strategy and to compare 
them between the two strains. 
In Table 6 the sequencing metrics for all the phage libraries obtained are 
reported. More than 1.4 million and more than 1 million reads were produced 
for HP-26695 and for HP-B128 phage libraries respectively, thus reaching a 
total genome coverage of more than 76X and 77X for HP-26695 and HP-
B128(B8). When analysing the coverage inside CDSs we found that more than 
93% and  89% of the total CDSs of HP-26695 and of HP-B128 where 
represented in  their respective genomic phage libraries, and the percentages 
of nucleotide covered by reads inside CDSs were respectively 73.5% and 
76.8%. The first step of the Interactome-seq pipeline (i.e. Putative Domain 
Detection) identified a total of 1761 Domains represented into the HP-26695 
phage library and 1237 Domains in the HP-B128 phage library (Table 7) (see 
APPENDIX 10.3); it should be noted that the number of domains detected can 
be higher than the number of total CDSs of the genome because more than 
one domain can be found inside a single CDS.  
To understand if the domains, found in common CDSs, represented inside the 
two phage libraries have the same features, in terms the portions of the CDS 
filtered out, I compared their aminoacidic sequences by blasting all the HP-
26695 domains against all the HP-B128 domains using BLASTx (search 
protein databases using a translated nucleotide query).The blasting step was 
performed by imposing the following parameters: aminoacidic sequence 
identity>30% and length overlapping>50%. Among the 1268 common domains 
98,82% have an aminoacid sequence identity more than 30% and 60% of 
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them have an overlap of the aminoacid sequence lenght higher than 50%. 
Thus after this preliminary comparative evaluation we can conclude that the 
two instruments constructed (i.e. HP-26695 and HP-B128 phage libraries) can 
be considered equally representative of H. pylori  domainome and can be used 
both separated or mixed together for the selection steps with sera from 
patients. 
  
7.6.2. Analysis of the three selections phage libraries 
The selections against sera from patients who developed: Gastric Cancer 
(selection A), Autoimmune Gastritis (selection B) and MALT lymphoma 
(Seleciton C) (Table3), were performed by using both genomic phage libraries 
previously obtained and described. The two genomic phage libraries of HP-
26695 and of HP-B128 were mixed up in equimolar concentration and then the 
pool of the two libraries was challenged against pools of sera from patients 
with the three different pathological outcomes. In the three selection steps we 
pooled together respectively 2 gastric cancer (sel A), 3 autoimmune gastritis 
(sel B), 2 MALT lymphoma (sel C) sera from patients HP positive, and 6 sera 
from healthy patients both HP positive or negative. 
The pooling of the two phage libraries was aimed at exploiting at maximum 
level their potentiality in terms of HP domains repertoire and it was validly 
justified by the previously described comparative analysis that demonstrated 
their complete functional similarity. The pooling of sera was necessary to 
reduce the inter-individual variability of antibody titer. In Table 6 the 
sequencing metrics for all the three selection phage libraries are reported. 
A total of more than 9 million paired end reads of 250 bp in length, were 
produced by sequencing the four selection phage libraries. For each selection 
library we generated 2.169.178 reads for Control, 815.891 reads for Selection 
A, 3.737.010 reads for Selection B and 1.633.626 reads for Selection C. After 
the alignment step, we mapped respectively 1.294.576 (71,97%), 503.401 
(73,94%), 2.563.391 (81,37%), 961.686 (75,22%) reads for the Control and for 
the three Selections A, B and C, and we observed that the total number of 
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CDSs covered at least by 10 reads were 1225, 1130, 1331, 1263 respectively. 
However, even if the number of CDSs represented inside the four selection 
phage libraries was high, and comparable with that obtained for the genomic 
phage library (Table 6), the percentage of nucleotides covered inside those 
CDSs decreased to 48,44% (control), 61,86% (sel A), 52,01%(sel B) and 44,97% 
(sel C). This result shows that the diversity of the libraries obtained after 
selections with patients’ sera was significantly reduced demonstrating that  
specific enrichment of precise portions of CDSs/Domains occurred, and that 
probably specific epitopes have been recognized by the antibodies, presents 
inside the sera from patients, as expected. 
	
 
HP-26695 
 
HP-B128 Control SelA SelB SelC 
Raw Reads 1.425.554  1.031.956 2.169.178 815.891 3.737.010 1.633.626 
Reads after trimming 1.216.124  954.895 1.798.722 680.764 3.149.939 1.278.335 
Mapping Reads 1.114.184  746.325 1.294.576 503.401 2.563.391 961.686 
% of Mapping reads 91,61%  89,10% 71,97% 73,94% 81,37% 75,22% 
Unmapping Reads 11158  158301 166,831 113,397 257,481 128,346 
Mean Coverage  76,81X  76,81X 96,13X 31,19X 155,82X 56,97X 
CDS covered  1372  1597 1225 1130 1331 1263 
% CDS covered   93,46%  93,80% 83,44% 76,97% 90,66% 86,03% 
Nucleotides covered inside CDS 1068020  1164096 703739 898694 755447 653331 
% of Nucleotide covered inside CDS 73,51%  76,80% 48,44% 61,86% 52,01% 44,97% 
	
Table 6 - Summary of mapping metrics of Genomic phage library and Selection libraries. The 
metrics reported are the total number of reads sequenced (Raw reads), number of reads after 
trimming step (Reads after trimming), number of mapping reads (Mapping reads) and 
percentage of mapping compare to the total number of reads (% of Mapping reads), number of 
unmapped reads (Unmapped reads), mean coverage is a parameter derived from number of 
reads * read length / genome size (Mean Coverage), the number of CDS covered is the number 
of CDS with almost 10 reads mapping, the percentage of CDS covered is number of CDS 
covered * 100/ total number of CDS annotated,number of nucleotides is the number of bases 
with depth different of 0 and the percentage of nucleotide covered inside CDS is the Nucleotides 
covered inside CDS* 100/total CDS nucleotide length. 
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7.6.2. Identification of common and/or specific biomarkers for HP 
infection progression 
The Interactome–seq data analysis pipeline identified  535, 627, 780 and 652 
putative domains respectively present in the Control and A, B, C selection 
phage libraries (Table 7). Afterwards through the second step of the analysis 
the domains differentially enriched (Q-value<0.05 and Focus>0.8) in the  
selection phage libraries respect to the genomic phage libraries were 
determined. As shown in Table 7, the number of  domains found significantly 
enriched are 115, 125, 183 and 117 respectively for the Control, A, B and C 
selections. Then the last step of the analysis was applied and output lists were 
parsed to generate sub-lists of domains/epitopes specific for the pathological 
outcomes and absent in the healthy controls. This step was carried out in order 
to eliminate poly-reactive domains and consists of a simple subtractive 
comparison between the domains lists of Selections A, B and C and the list of 
the Control selection  
 
HP-26695 Control SelA SelB SelC 
Putative Domains  1761 535 627 780 652 
DEG Domains  ### 115 125 183 117 
Domains subtracted Control ### ### 61 127 49 
 
Table 7 - Overview of putative domains detected, enriched and specific for selections. The first 
line of table shows the total of Putative domains that are detected for HP-26695 ORF-filtering 
library, Control and all Selections, the second line of table shows the total number of domains of  
Contol and Selections that are enriched compare to Genomic HP-26695 ORF-filtering library, in 
the third line are reported the domains of Selection A, B and C that are resulting after the 
exclusion of that domains in common with Control Selection. DEG: Differentially Expressed 
Gene 
 
The Venn diagram in Figure 16 shows the result of this last part of the 
analysis. It is evident that the most of the enriched domains, found after 
selections against sera (in total 138), are specific for the three pathological 
outcomes: Selection A (25), Selection B (85) and Selection C (28), while only 
45 enriched domains are common to two or to all the selections.  
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Figure 16 - Venn diagram of specific and common putative antigens. The Venn diagram shows 
the number of different CDS shared between the libraries. Group A represents sera from 
individuals affected by gastric adenocarcinoma, Group B represents sera from individuals 
affected by autoimmune gastritis and group C is sera from patients affected by MALT 
lymphoma.  
This result  is really promising, indeed our Interactome-Seq approach coupled 
with Interactome web-tool data analysis, allowed the identification of many 
putative domains specifc for the three different pathological outcomes under 
study.  
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7.6.3. Validation of one target for HP infection progression 
 
As previously elucidated, it is very important to find novel biomarkers that can 
provide a “disease signature” for different pathological outcomes, or at least 
biomarkers associated to HP infection progression towards serious diseases.  
Among the sub-lists of domains/epitopes specific for Gastric Cancer, 
Autoimmune Gastritis, MALT lymphoma and absent in the Healthy controls we 
selected the top list ones, having the highest Fold Change values (see 
APPENDIX 10.3-10.4-10.5-10.6-10.7-10.8-10.9) as putative targets for 
validation with ELISA assay. 
Our attention was, from the beginning, captured by the HP0527 gene domains 
filtered out by our approach and resulting significantly enriched after the 
selections. This gene also named cagY/cag7  encodes for a large protein of 
1927 aminoacids that has been described by Liu et al [149] as one of the main 
components of H. pylori cag T4SS-associated pilum. Interestingly, CagY has 
an unusual domain structure, in which a number of direct repeats is predicted 
to cause rearrangements that invariably yield in-frame insertions or deletions 
[150]. Recent infection studies in murine and non-human primate models have 
shown that the rearrangements in CagY are sufficient to cause gain or loss of 
function in the H. pylori T4SS and are driven by the host immune system [151]. 
It was therefore proposed that CagY may function as a sort of molecular switch 
that alters the function of the T4SS and tunes CagA injection and host pro-
inflammatory responses. A majority of H. pylori-positive MALT lymphoma 
patients were serum positive for CagA (9, 10), leading to the hypothesis that 
CagA might be one causative factor in MALT lymphoma. This observation 
could be supported by our results, as a matter of fact we find a portion of CagY 
highly enriched among the top list domains specific for the MALT selection (sel 
C). At the same time we found highly enriched also other portions of the CagY 
gene among the top list domains specific for the Gastric Cancer selection (sel 
A) but also among the top list domains common to all the three pathological 
conditions. 
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So we selected two different portions of this gene corresponding to: 
1. the domain identified between aminoacidic positions 600 and 853 
2. the domain identified between aminoacidic positions 344 and 396 
The first one resulted commonly enriched and differential in all the three 
selections (Figure 17 panel A red box) while the second one is specific for the 
MALT selection (sel C) and has a very high Fold Change of 7,71 and a length 
of 761 bp (Figure 17 panel A blue box). 
Both these domains were excised from the phagemid vector and cloned into a 
compatible pGEX-FLAG  [130] vector, creating for each output of selection a 
library for the expression of the selected domain as GST-fusion product (see 
materials and methods section 6.6)(Figure 17 panel B). 
Up to date it was possible to purify the correct recombinant protein only for the 
first of the two domains, the second one seems to be less soluble and further 
attempts for purification are ongoing. 
To investigate possible cross-reactivity and specificity of the first domain an 
antibody-capture ELISA assay was implemented (Figure 17 panel B) and a 
large number of sera, from HP positive and negative Healthy patients (51 
sera), from patients with Gastric cancer (29 sera), Autoimmune gastritis (10 
sera) and MALT lymphoma (6 sera) were tested (Figure 17 panel C). 
It should be noted that the number of patients affected by Autoimmune 
Gastritis and MALT lymphoma, that was possible to recruit, is much less than 
the number of patients affected by Gastric Cancer because these two 
outcomes are rare diseases. 
ELISA results show that all the Control Sera (healthy patients) are non-reactive 
independently from being HP positive or negative, so from this first result we 
can infer that the domain tested is specific for infection progression towards 
serious outcomes and not simply related to HP infection. Then looking at the 
results obtained with the sera from sick patients we found that almost all the 
sera of HP negative ill patients resulted non-reactive while for the sera of HP 
positive patients we obtained very high percentages of positive reactivity:  90% 
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for Gastric Cancer (9 over 10 sera); 75% for Autoimmune Gatsritis (3 over 4 
sera) and finally 83% for MALT Lymphoma (5 over 6 sera) (Figure 17 panel D).  
Thus after ELISA validation we can conclude that this first CagY domain could 
become a good new biomarker for HP infection progression towards serious 
pathologies. We expect to obtain much more specific results for the second 
CagY domain, that we are trying to purify, especially for MALT sera, because, 
as it can be appreciated from Figure 17 panel A blue box, this portion of the 
gene seems to be specifically enriched after selection with MALT sera (Sel C). 
We have already started to purify other specific domains indentified from our 
analysis for further ELISA validation assays. 
In the next future we will increase the number of sera of patients, that will be 
recruited over time; furthermore, we will continue with ELISA test validation on 
other new markers specific for gastric adenocarcinoma,  autoimmune gastritis 
and MALT lymphoma.  
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 Figure 17 - Schematic overview of HP0527 ELISA validation. Panel A shows genomic browser 
tracks of HP0527 for genomic and all selections. Panel B shows domains that were excised from 
the phagemid vector and cloned into a compatible pGEX-FLAG vector. Panel C shows ELISA 
test sera number used for validation. Panel D shows results of ELISA assay.  
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8. CONCLUSION AND FUTURE DIRECTIONS 
In  this section I will summarize the results obtained during the Thesis work 
and the future perspectives. 
The diagnosis of Gastric Cancer and MALT lymphoma is not easy because 
patients do not show notable symptoms of illness in early onset stages, at the 
same time they progress rapidly. The possibility of doing an early diagnosis 
increases the opportunity to save time for active therapy and to improve the 
survival rate of patients. Many of the previous studies, aiming at biomarkers 
discovery, were hypothesis-driven, limiting the identification of clinically 
significant antigens to those directed against proteins that had been already 
described in pathological outcomes associated with H. pylori infection. The 
Interactome Sequencing approach, here proposed and described, is an ideal 
unbiased and powerful high-throughput strategy to identify novel antigenic 
targets. We have exploited the huge data output generated by high throughput 
sequencing to investigate samples having great complexity, specifically sera 
samples from patients with different pathological outcomes.  
In this thesis work I was able to identify lists of new putative common and 
specific antigens by: i) constructing ORF genomic filtered libraries from two 
strains of H. pylori, HP-26695 and HP-B128; ii) developing a dedicated web-
tool for Interactome-seq data analysis iii) selecting the genomic phage libraries 
with sera from patients affected by gastric adenocarcinoma, autoimmune 
gastritis and MALT lymphoma and iv) validating one enriched protein domain 
specific for infection progression.  
Overall, we produced a panel of putative specific domains for three different 
pathological outcomes, these targets could be validated in the next future 
comprehensibly associated to the onset of serious diseases related to HP 
infection.  
The  new data analysis pipeline here developed and the web-tool implemented 
has been designed taking into consideration several factors: first of all it is 
compatible with all sequencing platforms outputs, secondly the “blind” 
detection of putative domains is very important for reducing the noise 
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background typical of approaches based on phage display coupled with NGS. 
Compared to softwares previously used for performing this kind of analysis 
(NGS-TRex), the Interactome-seq pipeline allows the identification of more 
than one putative domain/epitope from each protein, thus enabling to 
discriminate, for example, the portion of CagY specifically recognized by MALT 
sera from the portion commonly reactive by selections performed with all the 
three sets of sera tested.  
In order to make public and accessible this new pipeline a a web-tool was 
implemented; this is a user-friendly web interface that doesn't require any 
programming skills, thus allowing every user to perform Interactome-Seq 
analysis starting from raw-sequencing data, to sort and visualize the outputs 
and if needed to download the domain lists in tabular format for interpolation 
with other results. 
In conclusion this thesis work demonstrated that the Interactome-Seq 
technology is an easily available and powerful strategy, which can help 
deciphering the molecular mechanisms involved in modulating host immune 
response. 
Providing a new web-tool for data analysis the way to detection of new 
biomarkers by applying innovative approaches based on interactome 
sequencing strategy was open. 
The release of this tool is timely and relevant for the scientific and clinical 
community as the importance of using new unbiased experimental and data 
analysis approaches to discover new biomarkers, for improving early diagnosis 
of H. pylori infection progression towards serious pathological outcome, is 
among the WHO priorities. 
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10. APPENDIX 
 
10.1. Synteny plot of HP-26695 and HP-B128 
 
10.2. HP-26695 Genomic Domains 
CHR START END GENE_ID 
NC_000915 2750 3018 HP0005 
NC_000915 9339 9574 HP0011 
NC_000915 16862 17165 HP0018 
NC_000915 20596 20890 HP0021 
NC_000915 27157 27358 HP0026 
NC_000915 27642 28180 HP0027 
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NC_000915 28900 29293 HP0028 
NC_000915 31960 32344 HP0031 
NC_000915 34508 34722 HP0033 
NC_000915 41162 41382 HP0043 
NC_000915 43242 43482 HP0045 
NC_000915 47004 47542 HP0048 
NC_000915 50497 50927 HP0051 
NC_000915 52551 53065 HP0053 
NC_000915 61618 61828 HP0057 
NC_000915 67353 67792 HP0063 
NC_000915 75066 75320 HP0071 
NC_000915 84358 84667 HP0080 
NC_000915 87828 88141 HP0082 
NC_000915 98567 98901 HP0092 
NC_000915 100684 101444 HP0096 
NC_000915 101645 102356 HP0097 
NC_000915 112851 113200 HP0105 
NC_000915 115793 115996 HP0108 
NC_000915 124752 125086 HP0116 
NC_000915 128034 128489 HP0118 
NC_000915 128534 128964 HP0118 
NC_000915 135989 136323 HP0123 
NC_000915 143701 144650 HP0133 
NC_000915 144688 144835 HP0133 
NC_000915 149234 149334 HP0138 
NC_000915 152748 153301 HP0141 
NC_000915 153513 153628 HP0141 
NC_000915 156608 156999 HP0144 
NC_000915 160724 161118 HP0150 
NC_000915 167975 168396 HP0159 
NC_000915 178792 178988 HP0172 
NC_000915 181234 181434 HP0174 
NC_000915 181498 181717 HP0174a 
NC_000915 184797 185017 HP0178 
NC_000915 185865 186178 HP0179 
NC_000915 187996 188197 HP0181 
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NC_000915 188808 189236 HP0182 
NC_000915 194280 194374 HP0186 
NC_000915 201347 201606 HP0194 
NC_000915 202115 202470 HP0195 
NC_000915 210515 211056 HP0205 
NC_000915 212346 212878 HP0207 
NC_000915 213992 214434 HP0208 
NC_000915 216274 217226 HP0210 
NC_000915 219112 219302 HP0212 
NC_000915 222219 222375 HP0214 
NC_000915 222572 223080 HP0214 
NC_000915 234129 234412 HP0226 
NC_000915 237950 238457 HP0228 
NC_000915 238752 239071 HP0229 
NC_000915 243848 244379 HP0234 
NC_000915 246048 246165 HP0235 
NC_000915 246311 246588 HP0236 
NC_000915 246637 247082 HP0237 
NC_000915 252286 252662 HP0243 
NC_000915 255066 255396 HP0246 
NC_000915 258812 259536 HP0250 
NC_000915 263313 264080 HP0254 
NC_000915 264209 264599 HP0254 
NC_000915 271082 271647 HP0262 
NC_000915 271940 272436 HP0263 
NC_000915 274800 275196 HP0264 
NC_000915 275249 275546 HP0265 
NC_000915 281385 281576 HP0271 
NC_000915 285031 285280 HP0277 
NC_000915 292078 292479 HP0283 
NC_000915 297483 297726 HP0288 
NC_000915 298023 298299 HP0289 
NC_000915 305966 306705 HP0289 
NC_000915 313299 313663 HP0295 
NC_000915 315584 316040 HP0298 
NC_000915 316398 317096 HP0298 
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NC_000915 319842 319981 HP0301 
NC_000915 330903 331245 HP0316 
NC_000915 339414 339957 HP0323 
NC_000915 341636 342159 HP0326 
NC_000915 342227 342588 HP0326 
NC_000915 344522 344772 HP0329 
NC_000915 344953 345222 HP0329 
NC_000915 347606 347771 HP0333 
NC_000915 347848 347942 HP0333 
NC_000915 350699 350961 HP0339 
NC_000915 351632 351926 HP0342 
NC_000915 357559 358061 HP0349 
NC_000915 358325 358586 HP0350 
NC_000915 359148 359592 HP0351 
NC_000915 364020 364398 HP0354 
NC_000915 367318 367751 HP0357 
NC_000915 371481 371824 HP0361 
NC_000915 372084 372523 HP0362 
NC_000915 372964 373223 HP0363 
NC_000915 373261 373592 HP0363 
NC_000915 375534 375745 HP0366 
NC_000915 388335 388540 HP0378 
NC_000915 394214 394278 HP0383 
NC_000915 397675 398081 HP0388 
NC_000915 399370 399797 HP0390 
NC_000915 409033 409294 HP0398 
NC_000915 409706 409782 HP0399 
NC_000915 410825 411101 HP0399 
NC_000915 411443 411768 HP0400 
NC_000915 413340 413665 HP0402 
NC_000915 415062 415369 HP0402 
NC_000915 416701 416947 HP0404 
NC_000915 417345 417787 HP0405 
NC_000915 418393 418496 HP0406 
NC_000915 426979 427076 HP0414 
NC_000915 429602 429966 HP0416 
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NC_000915 430007 430078 HP0416 
NC_000915 430898 431265 HP0417 
NC_000915 435116 435532 HP0421 
NC_000915 437633 437784 HP0422 
NC_000915 441193 441440 HP0425 
NC_000915 457407 458128 HP0440 
NC_000915 465205 465587 HP0447 
NC_000915 466275 466510 HP0448 
NC_000915 468416 468662 HP0451 
NC_000915 471452 471869 HP0453 
NC_000915 471925 472218 HP0453 
NC_000915 482819 483147 HP0464 
NC_000915 485132 485328 HP0464 
NC_000915 485678 485904 HP0464 
NC_000915 487048 487349 HP0465 
NC_000915 487385 487874 HP0465 
NC_000915 487933 488302 HP0466 
NC_000915 488473 488677 HP0466 
NC_000915 489251 489441 HP0468 
NC_000915 491430 491662 HP0470 
NC_000915 491706 491872 HP0470 
NC_000915 492420 492697 HP0470 
NC_000915 494390 494939 HP0472 
NC_000915 495941 496238 HP0474 
NC_000915 497521 497891 HP0476 
NC_000915 501188 501462 HP0478 
NC_000915 505373 505686 HP0482 
NC_000915 523544 523700 HP0497 
NC_000915 525005 525134 HP0498 
NC_000915 531423 531718 HP0505 
NC_000915 534062 534201 HP0508 
NC_000915 539972 540398 HP0513 
NC_000915 540439 540659 HP0513 
NC_000915 541679 541949 HP0513 
NC_000915 542009 542405 HP0514 
NC_000915 545917 546002 HP0518 
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NC_000915 546489 547094 HP0519 
NC_000915 551488 551887 HP0524 
NC_000915 553687 553922 HP0526 
NC_000915 556188 556615 HP0527 
NC_000915 561239 561572 HP0528 
NC_000915 561680 562240 HP0529 
NC_000915 563419 563993 HP0530 
NC_000915 564421 565037 HP0531 
NC_000915 566332 566693 HP0534 
NC_000915 567168 567493 HP0535 
NC_000915 571310 571583 HP0539 
NC_000915 575313 576186 HP0544 
NC_000915 576363 576712 HP0544 
NC_000915 587251 587527 HP0552 
NC_000915 590683 591061 HP0556 
NC_000915 591724 592439 HP0557 
NC_000915 593321 593616 HP0558 
NC_000915 594171 594273 HP0559 
NC_000915 595016 595247 HP0561 
NC_000915 597616 597940 HP0565 
NC_000915 602303 602676 HP0570 
NC_000915 604551 604780 HP0572 
NC_000915 605318 605737 HP0574 
NC_000915 613103 613578 HP0582 
NC_000915 614858 615183 HP0584 
NC_000915 628704 629038 HP0595 
NC_000915 634050 634279 HP0599 
NC_000915 634313 634419 HP0599 
NC_000915 635442 635932 HP0600 
NC_000915 637289 637383 HP0601 
NC_000915 639068 639378 HP0602 
NC_000915 646838 647002 HP0608 
NC_000915 658734 658965 HP0614 
NC_000915 659821 660296 HP0615 
NC_000915 664090 664396 HP0618 
NC_000915 668383 668698 HP0621 
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NC_000915 669845 669981 HP0623 
NC_000915 675641 676047 HP0629 
NC_000915 681576 682018 HP0634 
NC_000915 683275 683592 HP0635 
NC_000915 691274 691581 HP0645 
NC_000915 695504 696012 HP0649 
NC_000915 696062 696326 HP0650 
NC_000915 710343 710500 HP0662 
NC_000915 711840 712255 HP0664 
NC_000915 712583 713073 HP0665 
NC_000915 719861 720393 HP0670 
NC_000915 722804 723057 HP0672 
NC_000915 724866 725065 HP0674 
NC_000915 732159 732513 HP0682 
NC_000915 736161 736382 HP0686 
NC_000915 743319 743580 HP0693 
NC_000915 748765 749324 HP0696 
NC_000915 752549 752745 HP0701 
NC_000915 762808 763267 HP0709 
NC_000915 766157 766390 HP0711 
NC_000915 773728 773939 HP0721 
NC_000915 794040 794302 HP0739 
NC_000915 798735 798905 HP0743 
NC_000915 801910 802058 HP0746 
NC_000915 809666 809937 HP0755 
NC_000915 809993 810267 HP0755 
NC_000915 810370 810748 HP0757 
NC_000915 811715 812383 HP0758 
NC_000915 813548 813910 HP0759 
NC_000915 815553 816147 HP0761 
NC_000915 817931 818133 HP0764 
NC_000915 819099 819378 HP0765 
NC_000915 819409 819836 HP0766 
NC_000915 819925 820213 HP0766 
NC_000915 822798 823195 HP0770 
NC_000915 823318 823477 HP0771 
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NC_000915 826297 826409 HP0773 
NC_000915 831369 831751 HP0778 
NC_000915 835101 835587 HP0781 
NC_000915 837900 838228 HP0783 
NC_000915 839632 839954 HP0786 
NC_000915 842312 842790 HP0787 
NC_000915 844821 844938 HP0788 
NC_000915 847584 847882 HP0791 
NC_000915 848115 848599 HP0791 
NC_000915 850760 850974 HP0793 
NC_000915 851070 851296 HP0794 
NC_000915 857557 858127 HP0803 
NC_000915 858233 858360 HP0804 
NC_000915 859765 860171 HP0805 
NC_000915 867029 867507 HP0813 
NC_000915 869926 870322 HP0817 
NC_000915 872480 872733 HP0819 
NC_000915 872930 873353 HP0820 
NC_000915 876506 876789 HP0823 
NC_000915 876903 877108 HP0824 
NC_000915 879410 879638 HP0827 
NC_000915 880025 880542 HP0828 
NC_000915 888470 888690 HP0836 
NC_000915 888960 889051 HP0837 
NC_000915 891218 891388 HP0839 
NC_000915 893756 894062 HP0842 
NC_000915 894148 894494 HP0842 
NC_000915 895836 895969 HP0844 
NC_000915 898918 899443 HP0846 
NC_000915 907123 907489 HP0854 
NC_000915 909944 910335 HP0856 
NC_000915 910541 910836 HP0857 
NC_000915 912335 912447 HP0859 
NC_000915 915419 915893 HP0863 
NC_000915 916013 916527 HP0863 
NC_000915 919264 919490 HP0867 
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NC_000915 922840 923104 HP0871 
NC_000915 923868 924139 HP0872 
NC_000915 930747 931075 HP0879 
NC_000915 932856 933115 HP0883 
NC_000915 933177 933328 HP0883 
NC_000915 933394 933857 HP0884 
NC_000915 934470 934742 HP0884 
NC_000915 937838 938190 HP0886 
NC_000915 942346 942720 HP0888 
NC_000915 946427 946611 HP0894 
NC_000915 950227 950360 HP0897 
NC_000915 963697 963773 HP0911 
NC_000915 964084 964571 HP0911 
NC_000915 969287 969691 HP0914 
NC_000915 969741 969859 HP0914 
NC_000915 975003 975682 HP0919 
NC_000915 994172 994373 HP0933 
NC_000915 995566 995987 HP0935 
NC_000915 997101 997701 HP0936 
NC_000915 999225 999413 HP0938 
NC_000915 1000759 1001003 HP0940 
NC_000915 1001336 1001949 HP0941 
NC_000915 1003728 1004032 HP0943 
NC_000915 1004307 1004458 HP0943 
NC_000915 1004970 1005306 HP0944 
NC_000915 1005801 1006038 HP0944a 
NC_000915 1011804 1012177 HP0951 
NC_000915 1015890 1016317 HP0957 
NC_000915 1020161 1020276 HP0961 
NC_000915 1020454 1020650 HP0962 
NC_000915 1021742 1021911 HP0963 
NC_000915 1024407 1024567 HP0965 
NC_000915 1026447 1026657 HP0967 
NC_000915 1032097 1032478 HP0971 
NC_000915 1033052 1033407 HP0972 
NC_000915 1033472 1033884 HP0972 
 97 
NC_000915 1034744 1034969 HP0973 
NC_000915 1035031 1035197 HP0973 
NC_000915 1040627 1041110 HP0978 
NC_000915 1051287 1051472 HP0988 
NC_000915 1055621 1055829 HP0994 
NC_000915 1058567 1058764 HP0996 
NC_000915 1061684 1062105 HP0998 
NC_000915 1062696 1063273 HP1000 
NC_000915 1063435 1063691 HP1001 
NC_000915 1064579 1064865 HP1002 
NC_000915 1068092 1068362 HP1006 
NC_000915 1070070 1070167 HP1008 
NC_000915 1073747 1073937 HP1010 
NC_000915 1077507 1077607 HP1013 
NC_000915 1077878 1078203 HP1014 
NC_000915 1079526 1079615 HP1016 
NC_000915 1082513 1082727 HP1019 
NC_000915 1085696 1086096 HP1022 
NC_000915 1088600 1088766 HP1025 
NC_000915 1089778 1090034 HP1026 
NC_000915 1090378 1090496 HP1027 
NC_000915 1091219 1091682 HP1029 
NC_000915 1093317 1093639 HP1031 
NC_000915 1101723 1101913 HP1041 
NC_000915 1103157 1103563 HP1042 
NC_000915 1107082 1107262 HP1045 
NC_000915 1109196 1109494 HP1046 
NC_000915 1112679 1112781 HP1048 
NC_000915 1113953 1114376 HP1051 
NC_000915 1116345 1116514 HP1054 
NC_000915 1124840 1125113 HP1065 
NC_000915 1126656 1126891 HP1068 
NC_000915 1127734 1127994 HP1069 
NC_000915 1129922 1130004 HP1071 
NC_000915 1132791 1132946 HP1073 
NC_000915 1135600 1135871 HP1076 
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NC_000915 1138149 1138495 HP1079 
NC_000915 1138897 1139274 HP1080 
NC_000915 1148973 1149187 HP1089 
NC_000915 1152212 1152543 HP1090 
NC_000915 1153779 1153960 HP1091 
NC_000915 1154694 1154869 HP1091 
NC_000915 1158084 1158505 HP1096 
NC_000915 1166498 1166655 HP1105 
NC_000915 1170806 1170873 HP1109 
NC_000915 1170927 1171077 HP1109 
NC_000915 1173477 1173861 HP1112 
NC_000915 1174043 1174284 HP1112 
NC_000915 1174394 1174721 HP1112 
NC_000915 1177137 1177472 HP1114 
NC_000915 1181738 1181976 HP1117 
NC_000915 1187736 1187938 HP1121 
NC_000915 1188624 1188715 HP1123 
NC_000915 1191488 1191945 HP1126 
NC_000915 1193310 1193695 HP1130 
NC_000915 1199218 1199653 HP1137 
NC_000915 1201115 1201308 HP1139 
NC_000915 1201480 1201820 HP1140 
NC_000915 1217000 1217500 HP1153 
NC_000915 1227036 1227441 HP1161 
NC_000915 1231304 1231489 HP1166 
NC_000915 1236909 1237113 HP1169 
NC_000915 1237337 1237411 HP1170 
NC_000915 1237931 1238373 HP1171 
NC_000915 1246053 1246369 HP1178 
NC_000915 1250863 1251116 HP1182 
NC_000915 1252456 1252759 HP1183 
NC_000915 1262097 1262393 HP1191 
NC_000915 1262487 1262920 HP1191 
NC_000915 1268024 1268205 HP1197 
NC_000915 1278505 1278953 HP1201 
NC_000915 1283324 1283823 HP1206 
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NC_000915 1287311 1287484 HP1210 
NC_000915 1290705 1291093 HP1214 
NC_000915 1293588 1293872 HP1217 
NC_000915 1295052 1295159 HP1218 
NC_000915 1295199 1295391 HP1218 
NC_000915 1301546 1301688 HP1226 
NC_000915 1304802 1305336 HP1230 
NC_000915 1305466 1305932 HP1231 
NC_000915 1308085 1308592 HP1234 
NC_000915 1308723 1308981 HP1234 
NC_000915 1316882 1317051 HP1242 
NC_000915 1320697 1321038 HP1245 
NC_000915 1323240 1323634 HP1248 
NC_000915 1324883 1325418 HP1249 
NC_000915 1327169 1327568 HP1252 
NC_000915 1342119 1342789 HP1269 
NC_000915 1343454 1343645 HP1271 
NC_000915 1345308 1345576 HP1272 
NC_000915 1351730 1352015 HP1276 
NC_000915 1356738 1356953 HP1281 
NC_000915 1359894 1360354 HP1283 
NC_000915 1362133 1362349 HP1285 
NC_000915 1363199 1363711 HP1287 
NC_000915 1369403 1369725 HP1295 
NC_000915 1370618 1370862 HP1299 
NC_000915 1373120 1373205 HP1302 
NC_000915 1373542 1373762 HP1303 
NC_000915 1377988 1378100 HP1314 
NC_000915 1380913 1381004 HP1320 
NC_000915 1381105 1381187 HP1320 
NC_000915 1383358 1383689 HP1323 
NC_000915 1385782 1386064 HP1326 
NC_000915 1391144 1391455 HP1329 
NC_000915 1392295 1392495 HP1331 
NC_000915 1393798 1394101 HP1333 
NC_000915 1396544 1396851 HP1335 
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NC_000915 1398076 1398202 HP1337 
NC_000915 1398406 1398773 HP1338 
NC_000915 1404034 1404242 HP1344 
NC_000915 1404307 1404701 HP1344 
NC_000915 1408652 1409376 HP1349 
NC_000915 1410347 1410786 HP1350 
NC_000915 1410860 1411136 HP1350 
NC_000915 1411540 1412039 HP1351 
NC_000915 1417966 1418060 HP1356 
NC_000915 1420222 1420538 HP1359 
NC_000915 1439500 1439757 HP1375 
NC_000915 1439835 1440194 HP1375 
NC_000915 1440901 1441274 HP1377 
NC_000915 1448465 1448550 HP1386 
NC_000915 1451036 1451490 HP1390 
NC_000915 1451807 1452053 HP1391 
NC_000915 1455330 1455763 HP1394 
NC_000915 1456023 1456117 HP1395 
NC_000915 1457699 1458465 HP1397 
NC_000915 1461441 1461832 HP1400 
NC_000915 1463488 1463949 HP1400 
NC_000915 1467843 1468219 HP1403 
NC_000915 1469991 1470103 HP1403 
NC_000915 1471413 1471901 HP1406 
NC_000915 1472305 1472411 HP1407 
NC_000915 1491052 1491686 HP1421 
NC_000915 1495383 1495675 HP1424 
NC_000915 1500414 1501468 HP1430 
NC_000915 1504984 1505478 HP1433 
NC_000915 1505690 1505945 HP1433 
NC_000915 1506158 1506399 HP1434 
NC_000915 1506509 1506963 HP1434 
NC_000915 1513703 1513922 HP1440 
NC_000915 1514042 1514508 HP1441 
NC_000915 1518702 1518907 HP1450 
NC_000915 1551682 1552025 HP1479 
 101 
NC_000915 1553479 1554095 HP1479 
NC_000915 1554239 1554866 HP1480 
NC_000915 1556767 1557257 HP1483 
NC_000915 1557297 1557730 HP1484 
NC_000915 1559814 1560455 HP1487 
NC_000915 1566597 1566727 HP1493 
NC_000915 1566765 1567093 HP1493 
NC_000915 1567365 1567460 HP1494 
NC_000915 1572432 1572562 HP1499 
NC_000915 1574912 1575645 HP1503 
NC_000915 1582409 1582503 HP1508 
NC_000915 1583275 1583534 HP1509 
NC_000915 1586946 1587022 HP1512 
NC_000915 1598455 1599164 HP1521 
NC_000915 1603617 1603912 HP1523 
NC_000915 1604072 1604388 HP1524 
NC_000915 1606198 1606588 HP1527 
NC_000915 1609151 1609335 HP1530 
NC_000915 1609367 1609491 HP1530 
NC_000915 1614361 1614764 HP1535 
NC_000915 1619538 1620295 HP1541 
NC_000915 1621953 1622038 HP1542 
NC_000915 1621953 1622038 HP1543 
NC_000915 1628475 1628749 HP1549 
NC_000915 1628829 1629246 HP1549 
NC_000915 1631259 1631650 HP1552 
NC_000915 1636517 1636755 HP1555 
NC_000915 1638022 1638497 HP1556 
NC_000915 1640037 1640328 HP1557 
NC_000915 1645303 1645820 HP1563 
NC_000915 1653484 1653716 HP1572 
NC_000915 1654700 1655013 HP1574 
NC_000915 1655316 1655571 HP1575 
NC_000915 1661399 1661849 HP1583 
NC_000915 1662677 1663071 HP1584 
NC_000915 1663172 1663361 HP1584 
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NC_000915 1667177 1667672 HP1589 
9.3 
CHR START END GENE_ID 
NC_014256 154 1527 HPB8_1_154_1527 
NC_014256 1780 3186 HPB8_2_1780_3186 
NC_014256 5193 7038 HPB8_6_5193_7038 
NC_014256 7126 8537 HPB8_7_7126_8537 
NC_014256 8572 12060 HPB8_9_8572_12060 
NC_014256 12178 13128 HPB8_10_12178_13128 
NC_014256 13346 15741 HPB8_10_13346_15741 
NC_014256 15784 16064 HPB8_11_15784_16064 
NC_014256 16575 16955 HPB8_12_16575_16955 
NC_014256 17400 17611 HPB8_13_17400_17611 
NC_014256 17997 18992 HPB8_14_17997_18992 
NC_014256 19439 20448 HPB8_15_19439_20448 
NC_014256 20675 23264 HPB8_17_20675_23264 
NC_014256 23485 23755 HPB8_18_23485_23755 
NC_014256 23787 24133 HPB8_19_23787_24133 
NC_014256 24232 24779 HPB8_20_24232_24779 
NC_014256 30591 32878 HPB8_26_30591_32878 
NC_014256 32928 33357 HPB8_27_32928_33357 
NC_014256 33551 34675 HPB8_28_33551_34675 
NC_014256 34837 34970 HPB8_29_34837_34970 
NC_014256 35098 36365 HPB8_29_35098_36365 
NC_014256 36847 37146 HPB8_30_36847_37146 
NC_014256 37458 37711 HPB8_31_37458_37711 
NC_014256 38109 38230 HPB8_31_38109_38230 
NC_014256 38428 39392 HPB8_32_38428_39392 
NC_014256 40631 41553 HPB8_35_40631_41553 
NC_014256 41600 42831 HPB8_36_41600_42831 
NC_014256 42926 43482 HPB8_37_42926_43482 
NC_014256 43551 43793 HPB8_38_43551_43793 
NC_014256 43942 45534 HPB8_39_43942_45534 
NC_014256 45646 46101 HPB8_40_45646_46101 
NC_014256 66762 69290 HPB8_61_66762_69290 
NC_014256 69444 70186 HPB8_62_69444_70186 
NC_014256 70241 70649 HPB8_63_70241_70649 
NC_014256 76396 77448 HPB8_71_76396_77448 
NC_014256 77596 81944 HPB8_72_77596_81944 
NC_014256 82057 82357 HPB8_74_82057_82357 
NC_014256 82741 83355 HPB8_77_82741_83355 
NC_014256 85587 85728 HPB8_81_85587_85728 
NC_014256 85806 88235 HPB8_83_85806_88235 
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NC_014256 93324 93637 HPB8_90_93324_93637 
NC_014256 95188 95317 HPB8_93_95188_95317 
NC_014256 95361 95582 HPB8_94_95361_95582 
NC_014256 95615 96098 HPB8_95_95615_96098 
NC_014256 96222 96968 HPB8_96_96222_96968 
NC_014256 99457 99798 HPB8_97_99457_99798 
NC_014256 100186 100619 HPB8_98_100186_100619 
NC_014256 100667 100977 HPB8_99_100667_100977 
NC_014256 101290 101644 HPB8_101_101290_101644 
NC_014256 101774 102014 HPB8_102_101774_102014 
NC_014256 102087 102378 HPB8_103_102087_102378 
NC_014256 102584 102841 HPB8_105_102584_102841 
NC_014256 103035 103760 HPB8_106_103035_103760 
NC_014256 103812 104662 HPB8_107_103812_104662 
NC_014256 104716 105039 HPB8_108_104716_105039 
NC_014256 105307 105609 HPB8_108_105307_105609 
NC_014256 106241 106536 HPB8_112_106241_106536 
NC_014256 106796 107605 HPB8_113_106796_107605 
NC_014256 107649 109499 HPB8_114_107649_109499 
NC_014256 111921 112142 HPB8_117_111921_112142 
NC_014256 112442 112751 HPB8_118_112442_112751 
NC_014256 112982 113251 HPB8_119_112982_113251 
NC_014256 113401 114021 HPB8_120_113401_114021 
NC_014256 118103 119649 HPB8_124_118103_119649 
NC_014256 119688 120467 HPB8_126_119688_120467 
NC_014256 121531 121665 HPB8_128_121531_121665 
NC_014256 121757 121802 HPB8_128_121757_121802 
NC_014256 122042 123079 HPB8_129_122042_123079 
NC_014256 126051 126968 HPB8_133_126051_126968 
NC_014256 127107 128267 HPB8_134_127107_128267 
NC_014256 130155 130295 HPB8_137_130155_130295 
NC_014256 130332 130453 HPB8_137_130332_130453 
NC_014256 130570 130951 HPB8_137_130570_130951 
NC_014256 130998 131089 HPB8_137_130998_131089 
NC_014256 131244 132184 HPB8_137_131244_132184 
NC_014256 135792 136084 HPB8_143_135792_136084 
NC_014256 136169 137245 HPB8_144_136169_137245 
NC_014256 137297 138428 HPB8_145_137297_138428 
NC_014256 138553 139647 HPB8_147_138553_139647 
NC_014256 139890 140282 HPB8_148_139890_140282 
NC_014256 144820 145994 HPB8_152_144820_145994 
NC_014256 146063 146440 HPB8_153_146063_146440 
NC_014256 146615 148279 HPB8_154_146615_148279 
NC_014256 148310 148898 HPB8_156_148310_148898 
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NC_014256 148932 149476 HPB8_157_148932_149476 
NC_014256 149722 150806 HPB8_158_149722_150806 
NC_014256 150973 151287 HPB8_159_150973_151287 
NC_014256 151343 151899 HPB8_160_151343_151899 
NC_014256 152064 152581 HPB8_161_152064_152581 
NC_014256 152709 152845 HPB8_162_152709_152845 
NC_014256 152882 153681 HPB8_163_152882_153681 
NC_014256 161666 161790 HPB8_181_161666_161790 
NC_014256 168526 169128 HPB8_194_168526_169128 
NC_014256 169254 169789 HPB8_195_169254_169789 
NC_014256 169915 170644 HPB8_196_169915_170644 
NC_014256 170720 171770 HPB8_197_170720_171770 
NC_014256 178956 179016 HPB8_204_178956_179016 
NC_014256 183601 184183 HPB8_207_183601_184183 
NC_014256 185558 185931 HPB8_208_185558_185931 
NC_014256 186120 186440 HPB8_209_186120_186440 
NC_014256 200243 200974 HPB8_226_200243_200974 
NC_014256 204874 205354 HPB8_230_204874_205354 
NC_014256 205611 206225 HPB8_231_205611_206225 
NC_014256 206263 207162 HPB8_232_206263_207162 
NC_014256 207212 208179 HPB8_232_207212_208179 
NC_014256 208215 208511 HPB8_233_208215_208511 
NC_014256 208627 208829 HPB8_233_208627_208829 
NC_014256 208894 209207 HPB8_233_208894_209207 
NC_014256 210419 210620 HPB8_236_210419_210620 
NC_014256 213815 214044 HPB8_241_213815_214044 
NC_014256 214163 215332 HPB8_242_214163_215332 
NC_014256 217740 218740 HPB8_246_217740_218740 
NC_014256 220666 221910 HPB8_249_220666_221910 
NC_014256 221984 222166 HPB8_250_221984_222166 
NC_014256 222213 222457 HPB8_250_222213_222457 
NC_014256 222555 222810 HPB8_250_222555_222810 
NC_014256 223174 223605 HPB8_252_223174_223605 
NC_014256 227906 228196 HPB8_258_227906_228196 
NC_014256 228291 229328 HPB8_259_228291_229328 
NC_014256 229405 229771 HPB8_260_229405_229771 
NC_014256 230915 233735 HPB8_263_230915_233735 
NC_014256 235249 235315 HPB8_266_235249_235315 
NC_014256 235745 236058 HPB8_268_235745_236058 
NC_014256 236798 238060 HPB8_270_236798_238060 
NC_014256 239402 240816 HPB8_273_239402_240816 
NC_014256 243786 244092 HPB8_276_243786_244092 
NC_014256 244713 244836 HPB8_278_244713_244836 
NC_014256 244875 245212 HPB8_278_244875_245212 
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NC_014256 249018 249577 HPB8_284_249018_249577 
NC_014256 250278 251474 HPB8_285_250278_251474 
NC_014256 251517 251657 HPB8_286_251517_251657 
NC_014256 251924 252103 HPB8_287_251924_252103 
NC_014256 253148 253840 HPB8_290_253148_253840 
NC_014256 253961 254449 HPB8_291_253961_254449 
NC_014256 254497 254871 HPB8_292_254497_254871 
NC_014256 257755 257930 HPB8_293_257755_257930 
NC_014256 263858 264260 HPB8_294_263858_264260 
NC_014256 264341 266835 HPB8_296_264341_266835 
NC_014256 267396 268325 HPB8_297_267396_268325 
NC_014256 268604 268756 HPB8_299_268604_268756 
NC_014256 268904 269928 HPB8_300_268904_269928 
NC_014256 270013 270714 HPB8_301_270013_270714 
NC_014256 274074 274795 HPB8_304_274074_274795 
NC_014256 275071 276246 HPB8_306_275071_276246 
NC_014256 278984 279734 HPB8_310_278984_279734 
NC_014256 279834 281084 HPB8_311_279834_281084 
NC_014256 281401 282630 HPB8_312_281401_282630 
NC_014256 285409 285736 HPB8_316_285409_285736 
NC_014256 286032 286082 HPB8_316_286032_286082 
NC_014256 289384 289515 HPB8_320_289384_289515 
NC_014256 289581 290885 HPB8_321_289581_290885 
NC_014256 291032 292186 HPB8_322_291032_292186 
NC_014256 292469 293007 HPB8_324_292469_293007 
NC_014256 293129 293962 HPB8_325_293129_293962 
NC_014256 294135 294756 HPB8_326_294135_294756 
NC_014256 296296 298350 HPB8_329_296296_298350 
NC_014256 298674 300073 HPB8_330_298674_300073 
NC_014256 300391 302028 HPB8_331_300391_302028 
NC_014256 302092 302965 HPB8_332_302092_302965 
NC_014256 303037 303252 HPB8_332_303037_303252 
NC_014256 303315 304230 HPB8_333_303315_304230 
NC_014256 304266 304453 HPB8_334_304266_304453 
NC_014256 304578 305054 HPB8_336_304578_305054 
NC_014256 305250 305743 HPB8_337_305250_305743 
NC_014256 305830 306208 HPB8_338_305830_306208 
NC_014256 306318 306501 HPB8_339_306318_306501 
NC_014256 315164 317767 HPB8_348_315164_317767 
NC_014256 317798 319090 HPB8_349_317798_319090 
NC_014256 320374 320986 HPB8_353_320374_320986 
NC_014256 321107 321430 HPB8_354_321107_321430 
NC_014256 322220 322378 HPB8_355_322220_322378 
NC_014256 322416 322838 HPB8_356_322416_322838 
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NC_014256 325440 325853 HPB8_358_325440_325853 
NC_014256 326074 327362 HPB8_359_326074_327362 
NC_014256 327411 327680 HPB8_360_327411_327680 
NC_014256 327873 328651 HPB8_360_327873_328651 
NC_014256 328845 329200 HPB8_360_328845_329200 
NC_014256 329253 329425 HPB8_360_329253_329425 
NC_014256 329595 329770 HPB8_360_329595_329770 
NC_014256 333335 333769 HPB8_364_333335_333769 
NC_014256 333818 334255 HPB8_365_333818_334255 
NC_014256 334311 334813 HPB8_366_334311_334813 
NC_014256 337318 338671 HPB8_369_337318_338671 
NC_014256 338729 339100 HPB8_370_338729_339100 
NC_014256 339134 339680 HPB8_371_339134_339680 
NC_014256 339732 340097 HPB8_372_339732_340097 
NC_014256 340152 340901 HPB8_373_340152_340901 
NC_014256 340942 342074 HPB8_374_340942_342074 
NC_014256 343789 344346 HPB8_377_343789_344346 
NC_014256 344458 344584 HPB8_378_344458_344584 
NC_014256 344653 344853 HPB8_379_344653_344853 
NC_014256 345019 345833 HPB8_380_345019_345833 
NC_014256 346074 346470 HPB8_381_346074_346470 
NC_014256 346510 348320 HPB8_382_346510_348320 
NC_014256 348394 350204 HPB8_384_348394_350204 
NC_014256 350472 351242 HPB8_385_350472_351242 
NC_014256 351520 351625 HPB8_386_351520_351625 
NC_014256 351782 352448 HPB8_386_351782_352448 
NC_014256 355762 357426 HPB8_390_355762_357426 
NC_014256 357482 357725 HPB8_390_357482_357725 
NC_014256 357803 358532 HPB8_391_357803_358532 
NC_014256 358638 359960 HPB8_392_358638_359960 
NC_014256 362679 363228 HPB8_396_362679_363228 
NC_014256 363507 364142 HPB8_397_363507_364142 
NC_014256 364229 365457 HPB8_398_364229_365457 
NC_014256 365657 366663 HPB8_399_365657_366663 
NC_014256 366851 367870 HPB8_400_366851_367870 
NC_014256 368042 368996 HPB8_401_368042_368996 
NC_014256 373616 374480 HPB8_406_373616_374480 
NC_014256 374730 375468 HPB8_407_374730_375468 
NC_014256 375507 376951 HPB8_408_375507_376951 
NC_014256 384302 384706 HPB8_416_384302_384706 
NC_014256 385105 385567 HPB8_417_385105_385567 
NC_014256 387763 388319 HPB8_420_387763_388319 
NC_014256 388544 390532 HPB8_421_388544_390532 
NC_014256 390667 391347 HPB8_422_390667_391347 
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NC_014256 391439 391779 HPB8_423_391439_391779 
NC_014256 391851 392839 HPB8_424_391851_392839 
NC_014256 392915 396390 HPB8_426_392915_396390 
NC_014256 397688 398984 HPB8_429_397688_398984 
NC_014256 399117 399899 HPB8_430_399117_399899 
NC_014256 399930 401114 HPB8_431_399930_401114 
NC_014256 401332 401835 HPB8_432_401332_401835 
NC_014256 401907 402645 HPB8_433_401907_402645 
NC_014256 402848 402994 HPB8_435_402848_402994 
NC_014256 403088 403288 HPB8_436_403088_403288 
NC_014256 403328 405142 HPB8_437_403328_405142 
NC_014256 405253 405926 HPB8_438_405253_405926 
NC_014256 405999 406630 HPB8_439_405999_406630 
NC_014256 406854 407354 HPB8_440_406854_407354 
NC_014256 407614 410556 HPB8_442_407614_410556 
NC_014256 413056 414836 HPB8_447_413056_414836 
NC_014256 414896 416420 HPB8_448_414896_416420 
NC_014256 416486 416966 HPB8_449_416486_416966 
NC_014256 417100 418665 HPB8_450_417100_418665 
NC_014256 424335 424499 HPB8_456_424335_424499 
NC_014256 424599 425910 HPB8_457_424599_425910 
NC_014256 425947 426537 HPB8_458_425947_426537 
NC_014256 426641 429031 HPB8_459_426641_429031 
NC_014256 431272 432054 HPB8_463_431272_432054 
NC_014256 436496 437611 HPB8_467_436496_437611 
NC_014256 439046 439447 HPB8_468_439046_439447 
NC_014256 440717 441842 HPB8_471_440717_441842 
NC_014256 441920 443748 HPB8_472_441920_443748 
NC_014256 444522 445179 HPB8_475_444522_445179 
NC_014256 445446 447228 HPB8_476_445446_447228 
NC_014256 447408 447722 HPB8_477_447408_447722 
NC_014256 452485 452648 HPB8_482_452485_452648 
NC_014256 452709 452755 HPB8_482_452709_452755 
NC_014256 453450 453550 HPB8_484_453450_453550 
NC_014256 453652 454107 HPB8_484_453652_454107 
NC_014256 454400 454929 HPB8_484_454400_454929 
NC_014256 455488 455736 HPB8_485_455488_455736 
NC_014256 455994 456330 HPB8_486_455994_456330 
NC_014256 456900 457157 HPB8_486_456900_457157 
NC_014256 458570 459764 HPB8_487_458570_459764 
NC_014256 460190 460437 HPB8_488_460190_460437 
NC_014256 460601 461167 HPB8_489_460601_461167 
NC_014256 461444 462117 HPB8_490_461444_462117 
NC_014256 462243 462717 HPB8_491_462243_462717 
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NC_014256 462906 463501 HPB8_492_462906_463501 
NC_014256 463629 463884 HPB8_493_463629_463884 
NC_014256 464776 464924 HPB8_496_464776_464924 
NC_014256 465243 465772 HPB8_497_465243_465772 
NC_014256 465884 466269 HPB8_498_465884_466269 
NC_014256 467038 467685 HPB8_501_467038_467685 
NC_014256 467939 468274 HPB8_501_467939_468274 
NC_014256 468572 468910 HPB8_501_468572_468910 
NC_014256 469222 470406 HPB8_503_469222_470406 
NC_014256 470644 470727 HPB8_504_470644_470727 
NC_014256 470816 471472 HPB8_505_470816_471472 
NC_014256 471747 472107 HPB8_506_471747_472107 
NC_014256 472436 479082 HPB8_506_472436_479082 
NC_014256 479458 479590 HPB8_507_479458_479590 
NC_014256 479641 479826 HPB8_508_479641_479826 
NC_014256 479902 480500 HPB8_509_479902_480500 
NC_014256 480631 481352 HPB8_510_480631_481352 
NC_014256 484238 485514 HPB8_512_484238_485514 
NC_014256 486679 487173 HPB8_515_486679_487173 
NC_014256 488451 488922 HPB8_517_488451_488922 
NC_014256 489238 489657 HPB8_518_489238_489657 
NC_014256 489714 490200 HPB8_518_489714_490200 
NC_014256 490731 491969 HPB8_519_490731_491969 
NC_014256 493724 493920 HPB8_521_493724_493920 
NC_014256 494189 494383 HPB8_521_494189_494383 
NC_014256 494711 494937 HPB8_522_494711_494937 
NC_014256 495334 495487 HPB8_522_495334_495487 
NC_014256 496776 497081 HPB8_525_496776_497081 
NC_014256 497113 497422 HPB8_525_497113_497422 
NC_014256 500601 501608 HPB8_528_500601_501608 
NC_014256 505645 506313 HPB8_532_505645_506313 
NC_014256 506360 506737 HPB8_533_506360_506737 
NC_014256 506866 507152 HPB8_534_506866_507152 
NC_014256 507660 508190 HPB8_535_507660_508190 
NC_014256 508251 508697 HPB8_536_508251_508697 
NC_014256 508766 510812 HPB8_537_508766_510812 
NC_014256 510846 512962 HPB8_538_510846_512962 
NC_014256 513025 513066 HPB8_539_513025_513066 
NC_014256 513353 513391 HPB8_539_513353_513391 
NC_014256 513577 514418 HPB8_540_513577_514418 
NC_014256 515320 515645 HPB8_542_515320_515645 
NC_014256 515733 516257 HPB8_543_515733_516257 
NC_014256 516295 517682 HPB8_543_516295_517682 
NC_014256 517921 519122 HPB8_544_517921_519122 
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NC_014256 519196 520774 HPB8_545_519196_520774 
NC_014256 520910 521407 HPB8_546_520910_521407 
NC_014256 522090 522931 HPB8_548_522090_522931 
NC_014256 522989 523441 HPB8_548_522989_523441 
NC_014256 524489 524613 HPB8_548_524489_524613 
NC_014256 525153 525383 HPB8_551_525153_525383 
NC_014256 525768 525998 HPB8_553_525768_525998 
NC_014256 526398 526448 HPB8_554_526398_526448 
NC_014256 527245 527467 HPB8_555_527245_527467 
NC_014256 527696 528268 HPB8_556_527696_528268 
NC_014256 529230 529881 HPB8_558_529230_529881 
NC_014256 530456 530520 HPB8_560_530456_530520 
NC_014256 530931 531598 HPB8_561_530931_531598 
NC_014256 531695 531785 HPB8_562_531695_531785 
NC_014256 532010 532567 HPB8_563_532010_532567 
NC_014256 532657 533220 HPB8_564_532657_533220 
NC_014256 533554 534700 HPB8_566_533554_534700 
NC_014256 537921 539210 HPB8_569_537921_539210 
NC_014256 542331 544429 HPB8_574_542331_544429 
NC_014256 544479 545667 HPB8_575_544479_545667 
NC_014256 545741 546751 HPB8_576_545741_546751 
NC_014256 546796 550468 HPB8_577_546796_550468 
NC_014256 550682 552287 HPB8_580_550682_552287 
NC_014256 552330 552605 HPB8_581_552330_552605 
NC_014256 556135 556373 HPB8_583_556135_556373 
NC_014256 556514 556888 HPB8_584_556514_556888 
NC_014256 559160 559869 HPB8_587_559160_559869 
NC_014256 559952 560871 HPB8_588_559952_560871 
NC_014256 561070 561792 HPB8_590_561070_561792 
NC_014256 561952 562623 HPB8_591_561952_562623 
NC_014256 562665 563291 HPB8_592_562665_563291 
NC_014256 565287 566125 HPB8_596_565287_566125 
NC_014256 566170 566577 HPB8_597_566170_566577 
NC_014256 566632 567601 HPB8_598_566632_567601 
NC_014256 568100 568412 HPB8_602_568100_568412 
NC_014256 568784 570243 HPB8_603_568784_570243 
NC_014256 571191 571535 HPB8_604_571191_571535 
NC_014256 571582 572808 HPB8_605_571582_572808 
NC_014256 572855 574154 HPB8_606_572855_574154 
NC_014256 574221 575347 HPB8_607_574221_575347 
NC_014256 576952 577299 HPB8_610_576952_577299 
NC_014256 577384 577555 HPB8_611_577384_577555 
NC_014256 577659 578469 HPB8_611_577659_578469 
NC_014256 579109 579780 HPB8_613_579109_579780 
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NC_014256 579830 580278 HPB8_613_579830_580278 
NC_014256 584771 585149 HPB8_618_584771_585149 
NC_014256 591922 599022 HPB8_627_591922_599022 
NC_014256 599197 600195 HPB8_628_599197_600195 
NC_014256 600338 600949 HPB8_629_600338_600949 
NC_014256 601162 604818 HPB8_630_601162_604818 
NC_014256 605005 605823 HPB8_632_605005_605823 
NC_014256 606158 607444 HPB8_634_606158_607444 
NC_014256 607918 609317 HPB8_636_607918_609317 
NC_014256 613235 613400 HPB8_640_613235_613400 
NC_014256 616917 617361 HPB8_643_616917_617361 
NC_014256 617420 619230 HPB8_644_617420_619230 
NC_014256 619454 620252 HPB8_645_619454_620252 
NC_014256 620303 621854 HPB8_646_620303_621854 
NC_014256 622111 623604 HPB8_647_622111_623604 
NC_014256 625480 626117 HPB8_652_625480_626117 
NC_014256 626169 627433 HPB8_654_626169_627433 
NC_014256 632724 633223 HPB8_661_632724_633223 
NC_014256 636035 639973 HPB8_666_636035_639973 
NC_014256 642747 643029 HPB8_668_642747_643029 
NC_014256 643215 643439 HPB8_669_643215_643439 
NC_014256 643530 644260 HPB8_669_643530_644260 
NC_014256 644334 644992 HPB8_669_644334_644992 
NC_014256 645047 645434 HPB8_670_645047_645434 
NC_014256 646125 646399 HPB8_671_646125_646399 
NC_014256 649551 649840 HPB8_674_649551_649840 
NC_014256 650220 650961 HPB8_675_650220_650961 
NC_014256 651102 651354 HPB8_675_651102_651354 
NC_014256 651518 651648 HPB8_676_651518_651648 
NC_014256 651792 651860 HPB8_677_651792_651860 
NC_014256 651915 652628 HPB8_677_651915_652628 
NC_014256 652674 653417 HPB8_678_652674_653417 
NC_014256 655088 655263 HPB8_680_655088_655263 
NC_014256 655333 655720 HPB8_681_655333_655720 
NC_014256 655971 656601 HPB8_682_655971_656601 
NC_014256 658164 658627 HPB8_683_658164_658627 
NC_014256 658741 659698 HPB8_684_658741_659698 
NC_014256 659771 659911 HPB8_685_659771_659911 
NC_014256 660041 660875 HPB8_685_660041_660875 
NC_014256 660926 663228 HPB8_686_660926_663228 
NC_014256 663350 664189 HPB8_687_663350_664189 
NC_014256 664253 664531 HPB8_688_664253_664531 
NC_014256 666967 667365 HPB8_692_666967_667365 
NC_014256 667400 667803 HPB8_692_667400_667803 
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NC_014256 668024 669376 HPB8_693_668024_669376 
NC_014256 669425 670157 HPB8_694_669425_670157 
NC_014256 670637 670855 HPB8_696_670637_670855 
NC_014256 672885 674751 HPB8_699_672885_674751 
NC_014256 676010 677314 HPB8_702_676010_677314 
NC_014256 679307 680173 HPB8_705_679307_680173 
NC_014256 680232 681362 HPB8_706_680232_681362 
NC_014256 682552 682702 HPB8_708_682552_682702 
NC_014256 682552 682702 HPB8_709_682552_682702 
NC_014256 683744 683872 HPB8_710_683744_683872 
NC_014256 684245 685022 HPB8_711_684245_685022 
NC_014256 685232 685685 HPB8_712_685232_685685 
NC_014256 686072 686482 HPB8_713_686072_686482 
NC_014256 686539 686647 HPB8_713_686539_686647 
NC_014256 686835 688425 HPB8_714_686835_688425 
NC_014256 688486 689921 HPB8_715_688486_689921 
NC_014256 691528 691703 HPB8_716_691528_691703 
NC_014256 691783 691998 HPB8_716_691783_691998 
NC_014256 693129 693171 HPB8_716_693129_693171 
NC_014256 693367 693455 HPB8_716_693367_693455 
NC_014256 693499 693650 HPB8_716_693499_693650 
NC_014256 693859 695531 HPB8_716_693859_695531 
NC_014256 695834 696214 HPB8_717_695834_696214 
NC_014256 697765 699528 HPB8_719_697765_699528 
NC_014256 699618 699833 HPB8_721_699618_699833 
NC_014256 702753 703086 HPB8_725_702753_703086 
NC_014256 703259 703754 HPB8_726_703259_703754 
NC_014256 703875 704105 HPB8_726_703875_704105 
NC_014256 704351 705782 HPB8_728_704351_705782 
NC_014256 705923 706376 HPB8_729_705923_706376 
NC_014256 706608 706948 HPB8_729_706608_706948 
NC_014256 707238 707608 HPB8_729_707238_707608 
NC_014256 712538 712595 HPB8_735_712538_712595 
NC_014256 712681 713040 HPB8_735_712681_713040 
NC_014256 713121 713395 HPB8_736_713121_713395 
NC_014256 713569 713636 HPB8_736_713569_713636 
NC_014256 714134 714646 HPB8_738_714134_714646 
NC_014256 715093 715170 HPB8_739_715093_715170 
NC_014256 715221 715396 HPB8_739_715221_715396 
NC_014256 716234 716422 HPB8_740_716234_716422 
NC_014256 716856 718850 HPB8_741_716856_718850 
NC_014256 718928 720370 HPB8_741_718928_720370 
NC_014256 721387 722149 HPB8_743_721387_722149 
NC_014256 722190 723504 HPB8_744_722190_723504 
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NC_014256 723770 723944 HPB8_745_723770_723944 
NC_014256 724020 724858 HPB8_746_724020_724858 
NC_014256 724932 725557 HPB8_747_724932_725557 
NC_014256 727450 727863 HPB8_750_727450_727863 
NC_014256 730640 730871 HPB8_755_730640_730871 
NC_014256 731102 731830 HPB8_756_731102_731830 
NC_014256 731889 732096 HPB8_757_731889_732096 
NC_014256 732204 733407 HPB8_758_732204_733407 
NC_014256 733619 733853 HPB8_760_733619_733853 
NC_014256 733892 734531 HPB8_761_733892_734531 
NC_014256 734663 735459 HPB8_762_734663_735459 
NC_014256 735629 736620 HPB8_763_735629_736620 
NC_014256 736771 737621 HPB8_764_736771_737621 
NC_014256 740324 740857 HPB8_767_740324_740857 
NC_014256 740903 741442 HPB8_768_740903_741442 
NC_014256 741556 741832 HPB8_769_741556_741832 
NC_014256 741883 742338 HPB8_770_741883_742338 
NC_014256 742379 742988 HPB8_771_742379_742988 
NC_014256 744989 745702 HPB8_774_744989_745702 
NC_014256 745758 746913 HPB8_774_745758_746913 
NC_014256 747127 747322 HPB8_775_747127_747322 
NC_014256 747533 748491 HPB8_776_747533_748491 
NC_014256 751913 752552 HPB8_782_751913_752552 
NC_014256 752629 752785 HPB8_783_752629_752785 
NC_014256 752831 753597 HPB8_784_752831_753597 
NC_014256 753629 753704 HPB8_784_753629_753704 
NC_014256 753792 755343 HPB8_784_753792_755343 
NC_014256 755477 756621 HPB8_785_755477_756621 
NC_014256 758322 759085 HPB8_788_758322_759085 
NC_014256 759128 759654 HPB8_789_759128_759654 
NC_014256 760666 761300 HPB8_791_760666_761300 
NC_014256 761691 763130 HPB8_793_761691_763130 
NC_014256 767117 767477 HPB8_796_767117_767477 
NC_014256 767569 768632 HPB8_797_767569_768632 
NC_014256 768906 769426 HPB8_798_768906_769426 
NC_014256 770010 770576 HPB8_799_770010_770576 
NC_014256 770830 772350 HPB8_800_770830_772350 
NC_014256 772511 773136 HPB8_801_772511_773136 
NC_014256 773214 773718 HPB8_802_773214_773718 
NC_014256 780828 790388 HPB8_808_780828_790388 
NC_014256 790707 790820 HPB8_809_790707_790820 
NC_014256 791263 791839 HPB8_810_791263_791839 
NC_014256 792229 792542 HPB8_812_792229_792542 
NC_014256 792660 792904 HPB8_813_792660_792904 
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NC_014256 792993 794612 HPB8_813_792993_794612 
NC_014256 794697 795608 HPB8_814_794697_795608 
NC_014256 798210 798494 HPB8_817_798210_798494 
NC_014256 798675 798763 HPB8_817_798675_798763 
NC_014256 799434 800139 HPB8_818_799434_800139 
NC_014256 800501 800913 HPB8_819_800501_800913 
NC_014256 808664 809648 HPB8_826_808664_809648 
NC_014256 810216 811952 HPB8_828_810216_811952 
NC_014256 812026 812597 HPB8_829_812026_812597 
NC_014256 812769 813923 HPB8_831_812769_813923 
NC_014256 816379 816880 HPB8_834_816379_816880 
NC_014256 816963 817938 HPB8_835_816963_817938 
NC_014256 817970 818420 HPB8_835_817970_818420 
NC_014256 818453 818847 HPB8_836_818453_818847 
NC_014256 818966 819418 HPB8_837_818966_819418 
NC_014256 819599 820494 HPB8_838_819599_820494 
NC_014256 820595 821281 HPB8_839_820595_821281 
NC_014256 821374 822117 HPB8_841_821374_822117 
NC_014256 822215 822541 HPB8_841_822215_822541 
NC_014256 824761 826080 HPB8_845_824761_826080 
NC_014256 826122 826359 HPB8_846_826122_826359 
NC_014256 826400 827989 HPB8_847_826400_827989 
NC_014256 830631 832033 HPB8_851_830631_832033 
NC_014256 832078 832657 HPB8_852_832078_832657 
NC_014256 834096 834719 HPB8_855_834096_834719 
NC_014256 835026 835237 HPB8_856_835026_835237 
NC_014256 835547 836209 HPB8_857_835547_836209 
NC_014256 836333 836598 HPB8_857_836333_836598 
NC_014256 856120 856338 HPB8_872_856120_856338 
NC_014256 857071 857098 HPB8_873_857071_857098 
NC_014256 858519 859331 HPB8_874_858519_859331 
NC_014256 859490 860656 HPB8_876_859490_860656 
NC_014256 862831 863871 HPB8_878_862831_863871 
NC_014256 863970 864379 HPB8_879_863970_864379 
NC_014256 864455 864787 HPB8_880_864455_864787 
NC_014256 864896 865211 HPB8_880_864896_865211 
NC_014256 865327 866266 HPB8_881_865327_866266 
NC_014256 866336 868700 HPB8_882_866336_868700 
NC_014256 868888 869131 HPB8_883_868888_869131 
NC_014256 869236 869354 HPB8_883_869236_869354 
NC_014256 869415 869713 HPB8_884_869415_869713 
NC_014256 869935 871231 HPB8_885_869935_871231 
NC_014256 871276 872014 HPB8_886_871276_872014 
NC_014256 872109 874362 HPB8_887_872109_874362 
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NC_014256 874654 876582 HPB8_888_874654_876582 
NC_014256 876725 877531 HPB8_889_876725_877531 
NC_014256 880343 880629 HPB8_893_880343_880629 
NC_014256 880660 881707 HPB8_893_880660_881707 
NC_014256 881870 881945 HPB8_894_881870_881945 
NC_014256 881979 882809 HPB8_894_881979_882809 
NC_014256 888389 889045 HPB8_900_888389_889045 
NC_014256 889829 892281 HPB8_902_889829_892281 
NC_014256 894445 894865 HPB8_907_894445_894865 
NC_014256 895548 898355 HPB8_909_895548_898355 
NC_014256 898538 899359 HPB8_910_898538_899359 
NC_014256 899535 900428 HPB8_912_899535_900428 
NC_014256 900482 900826 HPB8_913_900482_900826 
NC_014256 901030 901929 HPB8_914_901030_901929 
NC_014256 904353 905516 HPB8_916_904353_905516 
NC_014256 905716 906045 HPB8_918_905716_906045 
NC_014256 909469 910340 HPB8_923_909469_910340 
NC_014256 910449 911032 HPB8_924_910449_911032 
NC_014256 914622 915636 HPB8_928_914622_915636 
NC_014256 915714 917042 HPB8_929_915714_917042 
NC_014256 917145 919107 HPB8_930_917145_919107 
NC_014256 921308 922265 HPB8_933_921308_922265 
NC_014256 923794 924013 HPB8_936_923794_924013 
NC_014256 925570 926046 HPB8_939_925570_926046 
NC_014256 927426 928711 HPB8_941_927426_928711 
NC_014256 928795 929206 HPB8_942_928795_929206 
NC_014256 929265 930324 HPB8_943_929265_930324 
NC_014256 930474 930950 HPB8_944_930474_930950 
NC_014256 931045 931122 HPB8_945_931045_931122 
NC_014256 931175 932039 HPB8_945_931175_932039 
NC_014256 934823 935752 HPB8_949_934823_935752 
NC_014256 944184 946614 HPB8_959_944184_946614 
NC_014256 947319 947978 HPB8_962_947319_947978 
NC_014256 948157 949017 HPB8_964_948157_949017 
NC_014256 949162 950335 HPB8_965_949162_950335 
NC_014256 950601 950755 HPB8_966_950601_950755 
NC_014256 950809 951586 HPB8_966_950809_951586 
NC_014256 954047 954481 HPB8_969_954047_954481 
NC_014256 957290 957497 HPB8_974_957290_957497 
NC_014256 957563 958803 HPB8_974_957563_958803 
NC_014256 959089 960030 HPB8_977_959089_960030 
NC_014256 960219 960694 HPB8_978_960219_960694 
NC_014256 960729 961778 HPB8_979_960729_961778 
NC_014256 963947 965033 HPB8_982_963947_965033 
 115 
NC_014256 965083 966240 HPB8_983_965083_966240 
NC_014256 966349 968819 HPB8_984_966349_968819 
NC_014256 968955 969583 HPB8_986_968955_969583 
NC_014256 969694 970335 HPB8_987_969694_970335 
NC_014256 970513 973064 HPB8_988_970513_973064 
NC_014256 973147 973355 HPB8_989_973147_973355 
NC_014256 973681 974959 HPB8_990_973681_974959 
NC_014256 977460 977853 HPB8_993_977460_977853 
NC_014256 982263 983745 HPB8_996_982263_983745 
NC_014256 984109 984246 HPB8_998_984109_984246 
NC_014256 984307 984604 HPB8_998_984307_984604 
NC_014256 985339 987385 HPB8_999_985339_987385 
NC_014256 987436 988930 HPB8_1000_987436_988930 
NC_014256 988976 989460 HPB8_1001_988976_989460 
NC_014256 989495 990052 HPB8_1002_989495_990052 
NC_014256 990093 991428 HPB8_1003_990093_991428 
NC_014256 991642 992324 HPB8_1004_991642_992324 
NC_014256 992452 993187 HPB8_1005_992452_993187 
NC_014256 995098 995646 HPB8_1010_995098_995646 
NC_014256 995746 996574 HPB8_1011_995746_996574 
NC_014256 996663 996826 HPB8_1012_996663_996826 
NC_014256 996885 997654 HPB8_1012_996885_997654 
NC_014256 997802 998544 HPB8_1013_997802_998544 
NC_014256 998720 999274 HPB8_1014_998720_999274 
NC_014256 999343 1000834 HPB8_1015_999343_1000834 
NC_014256 1000875 1001721 HPB8_1015_1000875_1001721 
NC_014256 1001941 1002229 HPB8_1016_1001941_1002229 
NC_014256 1004152 1004355 HPB8_1020_1004152_1004355 
NC_014256 1004415 1005166 HPB8_1020_1004415_1005166 
NC_014256 1008738 1010299 HPB8_1026_1008738_1010299 
NC_014256 1010424 1010579 HPB8_1027_1010424_1010579 
NC_014256 1011328 1011646 HPB8_1029_1011328_1011646 
NC_014256 1011722 1013446 HPB8_1030_1011722_1013446 
NC_014256 1013483 1014739 HPB8_1031_1013483_1014739 
NC_014256 1014783 1015055 HPB8_1032_1014783_1015055 
NC_014256 1015200 1015433 HPB8_1033_1015200_1015433 
NC_014256 1015508 1016431 HPB8_1034_1015508_1016431 
NC_014256 1016726 1017532 HPB8_1035_1016726_1017532 
NC_014256 1017772 1017998 HPB8_1036_1017772_1017998 
NC_014256 1018417 1018968 HPB8_1037_1018417_1018968 
NC_014256 1023486 1024370 HPB8_1043_1023486_1024370 
NC_014256 1024446 1024944 HPB8_1044_1024446_1024944 
NC_014256 1024981 1025751 HPB8_1044_1024981_1025751 
NC_014256 1025985 1026269 HPB8_1045_1025985_1026269 
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NC_014256 1026978 1027571 HPB8_1047_1026978_1027571 
NC_014256 1035351 1038467 HPB8_1056_1035351_1038467 
NC_014256 1038623 1038892 HPB8_1057_1038623_1038892 
NC_014256 1039691 1041262 HPB8_1058_1039691_1041262 
NC_014256 1041653 1042405 HPB8_1059_1041653_1042405 
NC_014256 1042465 1042970 HPB8_1060_1042465_1042970 
NC_014256 1043162 1043378 HPB8_1060_1043162_1043378 
NC_014256 1043547 1043873 HPB8_1061_1043547_1043873 
NC_014256 1043914 1044232 HPB8_1061_1043914_1044232 
NC_014256 1048677 1050031 HPB8_1067_1048677_1050031 
NC_014256 1053206 1053330 HPB8_1072_1053206_1053330 
NC_014256 1053462 1054563 HPB8_1072_1053462_1054563 
NC_014256 1055698 1056116 HPB8_1075_1055698_1056116 
NC_014256 1056183 1057265 HPB8_1076_1056183_1057265 
NC_014256 1057357 1057664 HPB8_1077_1057357_1057664 
NC_014256 1057733 1058086 HPB8_1078_1057733_1058086 
NC_014256 1058147 1060296 HPB8_1079_1058147_1060296 
NC_014256 1060526 1060763 HPB8_1081_1060526_1060763 
NC_014256 1060810 1061254 HPB8_1082_1060810_1061254 
NC_014256 1061625 1061894 HPB8_1084_1061625_1061894 
NC_014256 1062012 1062214 HPB8_1085_1062012_1062214 
NC_014256 1062327 1063174 HPB8_1086_1062327_1063174 
NC_014256 1063350 1064836 HPB8_1087_1063350_1064836 
NC_014256 1065162 1068011 HPB8_1088_1065162_1068011 
NC_014256 1068141 1068852 HPB8_1090_1068141_1068852 
NC_014256 1069928 1070042 HPB8_1091_1069928_1070042 
NC_014256 1070232 1070969 HPB8_1092_1070232_1070969 
NC_014256 1071149 1071226 HPB8_1093_1071149_1071226 
NC_014256 1071483 1072834 HPB8_1094_1071483_1072834 
NC_014256 1072975 1074539 HPB8_1095_1072975_1074539 
NC_014256 1074825 1075697 HPB8_1096_1074825_1075697 
NC_014256 1076052 1076347 HPB8_1097_1076052_1076347 
NC_014256 1076847 1077800 HPB8_1098_1076847_1077800 
NC_014256 1078015 1078457 HPB8_1099_1078015_1078457 
NC_014256 1078751 1078982 HPB8_1100_1078751_1078982 
NC_014256 1079087 1081274 HPB8_1102_1079087_1081274 
NC_014256 1081328 1081458 HPB8_1103_1081328_1081458 
NC_014256 1081521 1082193 HPB8_1103_1081521_1082193 
NC_014256 1082351 1082726 HPB8_1103_1082351_1082726 
NC_014256 1082861 1083569 HPB8_1103_1082861_1083569 
NC_014256 1083984 1084067 HPB8_1104_1083984_1084067 
NC_014256 1084484 1084644 HPB8_1104_1084484_1084644 
NC_014256 1084993 1086374 HPB8_1106_1084993_1086374 
NC_014256 1086503 1087278 HPB8_1107_1086503_1087278 
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NC_014256 1087339 1087965 HPB8_1108_1087339_1087965 
NC_014256 1088063 1088732 HPB8_1109_1088063_1088732 
NC_014256 1088971 1089513 HPB8_1111_1088971_1089513 
NC_014256 1089912 1091100 HPB8_1112_1089912_1091100 
NC_014256 1096072 1097909 HPB8_1118_1096072_1097909 
NC_014256 1097969 1098449 HPB8_1119_1097969_1098449 
NC_014256 1098489 1098659 HPB8_1120_1098489_1098659 
NC_014256 1103059 1103577 HPB8_1123_1103059_1103577 
NC_014256 1104490 1105689 HPB8_1126_1104490_1105689 
NC_014256 1105747 1106494 HPB8_1126_1105747_1106494 
NC_014256 1106588 1107520 HPB8_1127_1106588_1107520 
NC_014256 1107606 1108922 HPB8_1128_1107606_1108922 
NC_014256 1108955 1109639 HPB8_1129_1108955_1109639 
NC_014256 1112050 1113401 HPB8_1133_1112050_1113401 
NC_014256 1113527 1114916 HPB8_1134_1113527_1114916 
NC_014256 1114974 1116182 HPB8_1135_1114974_1116182 
NC_014256 1116307 1117097 HPB8_1136_1116307_1117097 
NC_014256 1118300 1119550 HPB8_1141_1118300_1119550 
NC_014256 1120966 1121652 HPB8_1144_1120966_1121652 
NC_014256 1121710 1122132 HPB8_1144_1121710_1122132 
NC_014256 1126873 1127659 HPB8_1152_1126873_1127659 
NC_014256 1130673 1131151 HPB8_1156_1130673_1131151 
NC_014256 1131626 1132254 HPB8_1157_1131626_1132254 
NC_014256 1132295 1132540 HPB8_1157_1132295_1132540 
NC_014256 1132617 1132865 HPB8_1158_1132617_1132865 
NC_014256 1133008 1133691 HPB8_1159_1133008_1133691 
NC_014256 1133732 1135173 HPB8_1159_1133732_1135173 
NC_014256 1135240 1136274 HPB8_1160_1135240_1136274 
NC_014256 1136642 1137313 HPB8_1161_1136642_1137313 
NC_014256 1137667 1138779 HPB8_1162_1137667_1138779 
NC_014256 1138975 1140957 HPB8_1163_1138975_1140957 
NC_014256 1144928 1145807 HPB8_1169_1144928_1145807 
NC_014256 1148401 1149049 HPB8_1173_1148401_1149049 
NC_014256 1149196 1149340 HPB8_1174_1149196_1149340 
NC_014256 1149374 1150077 HPB8_1174_1149374_1150077 
NC_014256 1151830 1152631 HPB8_1177_1151830_1152631 
NC_014256 1152671 1153631 HPB8_1178_1152671_1153631 
NC_014256 1153721 1154138 HPB8_1179_1153721_1154138 
NC_014256 1154196 1154432 HPB8_1180_1154196_1154432 
NC_014256 1157282 1157862 HPB8_1185_1157282_1157862 
NC_014256 1161710 1162341 HPB8_1191_1161710_1162341 
NC_014256 1162420 1164846 HPB8_1192_1162420_1164846 
NC_014256 1165608 1165757 HPB8_1194_1165608_1165757 
NC_014256 1165822 1166834 HPB8_1194_1165822_1166834 
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NC_014256 1166999 1167487 HPB8_1195_1166999_1167487 
NC_014256 1167540 1168513 HPB8_1196_1167540_1168513 
NC_014256 1169594 1170213 HPB8_1198_1169594_1170213 
NC_014256 1170566 1171094 HPB8_1199_1170566_1171094 
NC_014256 1173502 1174892 HPB8_1202_1173502_1174892 
NC_014256 1175195 1176118 HPB8_1203_1175195_1176118 
NC_014256 1176185 1176696 HPB8_1204_1176185_1176696 
NC_014256 1176776 1177312 HPB8_1205_1176776_1177312 
NC_014256 1177383 1178194 HPB8_1206_1177383_1178194 
NC_014256 1178262 1180498 HPB8_1207_1178262_1180498 
NC_014256 1180627 1182876 HPB8_1208_1180627_1182876 
NC_014256 1182940 1185069 HPB8_1209_1182940_1185069 
NC_014256 1185329 1186609 HPB8_1210_1185329_1186609 
NC_014256 1186664 1187462 HPB8_1211_1186664_1187462 
NC_014256 1188152 1188294 HPB8_1214_1188152_1188294 
NC_014256 1194693 1196322 HPB8_1220_1194693_1196322 
NC_014256 1196381 1196620 HPB8_1221_1196381_1196620 
NC_014256 1196683 1197035 HPB8_1221_1196683_1197035 
NC_014256 1197347 1198242 HPB8_1223_1197347_1198242 
NC_014256 1198295 1198902 HPB8_1223_1198295_1198902 
NC_014256 1202575 1202926 HPB8_1229_1202575_1202926 
NC_014256 1203175 1203579 HPB8_1230_1203175_1203579 
NC_014256 1203707 1204334 HPB8_1231_1203707_1204334 
NC_014256 1206684 1207364 HPB8_1235_1206684_1207364 
NC_014256 1207547 1208368 HPB8_1236_1207547_1208368 
NC_014256 1208873 1209710 HPB8_1237_1208873_1209710 
NC_014256 1212705 1213881 HPB8_1243_1212705_1213881 
NC_014256 1213957 1214560 HPB8_1244_1213957_1214560 
NC_014256 1214664 1216469 HPB8_1246_1214664_1216469 
NC_014256 1216575 1217330 HPB8_1247_1216575_1217330 
NC_014256 1217703 1218923 HPB8_1249_1217703_1218923 
NC_014256 1225027 1226020 HPB8_1258_1225027_1226020 
NC_014256 1230737 1232321 HPB8_1264_1230737_1232321 
NC_014256 1233318 1235781 HPB8_1267_1233318_1235781 
NC_014256 1235887 1236906 HPB8_1268_1235887_1236906 
NC_014256 1237104 1238181 HPB8_1269_1237104_1238181 
NC_014256 1238224 1238774 HPB8_1269_1238224_1238774 
NC_014256 1238812 1239573 HPB8_1270_1238812_1239573 
NC_014256 1239688 1241177 HPB8_1272_1239688_1241177 
NC_014256 1241225 1249970 HPB8_1273_1241225_1249970 
NC_014256 1250042 1250515 HPB8_1274_1250042_1250515 
NC_014256 1258032 1259117 HPB8_1281_1258032_1259117 
NC_014256 1259277 1260071 HPB8_1282_1259277_1260071 
NC_014256 1260240 1261048 HPB8_1283_1260240_1261048 
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NC_014256 1261133 1262622 HPB8_1284_1261133_1262622 
NC_014256 1262705 1262947 HPB8_1285_1262705_1262947 
NC_014256 1264890 1265286 HPB8_1288_1264890_1265286 
NC_014256 1265319 1265750 HPB8_1289_1265319_1265750 
NC_014256 1267361 1267924 HPB8_1292_1267361_1267924 
NC_014256 1268027 1269307 HPB8_1293_1268027_1269307 
NC_014256 1269352 1269582 HPB8_1294_1269352_1269582 
NC_014256 1269653 1270829 HPB8_1295_1269653_1270829 
NC_014256 1272789 1272849 HPB8_1298_1272789_1272849 
NC_014256 1272906 1272978 HPB8_1298_1272906_1272978 
NC_014256 1273020 1275294 HPB8_1298_1273020_1275294 
NC_014256 1275437 1276190 HPB8_1299_1275437_1276190 
NC_014256 1277086 1277609 HPB8_1302_1277086_1277609 
NC_014256 1277861 1278810 HPB8_1303_1277861_1278810 
NC_014256 1278862 1280124 HPB8_1304_1278862_1280124 
NC_014256 1286833 1287822 HPB8_1312_1286833_1287822 
NC_014256 1287878 1289409 HPB8_1313_1287878_1289409 
NC_014256 1301576 1301905 HPB8_1327_1301576_1301905 
NC_014256 1302035 1303093 HPB8_1328_1302035_1303093 
NC_014256 1303828 1304358 HPB8_1331_1303828_1304358 
NC_014256 1307120 1307806 HPB8_1335_1307120_1307806 
NC_014256 1308045 1309331 HPB8_1336_1308045_1309331 
NC_014256 1309739 1310894 HPB8_1337_1309739_1310894 
NC_014256 1311295 1312150 HPB8_1338_1311295_1312150 
NC_014256 1312206 1312634 HPB8_1338_1312206_1312634 
NC_014256 1313350 1314150 HPB8_1341_1313350_1314150 
NC_014256 1314493 1315498 HPB8_1342_1314493_1315498 
NC_014256 1315678 1317048 HPB8_1343_1315678_1317048 
NC_014256 1317138 1317369 HPB8_1344_1317138_1317369 
NC_014256 1317535 1318515 HPB8_1345_1317535_1318515 
NC_014256 1318546 1319701 HPB8_1346_1318546_1319701 
NC_014256 1319873 1320337 HPB8_1347_1319873_1320337 
NC_014256 1320483 1321032 HPB8_1348_1320483_1321032 
NC_014256 1328084 1328836 HPB8_1354_1328084_1328836 
NC_014256 1329039 1330840 HPB8_1356_1329039_1330840 
NC_014256 1331059 1332361 HPB8_1357_1331059_1332361 
NC_014256 1332520 1333591 HPB8_1359_1332520_1333591 
NC_014256 1333713 1334799 HPB8_1360_1333713_1334799 
NC_014256 1334899 1335290 HPB8_1361_1334899_1335290 
NC_014256 1336072 1336670 HPB8_1361_1336072_1336670 
NC_014256 1336915 1338299 HPB8_1361_1336915_1338299 
NC_014256 1341129 1341262 HPB8_1367_1341129_1341262 
NC_014256 1341295 1341617 HPB8_1368_1341295_1341617 
NC_014256 1341700 1342041 HPB8_1369_1341700_1342041 
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NC_014256 1342147 1343286 HPB8_1370_1342147_1343286 
NC_014256 1352171 1353697 HPB8_1379_1352171_1353697 
NC_014256 1353778 1353888 HPB8_1380_1353778_1353888 
NC_014256 1359164 1359472 HPB8_1386_1359164_1359472 
NC_014256 1359679 1360424 HPB8_1386_1359679_1360424 
NC_014256 1365549 1366097 HPB8_1392_1365549_1366097 
NC_014256 1366271 1367008 HPB8_1393_1366271_1367008 
NC_014256 1367048 1368214 HPB8_1394_1367048_1368214 
NC_014256 1368284 1369357 HPB8_1395_1368284_1369357 
NC_014256 1372465 1373142 HPB8_1400_1372465_1373142 
NC_014256 1373207 1374427 HPB8_1401_1373207_1374427 
NC_014256 1376804 1377559 HPB8_1405_1376804_1377559 
NC_014256 1377818 1378675 HPB8_1406_1377818_1378675 
NC_014256 1381061 1381291 HPB8_1410_1381061_1381291 
NC_014256 1383719 1384051 HPB8_1413_1383719_1384051 
NC_014256 1384113 1384525 HPB8_1413_1384113_1384525 
NC_014256 1384659 1385346 HPB8_1414_1384659_1385346 
NC_014256 1386728 1387809 HPB8_1418_1386728_1387809 
NC_014256 1392846 1393498 HPB8_1424_1392846_1393498 
NC_014256 1393571 1394501 HPB8_1424_1393571_1394501 
NC_014256 1394551 1395611 HPB8_1425_1394551_1395611 
NC_014256 1395656 1396200 HPB8_1425_1395656_1396200 
NC_014256 1396346 1397146 HPB8_1426_1396346_1397146 
NC_014256 1399262 1399720 HPB8_1429_1399262_1399720 
NC_014256 1400381 1401725 HPB8_1431_1400381_1401725 
NC_014256 1401907 1403121 HPB8_1433_1401907_1403121 
NC_014256 1403158 1404494 HPB8_1434_1403158_1404494 
NC_014256 1404678 1404771 HPB8_1435_1404678_1404771 
NC_014256 1405144 1406004 HPB8_1436_1405144_1406004 
NC_014256 1406447 1406847 HPB8_1438_1406447_1406847 
NC_014256 1407213 1408060 HPB8_1440_1407213_1408060 
NC_014256 1408265 1408536 HPB8_1441_1408265_1408536 
NC_014256 1409559 1411316 HPB8_1444_1409559_1411316 
NC_014256 1411372 1411503 HPB8_1445_1411372_1411503 
NC_014256 1411683 1414115 HPB8_1446_1411683_1414115 
NC_014256 1415522 1416455 HPB8_1448_1415522_1416455 
NC_014256 1416582 1418658 HPB8_1449_1416582_1418658 
NC_014256 1418824 1420368 HPB8_1450_1418824_1420368 
NC_014256 1420426 1420782 HPB8_1451_1420426_1420782 
NC_014256 1420950 1422273 HPB8_1451_1420950_1422273 
NC_014256 1422347 1422614 HPB8_1452_1422347_1422614 
NC_014256 1422679 1423103 HPB8_1453_1422679_1423103 
NC_014256 1423151 1423268 HPB8_1453_1423151_1423268 
NC_014256 1423490 1423927 HPB8_1454_1423490_1423927 
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NC_014256 1424921 1426771 HPB8_1456_1424921_1426771 
NC_014256 1427090 1427585 HPB8_1457_1427090_1427585 
NC_014256 1429809 1430264 HPB8_1460_1429809_1430264 
NC_014256 1430425 1432119 HPB8_1461_1430425_1432119 
NC_014256 1432373 1434065 HPB8_1462_1432373_1434065 
NC_014256 1434102 1434812 HPB8_1463_1434102_1434812 
NC_014256 1434956 1435563 HPB8_1464_1434956_1435563 
NC_014256 1435872 1436095 HPB8_1466_1435872_1436095 
NC_014256 1436181 1436880 HPB8_1466_1436181_1436880 
NC_014256 1437189 1438968 HPB8_1467_1437189_1438968 
NC_014256 1439172 1440629 HPB8_1468_1439172_1440629 
NC_014256 1440737 1441450 HPB8_1469_1440737_1441450 
NC_014256 1441664 1442608 HPB8_1470_1441664_1442608 
NC_014256 1442681 1443211 HPB8_1471_1442681_1443211 
NC_014256 1443334 1444205 HPB8_1472_1443334_1444205 
NC_014256 1451844 1453391 HPB8_1479_1451844_1453391 
NC_014256 1454670 1456410 HPB8_1483_1454670_1456410 
NC_014256 1456463 1456660 HPB8_1483_1456463_1456660 
NC_014256 1456974 1458746 HPB8_1484_1456974_1458746 
NC_014256 1459022 1459782 HPB8_1485_1459022_1459782 
NC_014256 1460226 1461234 HPB8_1487_1460226_1461234 
NC_014256 1461358 1461627 HPB8_1488_1461358_1461627 
NC_014256 1469466 1469786 HPB8_1499_1469466_1469786 
NC_014256 1469846 1472280 HPB8_1501_1469846_1472280 
NC_014256 1479664 1479873 HPB8_1511_1479664_1479873 
NC_014256 1480253 1483743 HPB8_1512_1480253_1483743 
NC_014256 1483779 1484083 HPB8_1513_1483779_1484083 
NC_014256 1484263 1485250 HPB8_1513_1484263_1485250 
NC_014256 1485309 1485432 HPB8_1514_1485309_1485432 
NC_014256 1485774 1486457 HPB8_1516_1485774_1486457 
NC_014256 1486597 1486775 HPB8_1517_1486597_1486775 
NC_014256 1491489 1491623 HPB8_1522_1491489_1491623 
NC_014256 1491980 1492073 HPB8_1523_1491980_1492073 
NC_014256 1492327 1492581 HPB8_1524_1492327_1492581 
NC_014256 1492944 1494526 HPB8_1525_1492944_1494526 
NC_014256 1499064 1499888 HPB8_1531_1499064_1499888 
NC_014256 1500032 1500230 HPB8_1532_1500032_1500230 
NC_014256 1500363 1501030 HPB8_1532_1500363_1501030 
NC_014256 1504805 1505208 HPB8_1535_1504805_1505208 
NC_014256 1505275 1505916 HPB8_1536_1505275_1505916 
NC_014256 1509706 1510553 HPB8_1539_1509706_1510553 
NC_014256 1510616 1511196 HPB8_1539_1510616_1511196 
NC_014256 1511431 1512084 HPB8_1540_1511431_1512084 
NC_014256 1512179 1513220 HPB8_1541_1512179_1513220 
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NC_014256 1516091 1516462 HPB8_1545_1516091_1516462 
NC_014256 1516712 1516824 HPB8_1546_1516712_1516824 
NC_014256 1516878 1517540 HPB8_1547_1516878_1517540 
NC_014256 1517582 1520065 HPB8_1548_1517582_1520065 
NC_014256 1520126 1520904 HPB8_1549_1520126_1520904 
NC_014256 1521135 1521966 HPB8_1551_1521135_1521966 
NC_014256 1522089 1522840 HPB8_1552_1522089_1522840 
NC_014256 1523039 1523900 HPB8_1552_1523039_1523900 
NC_014256 1524094 1524749 HPB8_1553_1524094_1524749 
NC_014256 1524823 1526398 HPB8_1553_1524823_1526398 
NC_014256 1526808 1527796 HPB8_1555_1526808_1527796 
NC_014256 1527837 1528492 HPB8_1556_1527837_1528492 
NC_014256 1533342 1533555 HPB8_1562_1533342_1533555 
NC_014256 1533701 1535103 HPB8_1563_1533701_1535103 
NC_014256 1535241 1535812 HPB8_1564_1535241_1535812 
NC_014256 1536130 1536315 HPB8_1566_1536130_1536315 
NC_014256 1536396 1538235 HPB8_1567_1536396_1538235 
NC_014256 1539415 1539829 HPB8_1570_1539415_1539829 
NC_014256 1539947 1540077 HPB8_1571_1539947_1540077 
NC_014256 1542768 1542946 HPB8_1574_1542768_1542946 
NC_014256 1547604 1547698 HPB8_1578_1547604_1547698 
NC_014256 1550131 1551551 HPB8_1582_1550131_1551551 
NC_014256 1554587 1555642 HPB8_1587_1554587_1555642 
NC_014256 1557418 1559297 HPB8_1591_1557418_1559297 
NC_014256 1559371 1559489 HPB8_1591_1559371_1559489 
NC_014256 1563304 1564557 HPB8_1597_1563304_1564557 
NC_014256 1564762 1566042 HPB8_1598_1564762_1566042 
NC_014256 1566602 1568518 HPB8_1600_1566602_1568518 
NC_014256 1568937 1569022 HPB8_1601_1568937_1569022 
NC_014256 1569305 1570865 HPB8_1603_1569305_1570865 
NC_014256 1573761 1575201 HPB8_1607_1573761_1575201 
NC_014256 1575430 1577371 HPB8_1608_1575430_1577371 
NC_014256 1577513 1577723 HPB8_1608_1577513_1577723 
NC_014256 1578468 1579295 HPB8_1611_1578468_1579295 
NC_014256 1582399 1584420 HPB8_1615_1582399_1584420 
NC_014256 1584765 1586291 HPB8_1616_1584765_1586291 
NC_014256 1586394 1586651 HPB8_1616_1586394_1586651 
NC_014256 1586778 1586864 HPB8_1617_1586778_1586864 
NC_014256 1591958 1592274 HPB8_1625_1591958_1592274 
NC_014256 1592733 1593476 HPB8_1626_1592733_1593476 
NC_014256 1593579 1593691 HPB8_1627_1593579_1593691 
NC_014256 1594223 1594618 HPB8_1629_1594223_1594618 
NC_014256 1594713 1594991 HPB8_1630_1594713_1594991 
NC_014256 1595090 1595878 HPB8_1631_1595090_1595878 
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NC_014256 1596725 1597737 HPB8_1633_1596725_1597737 
NC_014256 1599661 1600668 HPB8_1638_1599661_1600668 
NC_014256 1601274 1601676 HPB8_1639_1601274_1601676 
NC_014256 1603301 1603515 HPB8_1641_1603301_1603515 
NC_014256 1604522 1605271 HPB8_1644_1604522_1605271 
NC_014256 1605381 1606470 HPB8_1645_1605381_1606470 
NC_014256 1609811 1611876 HPB8_1652_1609811_1611876 
NC_014256 1612375 1613190 HPB8_1655_1612375_1613190 
NC_014256 1613336 1613932 HPB8_1656_1613336_1613932 
NC_014256 1614173 1614508 HPB8_1657_1614173_1614508 
NC_014256 1614619 1614865 HPB8_1657_1614619_1614865 
NC_014256 1614996 1615132 HPB8_1657_1614996_1615132 
NC_014256 1615372 1616024 HPB8_1658_1615372_1616024 
NC_014256 1616063 1616216 HPB8_1658_1616063_1616216 
NC_014256 1616402 1617568 HPB8_1659_1616402_1617568 
NC_014256 1618823 1619149 HPB8_1663_1618823_1619149 
NC_014256 1619307 1621134 HPB8_1664_1619307_1621134 
NC_014256 1621450 1621751 HPB8_1665_1621450_1621751 
NC_014256 1621918 1622715 HPB8_1665_1621918_1622715 
NC_014256 1637672 1638103 HPB8_1678_1637672_1638103 
NC_014256 1638181 1638488 HPB8_1679_1638181_1638488 
NC_014256 1643029 1643823 HPB8_1682_1643029_1643823 
NC_014256 1643879 1644890 HPB8_1683_1643879_1644890 
NC_014256 1645812 1646823 HPB8_1686_1645812_1646823 
NC_014256 1646954 1647721 HPB8_1688_1646954_1647721 
NC_014256 1648341 1649277 HPB8_1689_1648341_1649277 
NC_014256 1649353 1649877 HPB8_1690_1649353_1649877 
NC_014256 1650001 1650334 HPB8_1690_1650001_1650334 
NC_014256 1651543 1652027 HPB8_1692_1651543_1652027 
NC_014256 1652172 1653656 HPB8_1693_1652172_1653656 
NC_014256 1653699 1654534 HPB8_1694_1653699_1654534 
NC_014256 1654720 1655428 HPB8_1696_1654720_1655428 
NC_014256 1656572 1657225 HPB8_1699_1656572_1657225 
NC_014256 1657360 1658488 HPB8_1700_1657360_1658488 
NC_014256 1658692 1659647 HPB8_1701_1658692_1659647 
NC_014256 1660005 1662516 HPB8_1702_1660005_1662516 
NC_014256 1662620 1663327 HPB8_1703_1662620_1663327 
NC_014256 1663620 1666264 HPB8_1704_1663620_1666264 
NC_014256 1666391 1668838 HPB8_1705_1666391_1668838 
NC_014256 1669787 1669959 HPB8_1706_1669787_1669959 
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10.3. SelectionA - Gastric Adenocarcinoma Unique Domains 
CHR START END GENE_ID FOLDCHANGE ANNOTATION FLAG  
NC_000915 432871 432986 HP0418 9,40 hypothetical protein Sel A unique 
NC_000915 749410 749497 HP0696 8,29 N-methylhydantoinase Sel A unique 
NC_000915 880251 880485 HP0828 5,06 ATP synthase F0F1 subunit A Sel A unique 
NC_000915 555864 556076 HP0527 4,79 
cag pathogenicity island protein 
cag7 Sel A unique 
NC_000915 1051051 1051229 HP0988 4,51 IS605 transposase TnpA Sel A unique 
NC_000915 356709 356816 HP0349 4,41 CTP synthetase Sel A unique 
NC_000915 1194612 1194688 HP1132 3,45 ATP synthase F0F1 subunit beta Sel A unique 
NC_000915 70004 70177 HP0066 3,10 ATP-binding protein Sel A unique 
NC_000915 271337 271508 HP0262 2,93 hypothetical protein Sel A unique 
NC_000915 1061927 1062105 HP0998 2,89 IS605 transposase TnpA Sel A unique 
NC_000915 312869 313125 HP0295 2,55 
flagellar hook-associated protein 
FlgL Sel A unique 
NC_000915 1563976 1564163 HP1490 2,50 hypothetical protein Sel A unique 
NC_000915 979186 979349 HP0921 2,49 
glyceraldehyde-3-phosphate 
dehydrogenase Sel A unique 
NC_000915 320256 320492 HP0302 2,45 
dipeptide ABC transporter ATP-
binding protein DppF Sel A unique 
NC_000915 951212 951394 HP0898 2,35 
hydrogenase expression/formation 
protein HypD Sel A unique 
NC_000915 846725 846835 HP0790 2,28 
anti-codon nuclease masking 
agent PrrB Sel A unique 
NC_000915 1063457 1063650 HP1001 2,25 hypothetical protein Sel A unique 
NC_000915 588313 588527 HP0553 2,21 hypothetical protein Sel A unique 
NC_000915 106698 106847 HP0100 2,17 hypothetical protein Sel A unique 
NC_000915 5875 6023 HP0009 2,07 hypothetical protein Sel A unique 
NC_000915 1243612 1243805 HP1177 2,06 hypothetical protein Sel A unique 
NC_000915 999864 1000073 HP0939 1,91 
amino acid ABC transporter 
permease Sel A unique 
NC_000915 176025 176197 HP0169 1,89 collagenase PrtC Sel A unique 
NC_000915 1047284 1047501 HP0983 1,88 hypothetical protein Sel A unique 
NC_000915 1372726 1372975 HP1301 1,78 50S ribosomal protein L15 Sel A unique 
 
 
10.4. SelectionB - Autoimmune Gastritis Unique Domains 
CHR START END GENE_ID FOLDCHANGE ANNOTATION FLAG 
NC_000915 1004123 1004218 HP0943 8,98 
D-amino acid dehydrogenase 
DadA Sel B unique 
NC_000915 864151 864245 HP0809 8,55 flagellar basal body protein FliL Sel B unique 
NC_000915 1491923 1492043 HP1422 8,18 isoleucyl-tRNA synthetase Sel B unique 
NC_000915 512074 512214 HP0487 5,27 hypothetical protein Sel B unique 
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NC_000915 1073160 1073202 HP1010 4,71 polyphosphate kinase Sel B unique 
NC_000915 945751 945866 HP0892 4,57 hypothetical protein Sel B unique 
NC_000915 373124 373195 HP0363 3,99 
protein-L-isoaspartate O-
methyltransferase Sel B unique 
NC_000915 918695 918813 HP0867 3,76 ipid-A-disaccharide synthase Sel B unique 
NC_000915 1574664 1574835 HP1502 3,73 hypothetical protein Sel B unique 
NC_000915 1158327 1158505 HP1096 3,60 IS605 transposase TnpA Sel B unique 
NC_000915 1028615 1028881 HP0969 3,47 cation efflux system protein CzCA Sel B unique 
NC_000915 140452 141127 HP0130 3,34 hypothetical protein Sel B unique 
NC_000915 555284 556076 HP0527 3,12 
cag pathogenicity island protein 
cag7 Sel B unique 
NC_000915 475825 476089 HP0457 3,06 hypothetical protein Sel B unique 
NC_000915 749410 749655 HP0696 3,05 N-methylhydantoinase Sel B unique 
NC_000915 1564206 1564417 HP1490 3,01 hypothetical protein Sel B unique 
NC_000915 1558353 1558552 HP1486 2,96 hypothetical protein Sel B unique 
NC_000915 576113 576186 HP0544 2,87 
cag pathogenicity island protein 
cag23 Sel B unique 
NC_000915 106624 106910 HP0100 2,84 hypothetical protein Sel B unique 
NC_000915 721767 722123 HP0671 2,80 hypothetical protein Sel B unique 
NC_000915 406342 406513 HP0396 2,79 hypothetical protein Sel B unique 
NC_000915 811715 811947 HP0758 2,79 hypothetical protein Sel B unique 
NC_000915 1627113 1627477 HP1547 2,75 leucyl-tRNA synthetase Sel B unique 
NC_000915 882360 883007 HP0830 2,74 
aspartyl/glutamyl-tRNA 
amidotransferase subunit A Sel B unique 
NC_000915 627603 628013 HP0593 2,69 
adenine-specific DNA 
methyltransferase Sel B unique 
NC_000915 1399532 1399604 HP1340 2,67 biopolymer transport protein ExbD Sel B unique 
NC_000915 852233 852399 HP0795 2,63 trigger factor Sel B unique 
NC_000915 278658 278779 HP0269 2,60 
(dimethylallyl)adenosine tRNA 
methylthiotransferase Sel B unique 
NC_000915 1338786 1338916 HP1266 2,58 NADH dehydrogenase subunit G Sel B unique 
NC_000915 146944 147190 HP0136 2,56 
bacterioferritin comigratory protein 
Bcp Sel B unique 
NC_000915 143701 144124 HP0133 2,55 serine transporter SdaC Sel B unique 
NC_000915 477705 478199 HP0459 2,52 protein VirB4 Sel B unique 
NC_000915 328396 328584 HP0312 2,49 ATP-binding protein Sel B unique 
NC_000915 1374888 1375034 HP1306 2,34 30S ribosomal protein S14 Sel B unique 
NC_000915 902944 903171 HP0851 2,32 hypothetical protein Sel B unique 
NC_000915 519533 519950 HP0493 2,32 
phospho-N-acetylmuramoyl-
pentapeptide-transferase Sel B unique 
NC_000915 552880 553202 HP0525 2,31 virB11-like protein Sel B unique 
NC_000915 10215 11080 HP0012 2,28 DNA primase Sel B unique 
NC_000915 1583199 1583444 HP1509 2,27 
glycerol-3-phosphate 
acyltransferase PlsY Sel B unique 
NC_000915 1382149 1382490 HP1321 2,27 hypothetical protein Sel B unique 
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NC_000915 951075 951395 HP0898 2,27 
hydrogenase expression/formation 
protein HypD Sel B unique 
NC_000915 907649 907838 HP0855 2,26 alginate O-acetylation protein AlgI Sel B unique 
NC_000915 60676 60803 HP0056 2,23 
delta-1-pyrroline-5-carboxylate 
dehydrogenase Sel B unique 
NC_000915 1026447 1026625 HP0967 2,20 
virulence associated protein D 
vapD Sel B unique 
NC_000915 497151 497374 HP0475 2,16 
molybdenum ABC transporter 
ATP-binding protein ModD Sel B unique 
NC_000915 397190 397438 HP0387 2,12 primosome assembly protein PriA Sel B unique 
NC_000915 320109 320326 HP0302 2,09 
dipeptide ABC transporter ATP-
binding protein DppF Sel B unique 
NC_000915 1284797 1284992 HP1207 2,08 hypothetical protein Sel B unique 
NC_000915 1334949 1335478 HP1262 2,06 NADH dehydrogenase subunit C Sel B unique 
NC_000915 1545372 1545572 HP1472 2,03 
type IIS restriction enzyme M 
protein Sel B unique 
NC_000915 1107752 1108034 HP1045 1,99 acetyl-CoA synthetase Sel B unique 
NC_000915 798735 798907 HP0743 1,99 
rod shape-determining protein 
MreB Sel B unique 
NC_000915 1570699 1570993 HP1498 1,98 hypothetical protein Sel B unique 
NC_000915 1354475 1354543 HP1279 1,98 
bifunctional indole-3-glycerol 
phosphate synthase isomerase Sel B unique 
NC_000915 835626 835696 HP0781 1,95 hypothetical protein Sel B unique 
NC_000915 972820 972958 HP0916 1,95 
iron-regulated outer membrane 
protein FrpB Sel B unique 
NC_000915 1117318 1117518 HP1055 1,94 hypothetical protein Sel B unique 
NC_000915 511175 511376 HP0487 1,92 hypothetical protein Sel B unique 
NC_000915 1332564 1332994 HP1258 1,91 hypothetical protein Sel B unique 
NC_000915 880169 880334 HP0828 1,90 ATP synthase F0F1 subunit A Sel B unique 
NC_000915 536705 536926 HP0510 1,89 dihydrodipicolinate reductase Sel B unique 
NC_000915 298023 298185 HP0289 1,87 toxin-like outer membrane protein Sel B unique 
NC_000915 837963 838354 HP0783 1,87 hypothetical protein Sel B unique 
NC_000915 1656737 1657203 HP1577 1,86 ABC transporter permease Sel B unique 
NC_000915 709780 709958 HP0661 1,85 ribonuclease H Sel B unique 
NC_000915 170854 171136 HP0162 1,83 hypothetical protein Sel B unique 
NC_000915 329641 329835 HP0313 1,82 nitrite extrusion protein NarK Sel B unique 
NC_000915 1536901 1537293 HP1466 1,82 hypothetical protein Sel B unique 
NC_000915 803140 803421 HP0747 1,81 
tRNA (guanine-N(7)-)-
methyltransferase Sel B unique 
NC_000915 1176168 1176502 HP1114 1,77 excinuclease ABC subunit B Sel B unique 
NC_000915 16862 17194 HP0018 1,76 hypothetical protein Sel B unique 
NC_000915 1557886 1558193 HP1485 1,72 hypothetical protein Sel B unique 
NC_000915 1374255 1374313 HP1304 1,70 50S ribosomal protein L6 Sel B unique 
NC_000915 21826 21995 HP0022 1,69 
lipid A phosphoethanolamine 
transferase Sel B unique 
NC_000915 237376 237722 HP0228 1,68 hypothetical protein Sel B unique 
NC_000915 32679 32942 HP0033 1,64 ATP-dependent C1p protease Sel B unique 
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ClpA 
NC_000915 855368 855623 HP0799 1,62 
molybdenum cofactor biosynthesis 
protein MogA Sel B unique 
NC_000915 78559 78755 HP0074 1,61 lipoprotein signal peptidase Sel B unique 
NC_000915 61634 61828 HP0057 1,58 hypothetical protein Sel B unique 
NC_000915 854493 854659 HP0797 1,57 flagellar sheath adhesin hpaA Sel B unique 
NC_000915 524327 524527 HP0498 1,56 
sodium- and chloride-dependent 
transporter Sel B unique 
NC_000915 1544120 1544616 HP1471 1,53 
type IIS restriction enzyme R 
protein Sel B unique 
NC_000915 84756 85321 HP0080 1,52 hypothetical protein Sel B unique 
NC_000915 983327 983850 HP0922 1,52 toxin-like outer membrane protein Sel B unique 
NC_000915 1172395 1172634 HP1111 1,51 
ferrodoxin oxidoreductase subunit 
beta Sel B unique 
 
10.5. SelectionC - MALT lymphoma Unique Domains 
CHR START END GENE_ID FOLDCHANGE ANNOTATION FLAG  
NC_000915 556305 557066 HP0527 7,71 
cag pathogenicity island protein 
cag7 Sel C unique  
NC_000915 777672 777742 HP0724 5,24 
anaerobic C4-dicarboxylate 
transporter Sel C unique  
NC_000915 1585441 1585851 HP1512 5,04 
iron-regulated outer membrane 
protein FrpB Sel C unique  
NC_000915 204394 204591 HP0197 4,12 S-adenosylmethionine synthetase Sel C unique  
NC_000915 17965 18272 HP0018 3,45 hypothetical protein Sel C unique  
NC_000915 712341 712488 HP0665 3,18 coproporphyrinogen III oxidase Sel C unique  
NC_000915 1317869 1317975 HP1243 3,10 hypothetical protein Sel C unique  
NC_000915 274274 274470 HP0264 3,01 
ATP-dependent protease binding 
subunit ClpB Sel C unique  
NC_000915 477730 477960 HP0459 2,91 protein VirB4 Sel C unique  
NC_000915 203274 203353 HP0196 2,82 
UDP-3-O-[3-hydroxymyristoyl] 
glucosamine N-acyltransferase Sel C unique  
NC_000915 1626372 1626445 HP1547 2,72 leucyl-tRNA synthetase Sel C unique  
NC_000915 1461955 1462126 HP1400 2,62 
iron(III) dicitrate transport protein 
FecA Sel C unique  
NC_000915 983602 984010 HP0922 2,55 toxin-like outer membrane protein Sel C unique  
NC_000915 422464 422818 HP0409 2,35 GMP synthase Sel C unique  
NC_000915 1024311 1024404 HP0965 2,31 hypothetical protein Sel C unique  
NC_000915 1249755 1250123 HP1181 2,21 multidrug-efflux transporter Sel C unique  
NC_000915 221588 221643 HP0213 2,12 
tRNA uridine 5-
carboxymethylaminomethyl 
modification protein GidA Sel C unique  
NC_000915 484059 484302 HP0464 2,11 
type I restriction enzyme R protein 
HsdR Sel C unique  
NC_000915 1332625 1332798 HP1258 2,04 hypothetical protein Sel C unique  
NC_000915 827888 827994 HP0775 1,98 
penta-phosphate guanosine-3'-
pyrophosphohydrolase SpoT Sel C unique  
NC_000915 1241938 1242043 HP1175 1,96 hypothetical protein Sel C unique  
NC_000915 411221 411357 HP0400 1,94 
4-hydroxy-3-methylbut-2-enyl 
diphosphate reductase Sel C unique  
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NC_000915 1019626 1019879 HP0961 1,90 
NAD(P)H-dependent glycerol-3-
phosphate dehydrogenase Sel C unique  
NC_000915 1206023 1206430 HP1143 1,85 hypothetical protein Sel C unique  
NC_000915 933394 933665 HP0884 1,79 hypothetical protein Sel C unique  
NC_000915 1428027 1428285 HP1366 1,77 
type IIS restriction enzyme R 
protein Sel C unique  
NC_000915 795181 795399 HP0740 1,74 
UDP-MurNac-pentapeptide 
presynthetase MurF Sel C unique  
NC_000915 1584941 1585092 HP1512 1,60 
iron-regulated outer membrane 
protein FrpB Sel C unique  
 
10.6. Common Domains between Selection A-B-C 
CHR START END GENE_ID FOLDCHANGE  ANNOTATION FLAG  
NC_000915 607582 607662 HP0577 5,33 
bifunctional 5,10-methylene-
tetrahydrofolate dehydrogenase 
Common 
between Sel 
A-B-C 
NC_000915 1592925 1592985 HP1517 3,03 
type IIS restriction enzyme R and 
M protein 
Common 
between Sel 
A-B-C 
NC_000915 241192 241296 HP0231 2,49 hypothetical protein 
Common 
between Sel 
A-B-C 
NC_000915 414784 414866 HP0402 2,21 
phenylalanyl-tRNA synthetase 
subunit beta 
Common 
between Sel 
A-B-C 
NC_000915 1396381 1396472 HP1335 2,09 
tRNA-specific 2-thiouridylase 
MnmA 
Common 
between Sel 
A-B-C 
NC_000915 577358 577581 HP0544 2,03 
cag pathogenicity island protein 
cag23 
Common 
between Sel 
A-B-C 
NC_000915 1018926 1019099 HP0960 1,65 
glycyl-tRNA synthetase subunit 
alpha 
Common 
between Sel 
A-B-C 
NC_000915 1642827 1643112 HP1561 1,64 
iron(III) ABC transportersubstrate-
binding protein CeuE 
Common 
between Sel 
A-B-C 
 
10.7. Common Domains between Selection A-C 
CHR START END GENE_ID FOLDCHANGE ANNOTATION FLAG  
NC_000915 437431 437598 HP0422 4,18 arginine decarboxylase 
Common 
between Sel 
A-C 
NC_000915 195103 195230 HP0189 2,65 hypothetical protein 
Common 
between Sel 
A-C 
NC_000915 1345616 1345804 HP1272 2,16 NADH dehydrogenase subunit M 
Common 
between Sel 
A-C 
 
10.8. Common Domains between Selection A-B 
CHR START END GENE_ID FOLDCHANGE  ANNOTATION FLAG  
NC_000915 1031857 1031904 HP0971 9,41 hypothetical protein 
Common 
between Sel 
A-B 
NC_000915 1051051 1051229 HP0988 5,57 IS605 transposase TnpA 
Common 
between Sel 
A-B 
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NC_000915 1555522 1555630 HP1481 5,40 hypothetical protein 
Common 
between Sel 
A-B 
NC_000915 168551 168654 HP0159 4,95 
lipopolysaccharide 1,2-
glucosyltransferase RfaJ 
Common 
between Sel 
A-B 
NC_000915 1614604 1614782 HP1535 4,63 IS605 transposase TnpA 
Common 
between Sel 
A-B 
NC_000915 1552411 1552496 HP1479 4,55 hypothetical protein 
Common 
between Sel 
A-B 
NC_000915 454329 454507 HP0437 4,28 IS605 transposase TnpA 
Common 
between Sel 
A-B 
NC_000915 769890 769985 HP0715 4,13 
ABC transporter ATP-binding 
protein 
Common 
between Sel 
A-B 
NC_000915 1061927 1062105 HP0998 4,04 IS605 transposase TnpA 
Common 
between Sel 
A-B 
NC_000915 614191 614470 HP0583 3,61 hypothetical protein 
Common 
between Sel 
A-B 
NC_000915 951646 951852 HP0898 3,60 
hydrogenase expression/formation 
protein HypD 
Common 
between Sel 
A-B 
NC_000915 1030389 1030578 HP0970 3,52 
nickel-cobalt-cadmium resistance 
protein NccB 
Common 
between Sel 
A-B 
NC_000915 1380289 1380602 HP1319 3,47 50S ribosomal protein L3 
Common 
between Sel 
A-B 
NC_000915 1187149 1187265 HP1121 3,21 
cytosine specific DNA 
methyltransferase 
Common 
between Sel 
A-B 
NC_000915 797809 798321 HP0743 3,09 
rod shape-determining protein 
MreB 
Common 
between Sel 
A-B 
NC_000915 1579060 1579204 HP1506 2,86 glutamate permease GltS 
Common 
between Sel 
A-B 
NC_000915 512849 513141 HP0488 2,70 hypothetical protein 
Common 
between Sel 
A-B 
NC_000915 1278378 1278463 HP1201 2,61 50S ribosomal protein L1 
Common 
between Sel 
A-B 
NC_000915 1410757 1410897 HP1350 2,60 protease 
Common 
between Sel 
A-B 
NC_000915 731951 732085 HP0681 2,48 hypothetical protein 
Common 
between Sel 
A-B 
NC_000915 11805 12001 HP0013 2,33 hypothetical protein 
Common 
between Sel 
A-B 
NC_000915 51391 51625 HP0052 2,30 hypothetical protein 
Common 
between Sel 
A-B 
NC_000915 79748 80106 HP0075 2,10 phosphoglucosamine mutase 
Common 
between Sel 
A-B 
NC_000915 657675 658335 HP0613 1,76 
ABC transporter ATP-binding 
protein 
Common 
between Sel 
A-B 
NC_000915 1295199 1295391 HP1218 1,71 
glycinamide ribonucleotide 
synthetase PurD 
Common 
between Sel 
A-B 
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10.9. Common Domains between Selection B-C 
CHR START END GENE_ID FOLDCHANGE  ANNOTATION FLAG  
NC_000915 524080 524265 HP0498 3,72 
sodium- and chloride-dependent 
transporter 
Common 
between Sel 
B-C 
NC_000915 890884 891033 HP0839 3,41 
outer membrane protein P1 
ompP1 
Common 
between Sel 
B-C 
NC_000915 1037115 1037287 HP0974 2,74 phosphoglyceromutase 
Common 
between Sel 
B-C 
NC_000915 1243612 1243988 HP1177 2,60 hypothetical protein 
Common 
between Sel 
B-C 
NC_000915 1034744 1034877 HP0973 2,07 hypothetical protein 
Common 
between Sel 
B-C 
NC_000915 1317869 1317975 HP1243 1,90 hypothetical protein 
Common 
between Sel 
B-C 
NC_000915 999625 1000073 HP0939 1,76 
amino acid ABC transporter 
permease 
Common 
between Sel 
B-C 
NC_000915 1584941 1585092 HP1512 1,73 
iron-regulated outer membrane 
protein FrpB 
Common 
between Sel 
B-C 
NC_000915 1184140 1184277 HP1118 1,54 gamma-glutamyltranspeptidase 
Common 
between Sel 
B-C 
 
9.10. List of strains used for comparative analysis 
 
Strain Name  Strain ID 
H. pylori strain ausabrJ05  CP011485  
H. pylori strain PNG84A  CP011487  
H. pylori strain ML3  AP014712  
H. pylori strain ML3  AP014713  
H. pylori strain ML2  AP014711  
H. pylori strain ML1,  AP014710  
H. pylori strain L7  CP011482  
H. pylori strain K26A1  CP011486  
H. pylori strain DU15  CP011483  
H. pylori strain CC33C  CP011484  
H. pylori strain BM013B  CP007606  
H. pylori strain BM013A  CP007604  
H. pylori strain BM012B  CP007605  
H. pylori strain 29CaP  CP012907  
H. pylori oki828  CP006826  
H. pylori oki673  CP006825  
H. pylori oki422  CP006824  
H. pylori oki154 CP006823  
H. pylori oki128  CP006822  
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H. pylori oki112  CP006821  
H. pylori oki102  CP006820  
H. pylori XZ274  CP003419  
H. pylori UM299  CP005491  
H. pylori UM298  CP006610  
H. pylori UM066  CP005493  
H. pylori UM037  
H. pylori UM032  CP005490  
H. pylori SouthAfrica7  CP002336  
H. pylori SouthAfrica20  CP006691  
H. pylori Shi470  NC_010698  
H. pylori Shi417  CP003472  
H. pylori Shi169  CP003473  
H. pylori Shi112  CP003474  
H. pylori Sat464  CP002071  
H. pylori SNT49  CP002983  
H. pylori SJM180  NC_014560  
H. pylori Rif2  CP003906  
H. pylori Rif1  CP003905  
H. pylori Puno135  CP002982  
H. pylori Puno120  CP002980  
H. pylori PeCan4  NC_014555  
H. pylori PeCan18  CP003475  
H. pylori P12  NC_011498  
H. pylori OK310  AP012601  
H. pylori OK113  AP012600  
H. pylori NY40  AP014523  
H. pylori Lithuania75  CP002334  
H. pylori J99  NC_000921  
H. pylori J166  CP007603  
H. pylori India7  CP002331  
H. pylori Hp238  CP010013  
H. pylori HUP-B14  CP003486  
H. pylori HPAG1  NC_008086  
H. pylori Gambia94/24  CP002332  
H. pylori G27  NC_011333  
H. pylori F57  AP011945  
H. pylori F32  AP011943  
H. pylori F30  AP011941  
H. pylori F16  AP011940  
H. pylori ELS37  CP002953  
H. pylori Cuz20  CP002076  
H. pylori BM012S  CP006889  
H. pylori BM012A  CP006888  
H. pylori B8  NC_014256  
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H. pylori B38  NC_012973  
H. pylori Aklavik86  CP003476  
H. pylori Aklavik117  CP003483  
H. pylori 908  CP002184  
H. pylori 83  CP002605  
H. pylori 52  CP001680  
H. pylori 51  CP000012  
H. pylori 35A  CP002096  
H. pylori 26695-1MET  CP010436  
H. pylori 26695-1CL  AP013356  
H. pylori 26695 NC_000915 
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